154361-50-9 | 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$13.00	$9.00
5g	98%	in stock	$18.00	$12.00
10g	98%	in stock	$22.00	$15.00

Description

• Catalog Number: AB50481
• Chemical Name: 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine
• CAS Number: 154361-50-9
• Molecular Formula: C15H22FN3O6
• Molecular Weight: 359.3501
• MDL Number: MFCD00930626
• SMILES: CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)C

Computed Properties

• Complexity: 582
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 4
• Heavy Atom Count: 25
• Hydrogen Bond Acceptor Count: 7
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 7
• XLogP3: 0.6

Literature

• Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients.

  British journal of cancer 20161122

• Possible Pathways of Capecitabine-Induced Hand-Foot Syndrome.

  Chemical research in toxicology 20161017

• Breast cancer drugs dampen vascular functions by interfering with nitric oxide signaling in endothelium.

  Toxicology and applied pharmacology 20130601

• Hepatic colorectal cancer metastases showing a distinctive pattern of pathological response after metronomic capecitabine and bevacizumab.

  Medical oncology (Northwood, London, England) 20121201

• Effects of neo-adjuvant chemotherapy for oesophago-gastric cancer on neuro-muscular gastric function.

  Molecular biology reports 20121201

• Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case.

  International journal of radiation oncology, biology, physics 20121115

• Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20121101

• Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer.

  European journal of cancer (Oxford, England : 1990) 20121101

• Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma.

  Surgery 20121101

• Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}.

  Annals of oncology : official journal of the European Society for Medical Oncology 20121101

• A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20121101

• Targeted therapy in brain metastasis.

  Current opinion in oncology 20121101

• A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.

  Cancer chemotherapy and pharmacology 20121101

• Efficacy and safety of capecitabine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma.

  Anti-cancer drugs 20121101

• S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial.

  The Lancet. Oncology 20121101

• Phase I-II study of radiopeptide 177Lu-octreotate in combination with capecitabine and temozolomide in advanced low-grade neuroendocrine tumors.

  Cancer biotherapy & radiopharmaceuticals 20121101

• Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20121010

• Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours.

  British journal of cancer 20121009

• Optimizing the administration of fixed-dose rate gemcitabine plus capecitabine using an alternating-week schedule: a dose finding and early efficacy study in advanced pancreatic and biliary carcinomas.

  American journal of clinical oncology 20121001

• Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarcinoma: a retrospective review.

  American journal of clinical oncology 20121001

• Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab.

  The European journal of health economics : HEPAC : health economics in prevention and care 20121001

• Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies.

  Investigational new drugs 20121001

• Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008.

  Pharmacoepidemiology and drug safety 20121001

• Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study.

  International journal of colorectal disease 20121001

• Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20121001

• Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer.

  Journal of cancer research and clinical oncology 20121001

• Neuroendocrine tumor disease: an evolving landscape.

  Endocrine-related cancer 20121001

• Radiotherapy for nasopharyngeal carcinoma and combined capecitabine and nimotuzumab treatment for lung metastases in a liver transplantation recipient: a case experience of sustained complete response.

  Cancer biotherapy & radiopharmaceuticals 20121001

• Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy.

  Anticancer research 20121001

• [A case of recurrent gastric cancer showing partial response to capecitabine/CDDP after treatment with S-1/CDDP].

  Gan to kagaku ryoho. Cancer & chemotherapy 20121001

• [Cardiovascular complications of chemotherapy].

  Giornale italiano di cardiologia (2006) 20121001

• Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.

  British journal of cancer 20120925

• Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120915

• A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120910

• Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer.

  Medical oncology (Northwood, London, England) 20120901

• Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer.

  Head & neck 20120901

• Treatment decisions after diagnosis of metastatic colorectal cancer.

  Clinical colorectal cancer 20120901

• Capecitabine non-adherence: exploration of magnitude, nature and contributing factors.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120901

• Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence.

  International journal of radiation oncology, biology, physics 20120901

• Chemotherapy for the biliary tract cancers: moving toward improved survival time.

  Journal of gastrointestinal cancer 20120901

• Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120901

• Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120901

• Outcome of first line systemic treatment in elderly compared to younger patients with metastatic colorectal cancer: a retrospective analysis of the CAIRO and CAIRO2 studies of the Dutch Colorectal Cancer Group (DCCG).

  Acta oncologica (Stockholm, Sweden) 20120901

• Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer.

  Cancer chemotherapy and pharmacology 20120901

• Colon carcinoma in a child treated with oxaliplatin and antiangiogenic treatment regimens.

  Pediatric hematology and oncology 20120901

• Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120901

• Acute myocardial infarction after capecitabine treatment: not always vasospasm is responsible.

  Chinese medical journal 20120901

• Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study.

  Anticancer research 20120901

• Cetuximab in preoperative treatment of rectal cancer - term outcome of the XERT trial.

  Radiology and oncology 20120901

• Identification of novel germline polymorphisms governing capecitabine sensitivity.

  Cancer 20120815

• A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications.

  British journal of cancer 20120807

• Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants.

  Fundamental & clinical pharmacology 20120801

• Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies.

  Investigational new drugs 20120801

• Biologic therapies in the metastatic colorectal cancer treatment continuum--applying current evidence to clinical practice.

  Cancer treatment reviews 20120801

• Increased mean corpuscular volume of erythrocytes predicts the response to metronomic cyclophosphamide, capecitabine and bevacizumab treatment: is it true for capecitabine treatment or more?

  Breast (Edinburgh, Scotland) 20120801

• Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20120801

• Sorafenib in locally advanced or metastatic breast cancer.

  Expert opinion on investigational drugs 20120801

• Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment.

  Neuromuscular disorders : NMD 20120801

• Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: a retrospective analysis of pooled data from 2 phase III randomized clinical trials.

  Clinical breast cancer 20120801

• Intrahepatic and systemic therapy with oxaliplatin combined with capecitabine in patients with hepatic metastases from breast cancer.

  Breast (Edinburgh, Scotland) 20120801

• Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters.

  Cancer chemotherapy and pharmacology 20120801

• Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.

  Anti-cancer drugs 20120801

• Synthesis and biological activity evaluation of cytidine-5'-deoxy-5-fluoro-N-[(alkoxy/aryloxy)] carbonyl-cyclic 2',3'-carbonates.

  European journal of medicinal chemistry 20120801

• Targeting angiogenesis in metastatic breast cancer.

  The oncologist 20120801

• Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinoma.

  Anticancer research 20120801

• Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II-III rectal cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120801

• [A case of metastatic pancreatic cancer which trastuzumab+capecitabine combination therapy was effective].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120801

• Adjuvant treatments for triple-negative breast cancers.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120801

• Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge.

  Cancer letters 20120728

• A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20120715

• Resected pancreatic neuroendocrine tumors: patterns of failure and disease-related outcomes with or without radiotherapy.

  International journal of radiation oncology, biology, physics 20120715

• Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer.

  International journal of radiation oncology, biology, physics 20120715

• Clinical and laboratory biomarkers in the management of pancreatic adenocarcinoma.

  JOP : Journal of the pancreas 20120710

• Clinical studies in the second line setting of advanced pancreatic cancer: are we making any progress?

  JOP : Journal of the pancreas 20120710

• Update on novel therapies for pancreatic neuroendocrine tumors.

  JOP : Journal of the pancreas 20120710

• Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20120701

• Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.

  Journal of hepato-biliary-pancreatic sciences 20120701

• Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.

  Annals of surgical oncology 20120701

• Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy.

  International journal of radiation oncology, biology, physics 20120701

• Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetaxel plus capecitabine.

  Journal of cancer research and clinical oncology 20120701

• Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis.

  Anti-cancer drugs 20120701

• Role of chemotherapy in treatments for biliary tract cancer.

  Journal of hepato-biliary-pancreatic sciences 20120701

• Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer.

  Breast cancer research and treatment 20120701

• The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix.

  European journal of obstetrics, gynecology, and reproductive biology 20120701

• X-ACT: an important step on an unfinished journey.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120701

• Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity.

  Breast cancer research and treatment 20120701

• A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103).

  Breast cancer research and treatment 20120701

• Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53.

  Cancer chemotherapy and pharmacology 20120701

• Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases.

  Cancer biology & therapy 20120701

• A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard).

  The oncologist 20120701

• Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20120701

• A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20120701

• SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120701

• Efficacy of combination chemotherapy using oral fluoropyrimidine S-1 with oxaliplatin (SOX) against colorectal cancer in vivo.

  Anticancer research 20120701

• [A case of HER2-positive breast cancer receiving lapatinib+capecitabine chemotherapy with ventriculoperitoneal shunting for hydrocephalus associated with brain metastases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120701

• New insights and emerging therapies for breast cancer brain metastases.

  Oncology (Williston Park, N.Y.) 20120701

• Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients.

  Pharmacogenomics 20120701

• Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer.

  Cancer 20120615

• Prospective phase I study of capecitabine and oxaliplatin concurrent with radiation therapy for the treatment of locally advanced pancreatic adenocarcinoma, and retrospective comparison to concurrent 5-fluorouracil/radiation and gemcitabine/radiation.

  Journal of gastrointestinal cancer 20120601

• Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer.

  Medical oncology (Northwood, London, England) 20120601

• Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients.

  Medical oncology (Northwood, London, England) 20120601

• Phase II, multicenter, uncontrolled trial of single-agent capecitabine in patients with non-clear cell metastatic renal cell carcinoma.

  American journal of clinical oncology 20120601

• Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinoma.

  American journal of clinical oncology 20120601

• Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer.

  American journal of clinical oncology 20120601

• A phase I trial of vandetanib combined with capecitabine, oxaliplatin and bevacizumab for the first-line treatment of metastatic colorectal cancer.

  Investigational new drugs 20120601

• A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.

  Investigational new drugs 20120601

• 5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trials.

  Medical oncology (Northwood, London, England) 20120601

• The fate of camptothecin glycoconjugate: report of a clinical hold during a phase II study of BAY 56-3722 (formerly BAY 38-3441), in patients with recurrent or metastatic colorectal cancer resistant/refractory to irinotecan.

  Investigational new drugs 20120601

• A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy.

  Investigational new drugs 20120601

• Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial.

  Medical oncology (Northwood, London, England) 20120601

• Capecitabine for the treatment for advanced gastric cancer: efficacy, safety and ethnicity.

  Journal of clinical pharmacy and therapeutics 20120601

• The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120601

• Kounis syndrome is likely culprit of coronary vasospasm induced by capecitabine.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120601

• Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120601

• Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120601

• Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.

  International journal of radiation oncology, biology, physics 20120601

• Beyond taxanes: the next generation of microtubule-targeting agents.

  Breast cancer research and treatment 20120601

• Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer.

  Clinical colorectal cancer 20120601

• Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.

  International journal of radiation oncology, biology, physics 20120601

• The predictive value of single nucleotide polymorphisms in the VEGF system to the efficacy of first-line treatment with bevacizumab plus chemotherapy in patients with metastatic colorectal cancer: results from the Nordic ACT trial.

  International journal of colorectal disease 20120601

• Literature review and practical aspects on the management of oxaliplatin-associated toxicity.

  Clinical colorectal cancer 20120601

• The effect of the introduction of the ERAS protocol in laparoscopic total mesorectal excision for rectal cancer.

  International journal of colorectal disease 20120601

• A observational study of the efficacy and safety of capecitabine versus bolus infusional 5-fluorouracil in pre-operative chemoradiotherapy for locally advanced rectal cancer.

  International journal of colorectal disease 20120601

• Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab.

  Breast (Edinburgh, Scotland) 20120601

• Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers.

  Angiogenesis 20120601

• Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial.

  Breast cancer research and treatment 20120601

• A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine.

  European journal of endocrinology 20120601

• A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.

  Clinical and experimental nephrology 20120601

• Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy.

  Anti-cancer drugs 20120601

• Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.

  The Lancet. Oncology 20120601

• Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity.

  Clinical breast cancer 20120601

• Capecitabine-induced systemic lupus erythematosus and palmoplantar erythrodysesthesia.

  Journal of drugs in dermatology : JDD 20120601

• Capecitabine in the treatment of rectal cancer.

  The Lancet. Oncology 20120601

• Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells.

  Journal of gastrointestinal and liver diseases : JGLD 20120601

• [Impact of AJCC staging system (2010 edition) on the choice of postoperative adjuvant chemotherapy after radical resection of gastric cancer].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20120601

• Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimen.

  Translational oncology 20120601

• A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20120601

• A phase II study of capecitabine and lapatinib in advanced refractory colorectal adenocarcinoma: A Wisconsin Oncology Network study.

  Journal of gastrointestinal oncology 20120601

• Lessons from the other side of the Atlantic.

  Prescrire international 20120601

• [Breast cancer and the hand-foot syndrome].

  Soins; la revue de reference infirmiere 20120601

• The role of capecitabine in locally advanced rectal cancer treatment: an update.

  Drugs 20120528

• Correlation of bevacizumab-induced hypertension and outcome in the BOXER study, a phase II study of capecitabine, oxaliplatin (CAPOX) plus bevacizumab as peri-operative treatment in 45 patients with poor-risk colorectal liver-only metastases unsuitable for upfront resection.

  British journal of cancer 20120522

• Multilevel latent variable models for global health-related quality of life assessment.

  Statistics in medicine 20120520

• Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120510

• A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management?

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20120501

• Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120501

• Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda.

  Breast cancer research and treatment 20120501

• A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120501

• Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120501

• Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease.

  Annals of surgical oncology 20120501

• Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.

  Acta oncologica (Stockholm, Sweden) 20120501

• HER2 testing in gastric cancer: a practical approach.

  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20120501

• Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer.

  Cancer chemotherapy and pharmacology 20120501

• A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20120501

• Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer. Treatment outcome outside clinical trials.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120501

• Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120501

• Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future.

  Upsala journal of medical sciences 20120501

• Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity.

  Expert opinion on drug metabolism & toxicology 20120501

• Eribulin mesylate: a novel halichondrin B analogue for the treatment of metastatic breast cancer.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120501

• Advances in first-line treatment for patients with HER-2+ metastatic breast cancer.

  The oncologist 20120501

• [Chemotherapy in elderly frail patients with advanced colorectal cancer. MRC FOCUS 2 (UK Medical Research Council Fluorouracil, Oxaliplatin, and Capecitabine: Use and Sequencing)].

  Der Internist 20120501

• [Side effect analyses in consideration of renal functions for capecitabine-administered patients].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120501

• [A case of primary adenocarcinoma of small intestine responding to XELOX chemotherapy and leading to a partial metabolic response].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120501

• Combinational therapy: new hope for pancreatic cancer?

  Cancer letters 20120428

• First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120415

• Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy.

  The pharmacogenomics journal 20120401

• A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.

  Investigational new drugs 20120401

• TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab.

  Breast cancer research and treatment 20120401

• Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40).

  Breast cancer research and treatment 20120401

• Oral vinorelbine in metastatic breast cancer: a review of current clinical trial results.

  Cancer treatment reviews 20120401

• Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II).

  Breast cancer research and treatment 20120401

• Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120401

• Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120401

• A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.

  Cancer chemotherapy and pharmacology 20120401

• Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review.

  Breast cancer research and treatment 20120401

• Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer.

  Cancer chemotherapy and pharmacology 20120401

• Phase II multicenter trial of albumin-bound paclitaxel and capecitabine in first-line treatment of patients with metastatic breast cancer.

  Clinical breast cancer 20120401

• A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20120401

• The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.

  Langenbeck's archives of surgery 20120401

• Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysis.

  Pharmacogenetics and genomics 20120401

• First-line treatment with capecitabine combined with irinotecan in patients with advanced colorectal carcinoma: a phase II study.

  Journal of clinical gastroenterology 20120401

• Capecitabine monotherapy: review of studies in first-line HER-2-negative metastatic breast cancer.

  The oncologist 20120401

• Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trial.

  Clinical breast cancer 20120401

• Treating metastatic breast cancer with systemic chemotherapies: current trends and future perspectives.

  Clinical journal of oncology nursing 20120401

• Phase II study of bevacizumab in combination with trastuzumab and capecitabine as first-line treatment for HER-2-positive locally recurrent or metastatic breast cancer.

  The oncologist 20120401

• Lapatinib for advanced or metastatic breast cancer.

  The oncologist 20120401

• Bilateral acute ptosis leading to the diagnosis of a presumed metastatic gastric adenocarcinoma.

  Orbit (Amsterdam, Netherlands) 20120401

• Adjuvant chemoradiation with 5-fluorouracil or capecitabine in patients with gastric cancer after D2 nodal dissection.

  Anticancer research 20120401

• Phase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer.

  Current oncology (Toronto, Ont.) 20120401

• Incidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008.

  Croatian medical journal 20120401

• The optimal selection of radiotherapy treatment for hepatocellular carcinoma.

  Gut and liver 20120401

• Prognostic significance of the lymph node ratio regarding recurrence and survival in rectal cancer patients treated with postoperative chemoradiotherapy.

  Gut and liver 20120401

• Temozolomide in aggressive pituitary adenomas and carcinomas.

  Clinics (Sao Paulo, Brazil) 20120401

• Kinase inhibitors for advanced medullary thyroid carcinoma.

  Clinics (Sao Paulo, Brazil) 20120401

• Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120320

• Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20120315

• Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer.

  British journal of cancer 20120313

• Management of borderline resectable pancreatic adenocarcinoma.

  JOP : Journal of the pancreas 20120310

• Is there a role of radiotherapy in the management of pancreatic neuroendocrine tumors (PNET)?

  JOP : Journal of the pancreas 20120310

• Capecitabine 'metronomic' chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy.

  Medical oncology (Northwood, London, England) 20120301

• Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120301

• Accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer.

  The British journal of radiology 20120301

• Retinal vein thrombosis in a patient with metastatic colon cancer receiving XELOX chemotherapy combined with bevacizumab pre-hepatic resection.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120301

• Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120301

• Unilateral hand-foot syndrome: does it take sides? Case report and literature review.

  Clinical colorectal cancer 20120301

• Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study.

  Clinical colorectal cancer 20120301

• Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.

  Cancer chemotherapy and pharmacology 20120301

• Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX.

  Cancer chemotherapy and pharmacology 20120301

• [Renal insufficiency and breast cancer].

  Bulletin du cancer 20120301

• Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis.

  Molecular nutrition & food research 20120301

• Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer.

  Scandinavian journal of gastroenterology 20120301

• Taxane-based mono- or combination therapy for managing metastatic breast cancer (MBC) in routine practice: a multinational prospective observational study.

  Current medical research and opinion 20120301

• Reliability of tumor primary cultures as a model for drug response prediction: expression profiles comparison of tissues versus primary cultures from colorectal cancer patients.

  Journal of cancer research and clinical oncology 20120301

• A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer.

  Angiogenesis 20120301

• A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.

  European journal of cancer (Oxford, England : 1990) 20120301

• Current treatment options for metastatic head and neck cancer.

  Current treatment options in oncology 20120301

• Combining capecitabine and bevacizumab in metastatic breast cancer: a comprehensive review.

  European journal of cancer (Oxford, England : 1990) 20120301

• Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120301

• Current management and future strategies of gastric cancer.

  Yonsei medical journal 20120301

• First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study.

  The oncologist 20120301

• Capecitabine and weekly paclitaxel as first-line therapy in Thai patients with metastatic breast cancer.

  Asia-Pacific journal of clinical oncology 20120301

• A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysis.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120301

• Cisplatin with capecitabine: tolerance and activity in a phase I/II study preferentially enrolling patients with gastric cancer.

  Anticancer research 20120301

• [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].

  Annales de dermatologie et de venereologie 20120301

• Adenocarcinoma arising in a duplication of the cecum.

  The Korean journal of internal medicine 20120301

• Severe hypertriglyceridaemia associated with the use of capecitabine.

  The Netherlands journal of medicine 20120301

• [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120301

• [A case of breast cancer with large cancer ulcer and multiple bone and liver metastasis responding to combination therapy of radiation and chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120301

• [A case of resected rectal cancer with hepatic node and multiple liver metastases effectively treated by preoperative modified FOLFOX6 and sLV5FU2 chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120301

• Targeted therapy for hepatocellular carcinoma: novel agents on the horizon.

  Oncotarget 20120301

• A case report of breast cancer with extensive pulmonary lymphovascular tumor emboli.

  Journal of breast cancer 20120301

• Present status and problems on molecular targeted therapy of cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20120301

• Prognostic Impact of Polymorphisms in the CASPASE Genes on Survival of Patients with Colorectal Cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20120301

• Five cases report of solid tumor synchronously with hematologic malignancy.

  Cancer research and treatment : official journal of Korean Cancer Association 20120301

• Update of adjuvant chemotherapy for resected gastric cancer.

  Journal of gastric cancer 20120301

• Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer.

  Collegium antropologicum 20120301

• Developments in metastatic pancreatic cancer: is gemcitabine still the standard?

  World journal of gastroenterology 20120227

• Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer.

  Investigational new drugs 20120201

• Phase I study of oral irinotecan as a single-agent and given sequentially with capecitabine.

  Investigational new drugs 20120201

• Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer.

  Investigational new drugs 20120201

• Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer.

  International journal of radiation oncology, biology, physics 20120201

• Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20120201

• TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres.

  Gut 20120201

• A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial.

  Annals of surgical oncology 20120201

• T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen.

  Annals of surgical oncology 20120201

• A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma.

  Cancer chemotherapy and pharmacology 20120201

• Dose adaptation of capecitabine based on individual prediction of limiting toxicity grade: evaluation by clinical trial simulation.

  Cancer chemotherapy and pharmacology 20120201

• Risk of thromboembolic events after perioperative chemotherapy versus surgery alone for esophageal adenocarcinoma.

  Annals of surgical oncology 20120201

• The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis.

  Cancer chemotherapy and pharmacology 20120201

• Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20120201

• Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study.

  Cancer chemotherapy and pharmacology 20120201

• An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study.

  Cancer chemotherapy and pharmacology 20120201

• Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20120201

• Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: a pooled subset analysis of two phase III studies.

  Breast (Edinburgh, Scotland) 20120201

• Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?

  Anti-cancer agents in medicinal chemistry 20120201

• Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts.

  Oncology reports 20120201

• Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial.

  Breast cancer research and treatment 20120201

• Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer.

  Journal of cancer research and clinical oncology 20120201

• Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

  Endocrine 20120201

• Evaluation of oral chemotherapy with capecitabine and cyclophosphamide plus thalidomide and prednisone in prostate cancer patients.

  Journal of cancer research and clinical oncology 20120201

• Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials.

  Clinical breast cancer 20120201

• Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.

  Cancer research 20120201

• Sudden death related to toxicity in a patient on capecitabine and irinotecan plus bevacizumab intake: pharmacogenetic implications.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120201

• Genomics and pharmacogenomics of pancreatic adenocarcinoma.

  The pharmacogenomics journal 20120201

• [Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120201

• Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis.

  APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20120201

• Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours.

  Endocrine-related cancer 20120201

• Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430.

  The oncologist 20120201

• Chemotherapy and fingerprint loss: beyond cosmetic.

  The oncologist 20120201

• [A case of breast cancer with brain metastases responding to paclitaxel and capecitabine therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120201

• Adjuvant chemotherapy in early breast cancer.

  Minerva ginecologica 20120201

• Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions.

  Future oncology (London, England) 20120201

• More than 7-year survival of a patient following repeat hepatectomy for total 20 colon cancer liver metastases.

  Journal of the Korean Surgical Society 20120201

• Lutetium-labelled peptides for therapy of neuroendocrine tumours.

  European journal of nuclear medicine and molecular imaging 20120201

• Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC).

  British journal of cancer 20120131

• Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

  Lancet (London, England) 20120128

• Bevacizumab added to neoadjuvant chemotherapy for breast cancer.

  The New England journal of medicine 20120126

• [Acute coronary syndrome in patient treated with capecitabine].

  Medicina clinica 20120121

• Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120120

• Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer.

  Cancer 20120115

• Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer.

  British journal of cancer 20120103

• Prognostic significance of human apurinic/apyrimidinic endonuclease (APE/Ref-1) expression in rectal cancer treated with preoperative radiochemotherapy.

  International journal of radiation oncology, biology, physics 20120101

• Etoposide, mitomycin, and methotrexate combination in heavily treated breast cancer: a retrospective study.

  Breast cancer (Tokyo, Japan) 20120101

• First-line bevacizumab-containing therapy for breast cancer: results in patients aged≥70 years treated in the ATHENA study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120101

• Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120101

• A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20120101

• Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial.

  Cancer chemotherapy and pharmacology 20120101

• A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen).

  Cancer chemotherapy and pharmacology 20120101

• A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine.

  Cancer chemotherapy and pharmacology 20120101

• Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial.

  European journal of cancer (Oxford, England : 1990) 20120101

• Preoperative treatment with capecitabine, bevacizumab and radiotherapy for primary locally advanced rectal cancer--a two stage phase II clinical trial.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120101

• Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer.

  European journal of cancer (Oxford, England : 1990) 20120101

• Combination of conservative and interventional therapy strategies for intra- and extrahepatic cholangiocellular carcinoma: a retrospective survival analysis.

  Gastroenterology research and practice 20120101

• Targeting the tumor microenvironment: focus on angiogenesis.

  Journal of oncology 20120101

• Resolving actinic keratoses: an expected side-effect of capecitabine therapy.

  Clinical and experimental dermatology 20120101

• Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.

  Breast cancer research and treatment 20120101

• Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120101

• Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors.

  Digestive diseases and sciences 20120101

• A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer.

  Breast cancer research and treatment 20120101

• Tumor angiogenesis: pericytes and maturation are not to be ignored.

  Journal of oncology 20120101

• Lack of efficacy of combined antiangiogenic therapies in xenografted human melanoma.

  Journal of oncology 20120101

• Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

  Gut 20120101

• Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120101

• Basal breast cancer: a complex and deadly molecular subtype.

  Current molecular medicine 20120101

• Reporting of adjuvant breast cancer trials: when is the right time?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120101

• Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120101

• Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.

  Acta oncologica (Stockholm, Sweden) 20120101

• Oxaliplatin: a review of approved uses.

  Expert opinion on pharmacotherapy 20120101

• Capecitabine induced cardiotoxicity: a case report and review of literature.

  Pakistan journal of pharmaceutical sciences 20120101

• Inoperable pancreatic adenocarcinoma rendered complete remission by high-intensity focused ultrasound concurrent with gemcitabine-capecitabine chemotherapy: case report and topic review.

  Journal of digestive diseases 20120101

• Adverse event profiles of 5-fluorouracil and capecitabine: data mining of the public version of the FDA Adverse Event Reporting System, AERS, and reproducibility of clinical observations.

  International journal of medical sciences 20120101

• Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway.

  International journal of biological sciences 20120101

• Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials.

  Journal of Cancer 20120101

• First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study.

  The oncologist 20120101

• Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service.

  PloS one 20120101

• CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab.

  Cancer investigation 20120101

• Aflibercept in the treatment of metastatic colorectal cancer.

  Clinical Medicine Insights. Oncology 20120101

• Treatment of high-risk gastric cancer postoperatively using intensity-modulated radiotherapy: a single-institution experience.

  Hepato-gastroenterology 20120101

• Comparing cystatin C changes as a measure of renal function before and after radiotherapy in patients with stomach cancer.

  Acta medica Iranica 20120101

• Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.

  PloS one 20120101

• Cancers of unknown primary origin: current perspectives and future therapeutic strategies.

  Journal of translational medicine 20120101

• Biomarkers for antitumor activity of bevacizumab in gastric cancer models.

  BMC cancer 20120101

• Monoclonal antibodies and Fc fragments for treating solid tumors.

  Biologics : targets & therapy 20120101

• Eribulin mesylate in the treatment of metastatic breast cancer.

  Biologics : targets & therapy 20120101

• Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer.

  Journal of oncology 20120101

• Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology.

  Frontiers in pharmacology 20120101

• Busulphan-cyclophosphamide cause endothelial injury, remodeling of resistance arteries and enhanced expression of endothelial nitric oxide synthase.

  PloS one 20120101

• A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer.

  Chemotherapy 20120101

• MiRNAs and LincRNAs: Could they be considered as biomarkers in colorectal cancer?

  International journal of molecular sciences 20120101

• Phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibition [corrected].

  Journal of translational medicine 20120101

• A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.

  Oncology 20120101

• Dilated cardiomyopathy following trastuzumab chemotherapy.

  Indian journal of pharmacology 20120101

• Irinotecan-induced dysarthria.

  Case reports in oncology 20120101

• Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

  Radiation oncology (London, England) 20120101

• First efficacy results of capecitabine with anthracycline- and taxane-based adjuvant therapy in high-risk early breast cancer: a meta-analysis.

  PloS one 20120101

• The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer.

  BMC cancer 20120101

• Long-term treatment of metastatic colorectal cancer with panitumumab.

  Clinical Medicine Insights. Oncology 20120101

• Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups.

  BMC cancer 20120101

• Insight into 144 patients with ocular vascular events during VEGF antagonist injections.

  Clinical ophthalmology (Auckland, N.Z.) 20120101

• Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine.

  OncoTargets and therapy 20120101

• Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?

  BMC cancer 20120101

• Efficacy and tolerability of lapatinib in the management of breast cancer.

  Breast cancer : basic and clinical research 20120101

• Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study.

  BMC research notes 20120101

• Triple-negative breast cancer: an update on neoadjuvant clinical trials.

  International journal of breast cancer 20120101

• SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation.

  BMC surgery 20120101

• Contribution of case reports to brain metastases research: systematic review and analysis of pattern of citation.

  PloS one 20120101

• Hepatic arterial therapy with drug-eluting beads in the management of metastatic pancreatic carcinoma to the liver: a multi-institutional registry.

  Journal of oncology 20120101

• HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature.

  Journal of Cancer 20120101

• The anatomic course of the first jejunal branch of the superior mesenteric vein in relation to the superior mesenteric artery.

  International journal of surgical oncology 20120101

• Lapatinib-based therapy in heavily pretreated HER2-positive metastatic breast cancer: a single institution experience.

  Tumori 20120101

• High lapatinib plasma levels in breast cancer patients: risk or benefit?

  Tumori 20120101

• A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer.

  Swiss medical weekly 20120101

• Analysis of polymorphisms and haplotype structure of the human thymidylate synthase genetic region: a tool for pharmacogenetic studies.

  PloS one 20120101

• Cyclodextrin-containing polymers: versatile platforms of drug delivery materials.

  Journal of drug delivery 20120101

• Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer.

  Cancer management and research 20120101

• Soft-tissue metastasis revealing a pancreatic adenocarcinoma: one case report and a review of literature.

  The Pan African medical journal 20120101

• Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations.

  Clinical Medicine Insights. Oncology 20120101

• Treatment of liver metastases in patients with neuroendocrine tumors of gastroesophageal and pancreatic origin.

  International journal of hepatology 20120101

• A multimodal approach to the management of neuroendocrine tumour liver metastases.

  International journal of hepatology 20120101

• Comparison of three a-priori models in the prediction of serum lithium concentration.

  Indian journal of pharmacology 20120101

• Fertility-sparing surgery in early epithelial ovarian cancer: a viable option?

  Obstetrics and gynecology international 20120101

• [Late-onset leukoencephalopathy induced by long-term chemotherapy with capecitabine and cyclophosphamide for liver metastasis from breast cancer].

  Rinsho shinkeigaku = Clinical neurology 20120101

• Portal vein thrombosis after restorative proctocolectomy for familial adenomatous polyposis and sigmoid cancer.

  Case reports in gastroenterology 20120101

• Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy.

  Hepato-gastroenterology 20120101

• Trastuzumab and Gemcitabine in Pretreated HER2 Overexpressing Metastatic Breast Cancer Patients: Retrospective Analysis of Our Series.

  Journal of oncology 20120101

• Effect of angiogenesis inhibitor bevacizumab on survival in patients with cancer: a meta-analysis of the published literature.

  PloS one 20120101

• Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update.

  TheScientificWorldJournal 20120101

• Giant epithelial malignancies (Basal cell carcinoma, squamous cell carcinoma): a series of 20 tumors from a single center.

  Journal of cutaneous and aesthetic surgery 20120101

• Does external beam radiation therapy improve survival following transarterial chemoembolization for unresectable hepatocellular carcinoma?

  Gastrointestinal cancer research : GCR 20120101

• Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancer.

  PloS one 20120101

• Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesothelioma.

  PloS one 20120101

• Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA.

  PloS one 20120101

• Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levels.

  PloS one 20120101

• Combination drug delivery approaches in metastatic breast cancer.

  Journal of drug delivery 20120101

• Metastatic squamous cell carcinoma of the anus: time for a shift in the treatment paradigm?

  ISRN oncology 20120101

• Docetaxel-induced hand foot syndrome: 'No dose is a safe dose'.

  Journal of pharmacology & pharmacotherapeutics 20120101

• Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone.

  Journal of oncology 20120101

• Carcinomatous pericarditis in 3 breast cancer patients with long-term survival.

  Case reports in oncology 20120101

• Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer.

  International journal of breast cancer 20120101

• Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity.

  International journal of nanomedicine 20120101

• Hepatocellular carcinoma: focus on different aspects of management.

  ISRN oncology 20120101

• Current knowledge on pancreatic cancer.

  Frontiers in oncology 20120101

• Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancer.

  Frontiers in oncology 20120101

• Locally advanced cancer of the esophagus, current treatment strategies, and future directions.

  Frontiers in oncology 20120101

• Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism.

  PloS one 20120101

• Therapeutic strategies based on polymeric microparticles.

  Journal of biomedicine & biotechnology 20120101

• Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma.

  Case reports in oncology 20120101

• PSA Response to Lenalidomide Therapy in a Pre-Treated Patient with Metastatic Prostate Cancer Refractory to Hormones and Chemotherapy: A Case Report.

  Case reports in oncology 20120101

• Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma.

  PloS one 20120101

• A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas.

  International journal of surgical oncology 20120101

• Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial.

  ISRN oncology 20120101

• KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors.

  PloS one 20120101

• The current state of targeted agents in rectal cancer.

  International journal of surgical oncology 20120101

• Is palliative laparoscopic hyperthermic intraperitoneal chemotherapy effective in patients with malignant hemorrhagic ascites?

  Case reports in gastroenterology 20120101

• Complete Response of Isolated Para-aortic Lymph Node Recurrence from Rectosigmoid Cancer Treated by Chemoradiation Therapy with Capecitabine/Oxaliplatin plus Bevacizumab: A Case Report.

  Case reports in oncology 20120101

• Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study.

  Radiation oncology (London, England) 20120101

• An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.

  Case reports in medicine 20120101

• Significant association between hand-foot syndrome and efficacy of capecitabine in patients with metastatic breast cancer.

  Biological & pharmaceutical bulletin 20120101

• Emerging new therapeutic applications of capecitabine as a first-line chemotherapeutic agent in the management of advanced carcinomas other than colorectal carcinoma.

  Cancer management and research 20120101

• [Will targeted therapies replace chemotherapy?].

  Revue medicale de Liege 20120101

• Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis.

  Journal of oncology 20120101

• Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer.

  PloS one 20120101

• Gene expression changes as markers of early lapatinib response in a panel of breast cancer cell lines.

  Molecular cancer 20120101

• Early start of chemotherapy after resection of brain metastasis from colon cancer with synchronous multiple liver metastases.

  Case reports in oncology 20120101

• Acute Reversible Heart Failure Caused by Coronary Vasoconstriction due to Continuous 5-Fluorouracil Combination Chemotherapy.

  Case reports in oncology 20120101

• Dacryoscintigraphy for the detection of ocular drainage system stenosis induced by docetaxel and fluorouracil.

  Hellenic journal of nuclear medicine 20120101

• XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.

  BMC cancer 20120101

• [Increased INR from concomitant use of acenocoumarol and capecitabine].

  Nederlands tijdschrift voor geneeskunde 20120101

• Cutaneous relapse of an ampullary carcinoma: an unusual presentation.

  BMJ case reports 20120101

• Capecitabine may induce coronary artery vasospasm.

  Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20120101

• Relationship between antimetabolite toxicity and pharmacogenetics in Turkish cancer patients.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Active home-based cancer treatment.

  Journal of multidisciplinary healthcare 20120101

• Antiemetic control with palonosetron in patients with gastrointestinal cancer receiving a fluoropyrimidine-based regimen in addition to either irinotecan or oxaliplatin: a retrospective study.

  Oncology 20120101

• A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II).

  BMC cancer 20120101

• Capecitabine in elderly patients with metastatic breast cancer.

  Tumori 20120101

• Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.

  Chemotherapy 20120101

• Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea.

  BMC cancer 20120101

• Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in her2-positive metastatic breast cancer.

  PloS one 20120101

• Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group.

  BMC cancer 20120101

• Capecitabine plus Cisplatin treatment for advanced gastric cancer in a patient with hepatic impairment secondary to metastases.

  Gastrointestinal cancer research : GCR 20120101

• [Hand-foot syndrome induced by chemotherapy: a case study].

  Revista brasileira de enfermagem 20120101

• Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trials.

  Oncology 20120101

• Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas.

  TheScientificWorldJournal 20120101

• Optimize administration protocol of capecitabine plus docetaxel combination in metastatic breast cancer patients.

  Current topics in medicinal chemistry 20120101

• ACR appropriateness criteria®  resectable rectal cancer.

  Radiation oncology (London, England) 20120101

• Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma.

  Radiation oncology (London, England) 20120101

• Capecitabine-induced hypertriglyceridemia and hyperglycemia: two cases.

  Pharmacology 20120101

• Preoperative radiotherapy of locally advanced rectal cancer: clinical outcome of short-course and long-course treatment with or without concomitant chemotherapy.

  Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20120101

• The use of capecitabine in daily practice: a study on adherence and patients' experiences.

  Patient preference and adherence 20120101

• Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma.

  Drugs 20111224

• Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111210

• Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold.

  Journal of medicinal chemistry 20111208

• Adjuvant therapy for early colon cancer: current status.

  Drugs 20111203

• Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor.

  Pituitary 20111201

• Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin.

  Medical oncology (Northwood, London, England) 20111201

• Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer.

  Investigational new drugs 20111201

• Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients.

  Medical oncology (Northwood, London, England) 20111201

• CA 19-9 level as indicator of early distant metastasis and therapeutic selection in resected pancreatic cancer.

  International journal of radiation oncology, biology, physics 20111201

• Evaluation of two modified ECF regimens in the treatment of advanced gallbladder cancer.

  Medical oncology (Northwood, London, England) 20111201

• A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer.

  Medical oncology (Northwood, London, England) 20111201

• Safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors: results of a phase 1 trial.

  Journal of clinical pharmacology 20111201

• Capecitabine-induced, nonneutropenic enterocolitis.

  Journal of gastrointestinal cancer 20111201

• Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20111201

• Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20111201

• Tumor growth modeling from clinical trials reveals synergistic anticancer effect of the capecitabine and docetaxel combination in metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20111201

• Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes.

  International journal of clinical oncology 20111201

• Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20111201

• A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.

  Cancer chemotherapy and pharmacology 20111201

• Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency.

  Cancer chemotherapy and pharmacology 20111201

• Empirical Bayes estimation of random effects of a mixed-effects proportional odds Markov model for ordinal data.

  Computer methods and programs in biomedicine 20111201

• Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies.

  Annals of surgical oncology 20111201

• Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases.

  Journal of neuro-oncology 20111201

• Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability.

  European radiology 20111201

• Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination.

  Angiogenesis 20111201

• Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer.

  Clinical breast cancer 20111201

• Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20111201

• A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20111201

• Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity.

  Molecular cancer therapeutics 20111201

• Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111201

• Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy.

  Pharmacogenomics 20111201

• How do I treat 'triple-negative' disease.

  Current treatment options in oncology 20111201

• Single-institution experience with solid pseudopapillary neoplasm of the pancreas.

  Scandinavian journal of gastroenterology 20111201

• Phase 2 study of capecitabine and irinotecan combination chemotherapy (modified XELIRI regimen) in patients with advanced gastric cancer.

  American journal of clinical oncology 20111201

• Capecitabine in gastric cancer.

  Expert review of anticancer therapy 20111201

• Recommendations and expert opinion on the treatment of locally advanced rectal cancer in Spain.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20111201

• Capecitabine-induced hand-foot syndrome complicated by pseudomonal superinfection resulting in bacterial sepsis and death: case report and review of the literature.

  Archives of dermatology 20111201

• [A case of local-recurring breast cancer under long term-treatment by capecitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• [Robotic rectal resection in rectal cancer: short term results in a monocentric prospective study].

  Minerva chirurgica 20111201

• Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment.

  Cancer research and treatment : official journal of Korean Cancer Association 20111201

• Simultaneous forequarter amputation and radical mastectomy for metastatic breast carcinoma in a male patient: a case report.

  Journal of the Korean Surgical Society 20111201

• Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer.

  Journal of breast cancer 20111201

• Locoregional recurrence of breast conserving surgery after preoperative chemotherapy in korean women with locally advanced breast cancer.

  Journal of breast cancer 20111201

• Have the changes in treatment of rectal cancer made a significant difference to our patients?

  Oncology (Williston Park, N.Y.) 20111201

• Isolated splenic metastasis from colorectal carcinoma in a high risk patient: a case report.

  Collegium antropologicum 20111201

• A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.

  Cancer letters 20111128

• Randomized placebo-controlled phase II trial of perifosine plus capecitabine as second- or third-line therapy in patients with metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111120

• KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20111115

• Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20111115

• Bevacizumab: a review of its use in combination with paclitaxel or capecitabine as first-line therapy for HER2-negative metastatic breast cancer.

  Drugs 20111112

• RIBBON-2: a randomized, double-blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111110

• Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter Phase II study.

  International journal of radiation oncology, biology, physics 20111101

• Prognosis of esophageal cancer patients with pathologic complete response after preoperative concurrent chemoradiotherapy.

  International journal of radiation oncology, biology, physics 20111101

• Nutritional status of patients with locally advanced pancreatic cancer: a pilot study.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20111101

• A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20111101

• A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopy.

  Cancer chemotherapy and pharmacology 20111101

• Chemotherapy/chemoradiation in anal cancer: a systematic review.

  Cancer treatment reviews 20111101

• Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.

  Annals of surgical oncology 20111101

• Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy.

  European journal of cancer (Oxford, England : 1990) 20111101

• Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature.

  Annals of surgical oncology 20111101

• Severe fluoropyrimidine-related toxicity: clinical implications of DPYD analysis and UH2/U ratio evaluation.

  Cancer chemotherapy and pharmacology 20111101

• A novel structural mechanism for redox regulation of uridine phosphorylase 2 activity.

  Journal of structural biology 20111101

• Capecitabine-phenytoin interaction is dose dependent with an unexpected time course.

  Anti-cancer drugs 20111101

• Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: what next?

  Advances in therapy 20111101

• Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo)radiotherapy.

  Acta oncologica (Stockholm, Sweden) 20111101

• [Preoperative chemoradiation (XELOX/RT) therapy for anal canal adenocarcinoma with the metastasis to inguinal lymph node].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [A case of breast cancer liver metastases responding to lapatinib and capecitabine therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [Two cases of ovarian metastasis of colon cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [Efficacy and safety of regimens of capecitabine-based chemotherapy in the treatment of advanced breast cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20111101

• A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male.

  Rare tumors 20111021

• Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111020

• Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy.

  Cancer 20111015

• Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20111015

• Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition.

  Oncogene 20111006

• A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens.

  Investigational new drugs 20111001

• Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer.

  Investigational new drugs 20111001

• Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studies.

  Investigational new drugs 20111001

• A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981.

  American journal of clinical oncology 20111001

• First-line chemotherapy for metastatic breast cancer in patients ≥75 years: a retrospective single-centre analysis.

  Critical reviews in oncology/hematology 20111001

• A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignancies.

  Acta oncologica (Stockholm, Sweden) 20111001

• Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20111001

• The economic burden of metastatic breast cancer: a systematic review of literature from developed countries.

  Cancer treatment reviews 20111001

• MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study.

  Annals of surgical oncology 20111001

• Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review.

  The Lancet. Oncology 20111001

• Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

  Cancer immunology, immunotherapy : CII 20111001

• Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: a randomised double blinded, placebo controlled pilot study.

  Clinical nutrition (Edinburgh, Scotland) 20111001

• Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer.

  European journal of cancer (Oxford, England : 1990) 20111001

• Preoperative radiotherapy combined with capecitabine chemotherapy in Chinese patients with locally advanced rectal cancer.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20111001

• [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20111001

• Management of breast cancer with nanoparticle albumin-bound (nab)-paclitaxel combination regimens: a clinical review.

  Breast (Edinburgh, Scotland) 20111001

• [Chemotherapy and rectal cancer].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20111001

• The role of chemotherapy in metastatic gastric cancer.

  Anticancer research 20111001

• OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer.

  Cell death & disease 20111001

• Inappropriate continuation of medication when patients are admitted acutely: the example of capecitabine.

  Clinical medicine (London, England) 20111001

• Endpoints in advanced breast cancer: methodological aspects & clinical implications.

  The Indian journal of medical research 20111001

• Colorectal cancer with multiple metastases: is palliative surgery needed?

  Journal of the Korean Society of Coloproctology 20111001

• Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer.

  Cancer 20110915

• Alternative dosing schedules and administration updates for ixabepilone.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20110901

• Steroids, cancer and vertebral fractures: a dreaded combination.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20110901

• Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20110901

• Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20110901

• Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma.

  Cancer chemotherapy and pharmacology 20110901

• A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110901

• Thymidylate synthase as a prognostic biomarker for locally advanced rectal cancer after multimodal treatment.

  Annals of surgical oncology 20110901

• AAPS workshop report: strategies to address therapeutic protein-drug interactions during clinical development.

  The AAPS journal 20110901

• Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110901

• Multidisciplinary discussion and management of rectal cancer: a population-based study.

  World journal of surgery 20110901

• Post-marketing safety evaluation of S-1 in patients with inoperable or recurrent breast cancer: especially in patients treated with S-1 + trastuzumab.

  Japanese journal of clinical oncology 20110901

• Nonsurgical management of esophageal adenocarcinoma.

  Clinical colorectal cancer 20110901

• A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer.

  Clinical colorectal cancer 20110901

• The efficacy of gemcitabine as salvage treatment in patients with refractory advanced colorectal cancer (CRC): a single institution experience.

  Anticancer research 20110901

• [A resected case of locally invasive rectal cancer successfully treated with neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110901

• Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity.

  Pharmacogenomics 20110901

• Genital erythrodysesthesia as a severe manifestation of capecitabine therapy: a report of 3 cases.

  Archives of dermatology 20110901

• Efficacy and safety of oxaliplatin, 5-Fluorouracil, and folinic Acid combination chemotherapy as first-line treatment in metastatic or recurrent gastric cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20110901

• No Association of Insulin-like Growth Factor Gene Polymorphisms with Survival in Patients with Colorectal Cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20110901

• [HER-2 expression in advanced gastric cancer and its correlation with clinical features, outcome and prognosis].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110901

• [Efficacy of late accelerated hyperfractionated conformal radiotherapy combined with capecitabine for esophageal carcinoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110901

• Chemotherapy for older patients with colorectal cancer.

  Lancet (London, England) 20110827

• Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.

  British journal of cancer 20110823

• Sequential expression of putative stem cell markers in gastric carcinogenesis.

  British journal of cancer 20110823

• Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.

  Cancer 20110815

• Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts.

  British journal of cancer 20110809

• Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma.

  International journal of radiation oncology, biology, physics 20110801

• Preoperative chemoradiation for rectal cancer using capecitabine and celecoxib correlated with posttreatment assessment of thymidylate synthase and thymidine phosphorylase expression.

  International journal of radiation oncology, biology, physics 20110801

• Cytotoxicity and genotoxicity of capecitabine in head and neck cancer and normal cells.

  Molecular biology reports 20110801

• Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110801

• Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis.

  Annals of surgical oncology 20110801

• Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.

  Annals of surgical oncology 20110801

• High survivin expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer.

  International journal of colorectal disease 20110801

• Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer.

  Journal of surgical oncology 20110801

• The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20110801

• Systemic gemcitabine and capecitabine plus intra-arterial epirubicin and cisplatin as second-line chemotherapy in gemcitabine-failure pancreatic cancer.

  Pancreas 20110801

• Autophagy facilitates the Lapatinib resistance of HER2 positive breast cancer cells.

  Medical hypotheses 20110801

• Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines.

  Oncology reports 20110801

• Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110801

• Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.

  Clinical breast cancer 20110801

• Current targeted therapies in breast cancer: clinical applications in the elderly woman.

  The oncologist 20110801

• Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801

• Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients.

  Journal of the American Academy of Dermatology 20110801

• Comparison of in vitro metabolic conversion of capecitabine to 5-FU in rats, mice, monkeys and humans--toxicological implications.

  The Journal of toxicological sciences 20110801

• Enzyme kinetics of the mitochondrial deoxyribonucleoside salvage pathway are not sufficient to support rapid mtDNA replication.

  PLoS computational biology 20110801

• Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatment.

  Archives of dermatology 20110801

• Clinical efficacy of capecitabine and cyclophosphamide (XC) in patients with metastatic breast cancer.

  Acta medica Okayama 20110801

• [Multimodal therapy for colon cancer: state of the art].

  Zentralblatt fur Chirurgie 20110801

• Systemic therapy for advanced gastric cancer: a clinical practice guideline.

  Current oncology (Toronto, Ont.) 20110801

• Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.

  Current oncology (Toronto, Ont.) 20110801

• 3rd congress of the International Academy of Oral Oncology.

  The Lancet. Oncology 20110801

• Application of the continual reassessment method to a phase I dose-finding trial in Japanese patients: East meets West.

  Statistics in medicine 20110730

• Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma.

  Cancer 20110715

• Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial.

  British journal of cancer 20110712

• Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110701

• Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists.

  European journal of cancer care 20110701

• Can localised (19)F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?

  Cancer chemotherapy and pharmacology 20110701

• Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994-1998 and 2003-2006.

  Breast cancer research and treatment 20110701

• Optimal use of adjuvant chemotherapy in stage II colorectal cancer.

  International journal of colorectal disease 20110701

• Lamellar crystalline self-assembly behaviour and solid lipid nanoparticles of a palmityl prodrug analogue of Capecitabine--a chemotherapy agent.

  Colloids and surfaces. B, Biointerfaces 20110701

• Metastatic pancreatic cancer: old drugs, new paradigms.

  Current opinion in oncology 20110701

• Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer.

  Cancer chemotherapy and pharmacology 20110701

• Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110701

• [Eighty-five-year-old patient with recurrent rectal cancer effectively treated with CapeOX chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110701

• Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110701

• Computer assisted quantitative immunofluorescence of tumor tissue marker expression and clinical outcome to chemotherapy in advanced breast cancer patients.

  Discovery medicine 20110701

• XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.

  British journal of cancer 20110628

• Cardiotoxicity in patients treated with bevacizumab is potentially reversible.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110620

• Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

  Lancet (London, England) 20110618

• First-line treatment of advanced colorectal cancer.

  Lancet (London, England) 20110618

• Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation.

  Science translational medicine 20110608

• Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer.

  British journal of cancer 20110607

• A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients with wild-type KRAS metastatic colorectal cancer.

  British journal of cancer 20110607

• Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

  The Lancet. Oncology 20110604

• Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.

  Investigational new drugs 20110601

• Bevacizumab, capecitabine, amifostine, and preoperative hypofractionated accelerated radiotherapy (HypoArc) for rectal cancer: a Phase II study.

  International journal of radiation oncology, biology, physics 20110601

• A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.

  Cancer chemotherapy and pharmacology 20110601

• Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.

  Cancer chemotherapy and pharmacology 20110601

• Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20110601

• Capecitabine-based chemotherapy for metastatic colorectal cancer.

  Journal of cancer research and clinical oncology 20110601

• A bilateral cicatricial ectropion and bilateral upper lid shortening caused by 5-fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency.

  Cutaneous and ocular toxicology 20110601

• Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20110601

• The effect of COX-2 inhibitor on capecitabine-induced hand-foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective study.

  Journal of cancer research and clinical oncology 20110601

• The efficacy of HER2-targeted agents in metastatic breast cancer: a meta-analysis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110601

• Laparoscopic proctectomy after neoadjuvant therapy: safety and long-term follow-up.

  Surgical endoscopy 20110601

• Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110601

• Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab.

  Breast cancer research and treatment 20110601

• Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20110601

• Approved agents for metastatic breast cancer.

  Seminars in oncology 20110601

• Targeting angiogenesis in esophagogastric adenocarcinoma.

  The oncologist 20110601

• [Main treatment and preventive measures for hand-foot syndrome, a dermatologic side effect of cancer therapy].

  Magyar onkologia 20110601

• Biomarker-based selection of therapy for colorectal cancer.

  Biomarkers in medicine 20110601

• Ixabepilone: clinical role in metastatic breast cancer.

  Clinical breast cancer 20110601

• [Multiple Sister Mary Joseph's nodules in a patient with gastric cancer].

  Deutsche medizinische Wochenschrift (1946) 20110601

• A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma.

  Future oncology (London, England) 20110601

• [The 9th international conference of the asian clinical oncology society in Japan after a twenty year interval--what is the standpoint of Japan in Asia ?].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110601

• [Tykerb for breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110601

• [A case of effective neoadjuvant chemoradiotherapy with capecitabine for locally advanced sigmoid colon cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110601

• [Adjuvant chemotherapy for gastric cancer: more drugs do not mean better efficacy].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20110601

• Combined chemotherapy with cisplatin, docetaxel and capecitabine for metastatic nasopharyngeal carcinoma: a retrospective analysis.

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20110601

• A retrospective study of first-line combination chemotherapy in advanced colorectal cancer: a Korean single-center experience.

  Cancer research and treatment : official journal of Korean Cancer Association 20110601

• Predictive value of in vitro adenosine triphosphate-based chemotherapy response assay in advanced gastric cancer patients who received oral 5-Fluorouracil after curative resection.

  Cancer research and treatment : official journal of Korean Cancer Association 20110601

• Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer.

  Journal of the Korean Society of Coloproctology 20110601

• Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.

  Clinical advances in hematology & oncology : H&O 20110601

• Phase II Study of Vinorelbine Plus Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes.

  Journal of breast cancer 20110601

• Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative.

  Clinical colorectal cancer 20110601

• A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer.

  Clinical colorectal cancer 20110601

• [Therapeutic adherence to oral cancer therapy and interdisciplinary management].

  Revue medicale suisse 20110525

• Trastuzumab beyond progression in HER2-positive advanced breast cancer: the Royal Marsden experience.

  British journal of cancer 20110524

• Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.

  Lancet (London, England) 20110521

• Do we need oncology trials tailored for the elderly or frail?

  Lancet (London, England) 20110521

• Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110515

• Novel approach to Gorlin syndrome: a patient treated with oral capecitabine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110510

• Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study.

  Cancer chemotherapy and pharmacology 20110501

• Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study.

  Cancer chemotherapy and pharmacology 20110501

• Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110501

• Ischemic colitis after capecitabine plus cisplatin treatment in advanced gastric cancer.

  Journal of thrombosis and thrombolysis 20110501

• Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110501

• Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review.

  Angiogenesis 20110501

• Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancer.

  European journal of cancer (Oxford, England : 1990) 20110501

• Analysis of tumor burden versus progression-free survival for Phase II decision making.

  Contemporary clinical trials 20110501

• A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study.

  European journal of cancer (Oxford, England : 1990) 20110501

• Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110501

• Lyotropic liquid crystalline self-assembly material behavior and nanoparticulate dispersions of a phytanyl pro-drug analogue of capecitabine-a chemotherapy agent.

  ACS applied materials & interfaces 20110501

• Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study.

  The oncologist 20110501

• The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.

  Nature materials 20110501

• Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients.

  Chinese journal of cancer 20110501

• Global experience with ixabepilone in breast cancer.

  Expert review of anticancer therapy 20110501

• [A case of toxicity caused by drug interaction between capecitabine and phenytoin in patient with colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110501

• Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity.

  Oncotarget 20110501

• Response to low-dose oral capecitabine monotherapy in an elderly frail patient with metastatic breast carcinoma and impaired renal function: documentation by fluorodeoxyglucose positron emission tomography.

  Japanese journal of radiology 20110501

• Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.

  Health technology assessment (Winchester, England) 20110501

• Bevacizumab in first-line therapy of metastatic colorectal cancer: a retrospective comparison of FOLFIRI and XELIRI.

  Anticancer research 20110501

• Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110501

• [Improved sensitivity of gastric carcinoma cells to fluorouracil-related drugs by transfection of thymidine phosphorylase gene].

  Zhonghua bing li xue za zhi = Chinese journal of pathology 20110501

• Eribulin mesylate (Halaven) for breast cancer.

  The Medical letter on drugs and therapeutics 20110418

• Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110410

• A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.

  Investigational new drugs 20110401

• Clinical outcomes of sorafenib treatment in patients with metastatic hepatocellular carcinoma who had been previously treated with fluoropyrimidine plus platinum-based chemotherapy.

  American journal of clinical oncology 20110401

• A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.

  American journal of clinical oncology 20110401

• Phase II trial of oxaliplatin and capecitabine after progression to first-line chemotherapy in androgen-independent prostate cancer patients.

  American journal of clinical oncology 20110401

• PharmGKB summary: fluoropyrimidine pathways.

  Pharmacogenetics and genomics 20110401

• Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma.

  Journal of neuro-oncology 20110401

• Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation.

  Bone marrow transplantation 20110401

• A Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas.

  Acta oncologica (Stockholm, Sweden) 20110401

• Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110401

• Outcomes from chemoradiotherapy for patients with esophageal cancer.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20110401

• Treatment for metastatic nasopharyngeal carcinoma.

  European annals of otorhinolaryngology, head and neck diseases 20110401

• Improvement of capecitabine antitumoral activity by melatonin in pancreatic cancer.

  Pancreas 20110401

• Unity is strength: one, two, or more drugs against advanced pancreatic cancer?

  Annals of oncology : official journal of the European Society for Medical Oncology 20110401

• Evolution of 5-fluorouracil-based chemoradiation in the management of rectal cancer.

  Anti-cancer drugs 20110401

• Development of second-generation VEGFR tyrosine kinase inhibitors: current status.

  Current oncology reports 20110401

• A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110401

• RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110401

• Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy.

  Journal of surgical oncology 20110401

• A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer.

  Oncology 20110401

• Bevacizumab in the treatment of metastatic breast cancer: three case reports.

  Current opinion in oncology 20110401

• [Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110401

• Capecitabine or infusional 5-fluorouracil for gastroesophageal cancer: a cost-consequence analysis.

  Current oncology (Toronto, Ont.) 20110401

• Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer.

  Anticancer research 20110401

• Full-dose capecitabine with local radiotherapy: one of the treatment options for inoperable T4 breast cancer.

  Japanese journal of radiology 20110401

• Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach.

  Clinical breast cancer 20110401

• Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer.

  Journal of chemotherapy (Florence, Italy) 20110401

• [Comparison between the effects of irinotecan or oxaliplatin combined with capecitabine in the treatment of advanced gastric cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110401

• [HER2 and gastric cancer. Recommendations for clinical practice in 2011].

  Annales de pathologie 20110401

• [Development of oral drugs in the standard therapy for metastatic colorectal cancer patients].

  Nihon rinsho. Japanese journal of clinical medicine 20110401

• Pancreatic endocrine tumors.

  North American journal of medical sciences 20110401

• Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma.

  North American journal of medical sciences 20110401

• Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse.

  British journal of cancer 20110329

• CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients.

  British journal of cancer 20110329

• FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer.

  British journal of cancer 20110329

• Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumours.

  British journal of cancer 20110329

• Severe hypertriglyceridaemia during treatment with capecitabine.

  British journal of cancer 20110329

• Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer.

  British journal of cancer 20110329

• Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a Phase II study.

  International journal of radiation oncology, biology, physics 20110315

• Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.

  Lancet (London, England) 20110312

• Durable remission of metastatic renal cell carcinoma with gemcitabine and capecitabine after failure of targeted therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310

• Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310

• Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310

• Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310

• Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

  World journal of clinical oncology 20110310

• First-line treatment for advanced pancreatic cancer. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011.

  JOP : Journal of the pancreas 20110309

• [Pharmacologic therapy for neuroendocrine tumours].

  Orvosi hetilap 20110306

• A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas.

  Cancer chemotherapy and pharmacology 20110301

• Plasma disposition of capecitabine and its metabolites 5'DFCR and 5'DFUR in a standard and dose-intensified monotherapy regimen.

  Cancer chemotherapy and pharmacology 20110301

• Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110301

• Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110301

• 2010 SSO John Wayne clinical research lecture: rectal cancer outcome improvements in Europe: population-based outcome registrations will conquer the world.

  Annals of surgical oncology 20110301

• Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20110301

• Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine.

  Biochemical pharmacology 20110301

• Capecitabine and hand-foot syndrome.

  Expert opinion on drug safety 20110301

• Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992-2008.

  Clinical & experimental metastasis 20110301

• Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

  Annals of surgical oncology 20110301

• Alterations of the retinoblastoma gene in metastatic breast cancer.

  Clinical & experimental metastasis 20110301

• Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer.

  The British journal of surgery 20110301

• Targeted therapies for metastatic esophagogastric cancer.

  Current treatment options in oncology 20110301

• Capecitabine monotherapy as salvage treatment after failure of chemotherapy containing oxaliplatin and irinotecan in patients with metastatic colorectal cancer.

  Asia-Pacific journal of clinical oncology 20110301

• Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20110301

• Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre.

  BJU international 20110301

• Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre.

  BJU international 20110301

• Recent advances in anti-angiogenic therapy of cancer.

  Oncotarget 20110301

• [Prominent efficacy from capecitabine mono-therapy for a case with lymphangiosis carcinomatosa derived from recurrent breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110301

• [A resected case of gastric regional lymph node metastasis from ascending colon cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110301

• Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.

  Oncotarget 20110301

• Current treatment strategies for castration-resistant prostate cancer.

  Korean journal of urology 20110301

• Vascular co-option in lung cancer metastatic to the eye after treatment with bevacizumab.

  Journal of ophthalmic inflammation and infection 20110301

• Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.

  Anticancer research 20110301

• Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group.

  Clinical colorectal cancer 20110301

• A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors.

  Clinical colorectal cancer 20110301

• [Randomized clinical case-control trial for the comparison of docetaxel plus thiotepa versus docetaxel plus capecitabine in patients with metastatic breast cancer].

  Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20110218

• Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.

  British journal of cancer 20110215

• Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity.

  British journal of cancer 20110215

• Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance.

  The Journal of biological chemistry 20110204

• The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer.

  The pharmacogenomics journal 20110201

• Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial.

  Cancer chemotherapy and pharmacology 20110201

• Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer.

  International journal of cancer 20110201

• A case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy.

  Archives of gynecology and obstetrics 20110201

• Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110201

• A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110201

• Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer-a per lesion validation study.

  European radiology 20110201

• Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.

  Annals of surgical oncology 20110201

• Effectiveness of image-guided radiotherapy for locally advanced rectal cancer.

  Annals of surgical oncology 20110201

• Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours.

  European journal of nuclear medicine and molecular imaging 20110201

• Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer.

  Anti-cancer drugs 20110201

• The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients.

  European journal of cancer (Oxford, England : 1990) 20110201

• Chemotherapy for thymic tumors: induction, consolidation, palliation.

  Thoracic surgery clinics 20110201

• Optimizing the efficacy of first-line chemotherapy plus bevacizumab in metastatic colorectal cancer: analysis of multiple methods.

  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20110201

• Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.

  Breast cancer research and treatment 20110201

• Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765).

  Breast cancer research and treatment 20110201

• Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer.

  Anti-cancer drugs 20110201

• Changing management and survival in patients with stage IV colorectal cancer.

  Diseases of the colon and rectum 20110201

• Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20110201

• Phase II trial of capecitabine and cisplatin in advanced, persistent, or recurrent carcinoma of the cervix.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20110201

• [Recent results of research on cancer of the colon, gastric cancer, sarcoma and bronchial carcinoma].

  Deutsche medizinische Wochenschrift (1946) 20110201

• XELOX in colorectal cancer: a convenient option for the future?

  Expert review of gastroenterology & hepatology 20110201

• Safety and efficacy of moderate-dose capecitabine as first-line therapy in metastatic breast cancer.

  Expert review of anticancer therapy 20110201

• Adjuvant chemotherapy for localised colon cancer. Fluorouracil + folinic acid for node-positive, non-metastatic disease.

  Prescrire international 20110201

• Talactoferrin immunotherapy in metastatic renal cell carcinoma: a case series of four long-term survivors.

  Journal of clinical medicine research 20110201

• Systematic review on infusion reactions associated with chemotherapies and monoclonal antibodies for metastatic colorectal cancer.

  Current clinical pharmacology 20110201

• Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer.

  British journal of cancer 20110118

• Single agent and combination studies of pralatrexate and molecular correlates of sensitivity.

  British journal of cancer 20110118

• First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas.

  Cancer 20110115

• Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110115

• Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction.

  British journal of cancer 20110104

• Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer.

  British journal of cancer 20110104

• Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'.

  British journal of cancer 20110104

• DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity.

  Cancer chemotherapy and pharmacology 20110101

• Capecitabine-induced, rapid decrease of renal function due to drug dispensing error in a hospital pharmacy.

  Journal of clinical pharmacology 20110101

• Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach.

  Breast cancer (Tokyo, Japan) 20110101

• Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers.

  International journal of radiation oncology, biology, physics 20110101

• Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head.

  International journal of radiation oncology, biology, physics 20110101

• Anal cancer with cerebral metastasis: a case report.

  Journal of neuro-oncology 20110101

• Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation.

  Surgical endoscopy 20110101

• New recommendation of doses in an ongoing phase II study of docetaxel, oxaliplatin and capecitabine as first line therapy in advanced gastro-oesophageal cancer.

  Acta oncologica (Stockholm, Sweden) 20110101

• High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer.

  Breast cancer research and treatment 20110101

• Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials.

  Breast cancer research and treatment 20110101

• Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials.

  Breast cancer research and treatment 20110101

• Capecitabine for skin cancer prevention in solid organ transplant recipients.

  Clinical transplantation 20110101

• Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics.

  Current medical research and opinion 20110101

• Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: how significant is peripheral neuropathy?

  Annals of oncology : official journal of the European Society for Medical Oncology 20110101

• Adjuvant radiotherapy for rectal cancer: recent results, new questions.

  Clinics and research in hepatology and gastroenterology 20110101

• Her-2/neu testing and therapy in gastroesophageal adenocarcinoma.

  Pathology research international 20110101

• Testing for HER2 in Breast Cancer: A Continuing Evolution.

  Pathology research international 20110101

• Targeting angiogenesis in childhood sarcomas.

  Sarcoma 20110101

• Renal function during rofecoxib therapy in patients with metastatic cancer: retrospective analysis of a prospective phase II trial.

  BMC research notes 20110101

• Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.

  Radiation oncology (London, England) 20110101

• Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study.

  BMC medical research methodology 20110101

• Saddle pulmonary embolism in a cancer patient with thrombocytopenia: a treatment dilemma.

  Cardiology research and practice 20110101

• Exudative, nonhealing scalp: a complication of systemic chemotherapy with capecitabine and bevacizumab.

  Archives of dermatology 20110101

• Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center.

  Journal of experimental & clinical cancer research : CR 20110101

• Blood-brain barrier integrity and breast cancer metastasis to the brain.

  Pathology research international 20110101

• A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer.

  Anticancer research 20110101

• 5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.

  Anticancer research 20110101

• Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer.

  Neoplasma 20110101

• Second-line combination chemotherapy with vinorelbine and capecitabine in patients with advanced breast cancer previously treated with anthracyclines and/or taxanes.

  Chemotherapy 20110101

• Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

  Molecular cancer 20110101

• Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial.

  BMC cancer 20110101

• A case of long partial response to combination therapy of bevacizumab and capecitabine for liver metastases of rectal cancer.

  Case reports in gastroenterology 20110101

• Palmar-plantar erythrodysesthesia secondary to docetaxel chemotherapy: a case report.

  Journal of medical case reports 20110101

• Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report.

  Journal of medical case reports 20110101

• A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.

  PloS one 20110101

• Functional characterization of human cancer-derived TRKB mutations.

  PloS one 20110101

• Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer.

  BMC cancer 20110101

• Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences.

  Korean journal of radiology 20110101

• Impact of KRAS Mutations on Management of Colorectal Carcinoma.

  Pathology research international 20110101

• A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma.

  Journal of hematology & oncology 20110101

• Significant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000.

  BMC cancer 20110101

• Prolonged neutropenia after neoadjuvant radiation therapy and chemotherapy using oxaliplatin and capecitabine for rectal cancer.

  Gastrointestinal cancer research : GCR 20110101

• An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development.

  Journal of Cancer 20110101

• Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer.

  Journal of experimental & clinical cancer research : CR 20110101

• Acceptance of oral chemotherapy in breast cancer patients - a survey study.

  BMC cancer 20110101

• Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis.

  BMC cancer 20110101

• [Ileitis following capecitabine use].

  Nederlands tijdschrift voor geneeskunde 20110101

• Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.

  Molecular cancer 20110101

• Ixabepilone as monotherapy or in combination with capecitabine for the treatment of advanced breast cancer.

  Breast cancer : basic and clinical research 20110101

• Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity.

  PloS one 20110101

• Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes.

  Radiation oncology (London, England) 20110101

• Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo.

  Breast cancer research : BCR 20110101

• Capecitabine in combination with oxaliplatin as first-line therapy for advanced gastric cancer: a case report.

  Tumori 20110101

• Medication safety of five oral chemotherapies: a proactive risk assessment.

  Journal of oncology practice 20110101

• Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment.

  Case reports in oncology 20110101

• New developments in the treatment of metastatic gastric cancer: focus on trastuzumab.

  OncoTargets and therapy 20110101

• Critical appraisal of trastuzumab in treatment of advanced stomach cancer.

  Cancer management and research 20110101

• Safety and pharmacokinetics of motesanib in combination with panitumumab and gemcitabine-Cisplatin in patients with advanced cancer.

  Journal of oncology 20110101

• Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment.

  BMC medical genomics 20110101

• The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study.

  BMC surgery 20110101

• Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials.

  Journal of experimental & clinical cancer research : CR 20110101

• Combination therapy of lapatinib and Capecitabine for ErbB2-positive metastatic or locally advanced breast cancer: results from the Lapatinib Expanded Access Program (LEAP) in Central and Eastern Europe.

  Onkologie 20110101

• Ixabepilone for the treatment of breast cancer.

  Annals of medicine 20110101

• Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.

  BMC cancer 20110101

• Societal costs and benefits of treatment with trastuzumab in patients with early HER2neu-overexpressing breast cancer in Singapore.

  BMC cancer 20110101

• Small invasive colon cancer with systemic metastasis: a case report.

  BMC gastroenterology 20110101

• Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer.

  Radiation oncology (London, England) 20110101

• Systemic therapy for elderly patients with gastrointestinal cancer.

  Clinical Medicine Insights. Oncology 20110101

• Self-reported compliance with capecitabine: findings from a prospective cohort analysis.

  Oncology 20110101

• Clusterin confers gemcitabine resistance in pancreatic cancer.

  World journal of surgical oncology 20110101

• Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study.

  BMC cancer 20110101

• Interpreting clinical assays for histone deacetylase inhibitors.

  Cancer management and research 20110101

• Capecitabine in the management of colorectal cancer.

  Cancer management and research 20110101

• Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients.

  BMC cancer 20110101

• Molecular profile and copy number analysis of sporadic colorectal cancer in Taiwan.

  Journal of biomedical science 20110101

• Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma.

  Radiation oncology (London, England) 20110101

• Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study.

  Radiation oncology (London, England) 20110101

• Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors.

  Journal of hematology & oncology 20110101

• PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib.

  BMC cancer 20110101

• Early start of chemotherapy after resection of primary colon cancer with synchronous multiple liver metastases: a case report.

  Case reports in oncology 20110101

• Predicting selective drug targets in cancer through metabolic networks.

  Molecular systems biology 20110101

• Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer.

  Clinical Medicine Insights. Oncology 20110101

• Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment.

  Breast cancer research : BCR 20110101

• Dramatic response of recalcitrant warts as a side effect of colorectal cancer treatment with oral capecitabine.

  European journal of dermatology : EJD 20110101

• Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.

  BMC cancer 20110101

• Promising molecular targeted therapies in breast cancer.

  Indian journal of pharmacology 20110101

• Targeting EGFR in Triple Negative Breast Cancer.

  Journal of Cancer 20110101

• The use of erlotinib in daily practice: a study on adherence and patients' experiences.

  BMC cancer 20110101

• Capecitabine (and 5 fluorouracil) cardiotoxicity. Metabolic considerations.

  The breast journal 20110101

• Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma.

  Hematology/oncology and stem cell therapy 20110101

• Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer.

  BMC cancer 20110101

• Gastric cancer in India.

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101

• Final results of ERASME-4: a randomized trial of first-line docetaxel plus either capecitabine or epirubicin for metastatic breast cancer.

  Oncology 20110101

• Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.

  Oncology 20110101

• Synchronous breast and rectal cancers in a man.

  Case reports in oncology 20110101

• Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis.

  PloS one 20110101

• Specific β-tubulin isotypes can functionally enhance or diminish epothilone B sensitivity in non-small cell lung cancer cells.

  PloS one 20110101

• Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement.

  BMC cancer 20110101

• Secondary signet-ring cell adenocarcinoma of urinary bladder from a gastric primary.

  Urology annals 20110101

• Breast Tumor Angiogenesis and Tumor-Associated Macrophages: Histopathologist's Perspective.

  Pathology research international 20110101

• Effects of bolus injection of 5-fluorouracil on steady-state plasma concentrations of 5-fluorouracil in Japanese patients with advanced colorectal cancer.

  International journal of medical sciences 20110101

• Common side effects and interactions of colorectal cancer therapeutic agents.

  The Journal of practical nursing 20110101

• Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans.

  PloS one 20110101

• Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma.

  BMC cancer 20110101

• Endopancreatic bile duct cholangiocarcinoma in a patient with peutz-jeghers syndrome.

  HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 20110101

• The effect of antivascular endothelial growth factor on the development of adhesion formation in laparotomized rats: experimental study.

  Gastroenterology research and practice 20110101

• How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101

• Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis.

  Case reports in gastroenterology 20110101

• The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series.

  Journal of oncology 20110101

• Synergistic activity of ixabepilone plus other anticancer agents: preclinical and clinical evidence.

  Therapeutic advances in medical oncology 20110101

• AST1306, a novel irreversible inhibitor of the epidermal growth factor receptor 1 and 2, exhibits antitumor activity both in vitro and in vivo.

  PloS one 20110101

• Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval.

  OncoTargets and therapy 20110101

• Latest developments and emerging treatment options in the management of stomach cancer.

  Cancer management and research 20110101

• Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients.

  Radiation oncology (London, England) 20110101

• Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer.

  Vascular cell 20110101

• Progressive resistance training and cancer testis (PROTRACT) - efficacy of resistance training on muscle function, morphology and inflammatory profile in testicular cancer patients undergoing chemotherapy: design of a randomized controlled trial.

  BMC cancer 20110101

• [Results of adjuvant chemotherapy (XELOX) of advanced colorectal cancer].

  Voprosy onkologii 20110101

• [End results of combined treatment in metastatic colorectal cancer].

  Voprosy onkologii 20110101

• Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).

  BMC cancer 20110101

• The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract.

  European journal of medical research 20110101

• Docetaxel plus oxaliplatin in combination with capecitabine as first-line treatment for advanced gastric cancer.

  Oncology 20110101

• Drug therapy for hereditary cancers.

  Hereditary cancer in clinical practice 20110101

• Rhodococcus equi venous catheter infection: a case report and review of the literature.

  Journal of medical case reports 20110101

• The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy.

  BMC cancer 20110101

• Extended lymph node dissection for gastric cancer from a European perspective.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20110101

• Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20110101

• Clinical pharmacology of chemotherapy agents in older people with cancer.

  Current gerontology and geriatrics research 20110101

• Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study.

  BMC cancer 20110101

• Current neoadjuvant treatment options for HER2-positive breast cancer.

  Biologics : targets & therapy 20110101

• Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy.

  BMC cancer 20110101

• Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy.

  Chinese medicine 20110101

• A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial.

  BMC cancer 20110101

• Management options in triple-negative breast cancer.

  Breast cancer : basic and clinical research 20110101

• Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit?

  BMC cancer 20110101

• Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial.

  BMC cancer 20110101

• Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B12: a case report.

  Journal of medical case reports 20110101

• Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study.

  Radiation oncology (London, England) 20110101

• [Effectiveness of neoadjuvant chemoradiotherapy of locally advanced rectal cancer in conjunction with local hyperthermia and metronidazole].

  Voprosy onkologii 20110101

• Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions.

  PloS one 20110101

• The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner in colon and breast cancer cells.

  PloS one 20110101

• Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma.

  BMC cancer 20110101

• Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study.

  Biology of sex differences 20110101

• Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death.

  BMC cancer 20110101

• Use of capecitabine in management of early colon cancer.

  Cancer management and research 20110101

• Pulmonary toxicity with oxaliplatin and capecitabine/5-Fluorouracil chemotherapy: a case report and review of the literature.

  Onkologie 20110101

• Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV).

  Case reports in oncology 20110101

• Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.

  Radiation oncology (London, England) 20110101

• Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma?

  World journal of surgical oncology 20110101

• Postoperative chemoradiation for resected gastric cancer--is the Macdonald Regimen Tolerable? a retrospective multi-institutional study.

  Radiation oncology (London, England) 20110101

• Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients.

  Clinical & developmental immunology 20110101

• Flare hypercalcemia after letrozole in a patient with liver metastasis from breast cancer: a case report.

  Journal of medical case reports 20110101

• Neuroendocrine tumor presenting like lymphoma: a case report.

  Journal of medical case reports 20110101

• Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).

  Onkologie 20110101

• Doses of capecitabine and oral vinorelbine are not relevant for efficacy in breast cancer patients: an analysis of dose intensity.

  Tumori 20110101

• Use of metronomic chemotherapy in oncology: results from a national Italian survey.

  Tumori 20110101

• Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer.

  Tumori 20110101

• Targeted therapy in hepatocellular carcinoma.

  International journal of hepatology 20110101

• Clinical and electrocardiography changes in patients treated with capecitabine.

  Chemotherapy 20110101

• Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.

  International journal of hepatology 20110101

• Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.

  BMC cancer 20110101

• Viscum album exerts anti-inflammatory effect by selectively inhibiting cytokine-induced expression of cyclooxygenase-2.

  PloS one 20110101

• Isolated metastasis of colon cancer to the scapula: is surgical resection warranted?

  World journal of surgical oncology 20110101

• Dosimetric and motion analysis of margin-intensive therapy by stereotactic ablative radiotherapy for resectable pancreatic cancer.

  Radiation oncology (London, England) 20110101

• SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus.

  BMC cancer 20110101

• Bilateral kidney preservation by volumetric-modulated arc therapy (RapidArc) compared to conventional radiation therapy (3D-CRT) in pancreatic and bile duct malignancies.

  Radiation oncology (London, England) 20110101

• Trastuzumab treatment beyond progression in advanced breast cancer: patterns of care in six Swiss breast cancer centers.

  Oncology 20110101

• Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab for Advanced Hepatocellular Carcinoma.

  Gastrointestinal cancer research : GCR 20110101

• Results of combined treatment of anaplastic thyroid carcinoma (ATC).

  BMC cancer 20110101

• Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets.

  PloS one 20110101

• [Neoadjuvant chemoradiotherapy of rectal carcinoma with bevacizumab].

  Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20110101

• Biomarkers in tumor angiogenesis and anti-angiogenic therapy.

  International journal of molecular sciences 20110101

• Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation.

  Molecular cancer 20110101

• Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.

  Journal of computer assisted tomography 20110101

• Synchronous Laparoscopic Radical Nephrectomy Left and Contralateral Right Hemicolectomy during the Same Endoscopic Procedure.

  ISRN surgery 20110101

• Metastatic bladder cancer: a review of current management.

  ISRN urology 20110101

• [A woman with palmar and plantar hyperpigmentation].

  Nederlands tijdschrift voor geneeskunde 20110101

• A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-line treatment for advanced breast cancer: a Gruppo Oncologico Italia Meridionale study.

  Oncology 20110101

• Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.

  BMC cancer 20110101

• Fast track multi-discipline treatment (FTMDT trial) versus conventional treatment in colorectal cancer--the design of a prospective randomized controlled study.

  BMC cancer 20110101

• miRNA signature associated with outcome of gastric cancer patients following chemotherapy.

  BMC medical genomics 20110101

• Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer.

  Breast cancer research : BCR 20110101

• Treatment of colorectal liver metastases.

  World journal of surgical oncology 20110101

• Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation.

  Breast cancer research : BCR 20110101

• Metachronous pulmonary and adrenal metastases after liver transplantation for hepatocarcinoma.

  World journal of surgical oncology 20110101

• Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations.

  Diagnostic pathology 20110101

• Identification of prognostic genes for recurrent risk prediction in triple negative breast cancer patients in Taiwan.

  PloS one 20110101

• Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

  BMC cancer 20110101

• Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma.

  Oncology 20110101

• Expression of thymidine phosphorylase in lymph nodes involved with mycosis fungoides and sézary syndrome.

  Advances in hematology 20110101

• Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer.

  OncoTargets and therapy 20110101

• Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies.

  OncoTargets and therapy 20110101

• The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery.

  BMC surgery 20110101

• Efficacy of bevacizumab-capecitabine in combination for the first-line treatment of metastatic breast cancer.

  Breast cancer : basic and clinical research 20110101

• A case of diffuse alveolar hemorrhage associated with tegafur plus uracil and warfarin therapy.

  Clinical medicine insights. Case reports 20110101

• Identifying HER2 inhibitors from natural products database.

  PloS one 20110101

• Efficient blockade of Akt signaling is a determinant factor to overcome resistance to matuzumab.

  Molecular cancer 20110101

• Radiotherapy and 'new' drugs-new side effects?

  Radiation oncology (London, England) 20110101

• Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting.

  PloS one 20110101

• Oxaliplatin-induced neuropathy in colorectal cancer.

  Journal of oncology 20110101

• Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment.

  World journal of surgical oncology 20110101

• Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells.

  PloS one 20110101

• Luminal-B breast cancer and novel therapeutic targets.

  Breast cancer research : BCR 20110101

• False-Positive Mediastinal Lymphadenopathy on 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography after Rectal Cancer Resection: A Case Report of Thoracoscopic Surgery in the Prone Position.

  Case reports in oncology 20110101

• Radioembolization in the treatment of neuroendocrine tumor metastases to the liver.

  International journal of hepatology 20110101

• Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.

  International journal of nanomedicine 20110101

• Novel immunotherapeutic strategies of gastric cancer treatment.

  Journal of biomedicine & biotechnology 20110101

• Mobile health for drug dose optimisation.

  Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20110101

• The state of research into children with cancer across Europe: new policies for a new decade.

  Ecancermedicalscience 20110101

• Tips and tricks in triple-negative breast cancer: how to manage patients in real-life practice?

  Ecancermedicalscience 20110101

• Endocrine-responsive breast cancer: a 28-year Odyssey.

  Ecancermedicalscience 20110101

• A phase II study of oxaliplatin with 5-FU/folinic acid and concomitant radiotherapy as a preoperative treatment in patients with locally advanced rectal cancer.

  Biomedical imaging and intervention journal 20110101

• The prospective role of plant products in radiotherapy of cancer: a current overview.

  Frontiers in pharmacology 20110101

• Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis.

  Gastrointestinal cancer research : GCR 20110101

• Role of HER2-Targeted Agents in Adjuvant Treatment for Breast Cancer.

  Chemotherapy research and practice 20110101

• Neoadjuvant treatment in rectal cancer: actual status.

  Chemotherapy research and practice 20110101

• Development of an oral form of azacytidine: 2'3'5'triacetyl-5-azacytidine.

  Chemotherapy research and practice 20110101

• Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support.

  International journal of breast cancer 20110101

• Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data.

  International journal of surgical oncology 20110101

• Colorectal liver metastases.

  International journal of surgical oncology 20110101

• Concomitant radiotherapy and chemotherapy for high-risk nonmelanoma skin carcinomas of the head and neck.

  International journal of surgical oncology 20110101

• Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience.

  International journal of surgical oncology 20110101

• Treatment of pancreatic and periampullary cancers at a community hospital: successful application of tertiary care treatment standards.

  International journal of surgical oncology 20110101

• Triple-negative breast cancer: adjuvant therapeutic options.

  Chemotherapy research and practice 20110101

• Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical response.

  Tumori 20110101

• Pancreatic cancer: chemotherapy and radiotherapy.

  North American journal of medical sciences 20110101

• Molecular aspects of breast cancer metastasis to the brain.

  Genetics research international 20110101

• Metachronous anal canal and prostate cancers with simultaneous definitive therapy: a case report and review of the literature.

  Case reports in oncological medicine 20110101

• Hepatocellular Carcinoma Metastasis to the Orbit in a Coinfected HIV+ HBV+ Patient Previously Treated with Orthotopic Liver Transplantation: A Case Report.

  Case reports in ophthalmological medicine 20110101

• Endovascular treatment of a right-sided ureteroiliac fistula in a patient with a simultaneous left-sided ureteroileal fistula.

  Case reports in urology 20110101

• Cell death signaling and anticancer therapy.

  Frontiers in oncology 20110101

• Diagnostic uncertainty around seizures in advanced malignancy.

  BMJ case reports 20110101

• A case of pancreatic acinar cell carcinoma metastatic to skin.

  Rare tumors 20101231

• Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101210

• Cancer and renal insufficiency results of the BIRMA study.

  British journal of cancer 20101207

• Standard-dose tegafur combined with uracil is not safe treatment after severe toxicity from 5-fluorouracil or capecitabine.

  Annals of internal medicine 20101207

• Trastuzumab: in HER2-positive metastatic gastric cancer.

  Drugs 20101203

• Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues.

  Breast cancer research and treatment 20101201

• Capecitabine-induced cerebellar toxicity in a patient with metastatic colorectal cancer.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20101201

• The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater.

  Medical oncology (Northwood, London, England) 20101201

• The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer.

  Medical oncology (Northwood, London, England) 20101201

• Atypical presentation of acute neurotoxicity secondary to oxaliplatin.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20101201

• Identifying subsets of metastatic breast cancer patients likely to benefit from treatment with the epothilone B analog ixabepilone.

  American journal of clinical oncology 20101201

• Cost comparison of capecitabine in patients with breast cancer.

  American journal of clinical oncology 20101201

• Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma.

  Journal of cancer research and clinical oncology 20101201

• Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101201

• Modular therapy approach in metastatic castration-refractory prostate cancer.

  World journal of urology 20101201

• Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.

  Annals of surgical oncology 20101201

• The addition of pravastatin to chemotherapy in advanced gastric carcinoma: a randomised phase II trial.

  European journal of cancer (Oxford, England : 1990) 20101201

• First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial.

  European journal of cancer (Oxford, England : 1990) 20101201

• [Chemotherapy in gallbladder carcinoma].

  Presse medicale (Paris, France : 1983) 20101201

• Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20101201

• Bevacizumab-based therapy and complication risk after colonic stent placement: is it time for a warning?

  Gastrointestinal endoscopy 20101201

• Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy.

  Asia-Pacific journal of clinical oncology 20101201

• Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection.

  Asia-Pacific journal of clinical oncology 20101201

• Comparison of the 5-fluorouracil-warfarin and capecitabine-warfarin drug interactions.

  Pharmacotherapy 20101201

• [HER2 and gastric cancer: a novel therapeutic target for trastuzumab].

  Bulletin du cancer 20101201

• ABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients.

  Pharmacogenomics 20101201

• A tolerability and pharmacokinetic study of adjuvant erlotinib and capecitabine with concurrent radiation in resected pancreatic cancer.

  Translational oncology 20101201

• [A case of capecitabine-resistant recurrent breast cancer found to be responsive to S-1].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101201

• A rapid and simple HPLC assay for quantification of capecitabine for drug monitoring purposes.

  Anticancer research 20101201

• Oxaliplatin-induced chronic peripheral neurotoxicity: a prospective analysis in patients with colorectal cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20101201

• Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era.

  Cancer research and treatment : official journal of Korean Cancer Association 20101201

• Lapatinib in breast cancer - the predictive significance of HER1 (EGFR), HER2, PTEN and PIK3CA genes and lapatinib plasma level assessment.

  Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20101201

• 1,2,3-Tri-O-acetyl-5-de-oxy-d-ribofuran-ose.

  Acta crystallographica. Section E, Structure reports online 20101201

• BRAF p.Val600Glu (V600E) Testing for Assessment of Treatment Options in Metastatic Colorectal Cancer.

  PLoS currents 20101126

• Trastuzumab for gastric cancer treatment.

  Lancet (London, England) 20101120

• Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma.

  British journal of cancer 20101109

• A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer.

  British journal of cancer 20101109

• Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitor.

  British journal of cancer 20101109

• Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials.

  British journal of cancer 20101109

• Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer.

  British journal of cancer 20101109

• The impact of new treatment options for advanced colorectal cancer on routine care: results of a retrospective analysis of 206 consecutive patients treated in a community-based oncology group practice in Germany.

  European journal of cancer care 20101101

• Sequential surgical resection of hepatic and pulmonary metastases from colorectal cancer.

  Langenbeck's archives of surgery 20101101

• Optimising the dose of capecitabine in metastatic breast cancer: confused, clarified or confirmed?

  Annals of oncology : official journal of the European Society for Medical Oncology 20101101

• Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer.

  Acta oncologica (Stockholm, Sweden) 20101101

• Trastuzumab beyond progression: a cost-utility analysis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101101

• Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101101

• Capecitabine dosing is not yet optimized for breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101101

• Management of ErbB2-positive breast cancer: insights from preclinical and clinical studies with lapatinib.

  Japanese journal of clinical oncology 20101101

• A phase II trial evaluating weekly docetaxel and capecitabine in patients with metastatic or advanced, locally recurrent head and neck cancers.

  Cancer investigation 20101101

• Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study.

  Breast cancer research and treatment 20101101

• Management of intractable hypoglycemia with Yttirum-90 radioembolization in a patient with malignant insulinoma.

  The American journal of the medical sciences 20101101

• Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity.

  Human genetics 20101101

• Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy.

  Breast cancer research and treatment 20101101

• Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine.

  Cancer biology & therapy 20101101

• Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101101

• Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study.

  Cancer chemotherapy and pharmacology 20101101

• Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20101101

• Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine.

  British journal of cancer 20101101

• Radiation recall with anticancer agents.

  The oncologist 20101101

• Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.

  British journal of cancer 20101101

• [Two cases of HER2-positive advanced or metastatic breast cancer, responding to lapatinib and capecitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [Weekly irinotecan plus capecitabine as a second-line chemotherapy for advanced gastric cancer: an analysis of 21 cases].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20101101

• XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer.

  Anticancer research 20101101

• Colorectal cancer screening for average-risk North Americans: an economic evaluation.

  PLoS medicine 20101101

• Update on capecitabine alone and in combination regimens in colorectal cancer patients.

  Cancer treatment reviews 20101101

• Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer.

  Chinese medical journal 20101101

• [Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20101101

• Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future.

  Oncotarget 20101101

• A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours.

  British journal of cancer 20101026

• Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy.

  British journal of cancer 20101026

• A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients.

  British journal of cancer 20101026

• A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer.

  British journal of cancer 20101026

• Phase I studies of drug combinations.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101020

• Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101020

• [Expression of phosphatase and tensin homolog in lower rectal cancer on neoadjuvant chemoradiotherapy].

  Zhonghua yi xue za zhi 20101019

• Elevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice.

  British journal of cancer 20101012

• Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α.

  British journal of cancer 20101012

• Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation.

  British journal of cancer 20101012

• Radiosensitizing drugs: lessons to be learned from the oxaliplatin story.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010

• Are we ready to use an early alternative end point as the primary end point of a phase III study in rectal cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010

• A phase I study of sunitinib plus capecitabine in patients with advanced solid tumors.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010

• Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer.

  Breast cancer (Tokyo, Japan) 20101001

• Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20101001

• Impact of prophylactic pyridoxine on occurrence of hand-foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer.

  Breast cancer (Tokyo, Japan) 20101001

• Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer.

  Journal of surgical oncology 20101001

• Ixabepilone, a new treatment option for metastatic breast cancer.

  American journal of clinical oncology 20101001

• Increased anticoagulant activity of warfarin used in combination with doxifluridine.

  Cancer chemotherapy and pharmacology 20101001

• Renal atrophy secondary to chemoradiotherapy of abdominal malignancies.

  International journal of radiation oncology, biology, physics 20101001

• Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials.

  International journal of radiation oncology, biology, physics 20101001

• Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO).

  Critical reviews in oncology/hematology 20101001

• Moderate dose capecitabine in older patients with metastatic breast cancer: a standard option for first line treatment?

  Breast (Edinburgh, Scotland) 20101001

• 177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide.

  European journal of nuclear medicine and molecular imaging 20101001

• Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer.

  Japanese journal of clinical oncology 20101001

• Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling.

  International journal of radiation oncology, biology, physics 20101001

• Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine).

  Breast cancer research and treatment 20101001

• A phase I study of docetaxel, oxaliplatin, & capecitabine (DOC) as first-line therapy of patients with locally advanced or metastatic adenocarcinoma of stomach and GE junction.

  Cancer investigation 20101001

• Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomised phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101001

• Limited value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: a prospective study with long-term follow-up.

  Annals of surgical oncology 20101001

• Medical oncology: A novel low-toxicity regimen for advanced colorectal cancer?

  Nature reviews. Clinical oncology 20101001

• Ixabepilone plus capecitabine for breast cancer patients with an early metastatic relapse after adjuvant chemotherapy: two clinical trials.

  Clinical breast cancer 20101001

• Patients with locally advanced and metastatic colorectal cancer treated with capecitabine versus 5-fluorouracil as monotherapy or combination therapy with oxaliplatin: a cost comparison.

  Clinical colorectal cancer 20101001

• Differences in efficacy and safety between capecitabine and infusional 5-fluorouracil when combined with irinotecan for the treatment of metastatic colorectal cancer.

  Clinical colorectal cancer 20101001

• Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents.

  The oncologist 20101001

• Challenges of drug resistance in the management of pancreatic cancer.

  Expert review of anticancer therapy 20101001

• How to integrate molecular targeted agents in the continuum of care.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101001

• Capecitabine for the treatment of advanced gastric cancer.

  Health technology assessment (Winchester, England) 20101001

• Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer.

  Health technology assessment (Winchester, England) 20101001

• Surgical resection for lung metastases from colorectal cancer.

  Journal of the Korean Society of Coloproctology 20101001

• Chemotherapy of metastatic colorectal cancer.

  Prescrire international 20101001

• An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity?

  Indian journal of pharmacology 20101001

• Non-surgical treatment of primary female urethral cancer.

  Rare tumors 20100930

• A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours.

  British journal of cancer 20100928

• Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours.

  British journal of cancer 20100928

• Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.

  British journal of cancer 20100928

• Cardiac side-effects of cancer chemotherapy.

  International journal of cardiology 20100924

• High-dose-rate intraluminal brachytherapy during preoperative chemoradiation for locally advanced rectal cancers.

  World journal of gastroenterology 20100921

• Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma.

  British journal of cancer 20100907

• Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients.

  British journal of cancer 20100907

• Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer.

  Medical oncology (Northwood, London, England) 20100901

• Role of low dose capecitabine combined to irinotecan in advanced and metastatic gastric cancer.

  Medical oncology (Northwood, London, England) 20100901

• Capecitabine cardiac toxicity presenting as effort angina: a case report.

  Journal of cardiovascular medicine (Hagerstown, Md.) 20100901

• Complications after sphincter-saving resection in rectal cancer patients according to whether chemoradiotherapy is performed before or after surgery.

  International journal of radiation oncology, biology, physics 20100901

• Local excision of rectal cancer after chemoradiation: feasibility depends on the primary stage.

  International journal of colorectal disease 20100901

• The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy.

  Annals of surgical oncology 20100901

• Chemoradiotherapy with or without induction chemotherapy for locally advanced pancreatic cancer: a UK multi-institutional experience.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20100901

• Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20100901

• Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100901

• Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100901

• Safety of capecitabine: a review.

  Expert opinion on drug safety 20100901

• Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: final survival analysis of a phase III randomized trial.

  The oncologist 20100901

• Quality of life in hormone receptor-positive HER-2+ metastatic breast cancer patients during treatment with letrozole alone or in combination with lapatinib.

  The oncologist 20100901

• [Adverse events in patients treated with capecitabine as adjuvant chemotherapy after surgery for colorectal cancer--countermeasures against hand-foot syndrome].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100901

• Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancer.

  The Netherlands journal of medicine 20100901

• Sister Mary Joseph's nodule as a metastasis of ovarian adenocarcinoma.

  International journal of dermatology 20100901

• A brief report: Yale Research Symposium on Complementary and Integrative Medicine.

  The Yale journal of biology and medicine 20100901

• Is pyridoxine helpful in preventing palmar-plantar erythrodysesthesia associated with capecitabine?

  Asia-Pacific journal of clinical oncology 20100901

• Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia.

  Asia-Pacific journal of clinical oncology 20100901

• Efficacy of S-1 in patients with capecitabine-resistant breast cancer-Japan Breast Cancer Research Network (JBCRN) 04-1 trial.

  Anticancer research 20100901

• Using bevacizumab with different chemotherapeutic regimens in metastatic colorectal cancer: balancing utility with low toxicity.

  Therapeutic advances in medical oncology 20100901

• A case report of 5-fluorouracil-induced coronary artery vasospasm.

  The Ulster medical journal 20100901

• Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

  Lancet (London, England) 20100828

• The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective study.

  British journal of cancer 20100824

• A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit.

  British journal of cancer 20100824

• Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer.

  British journal of cancer 20100824

• Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100820

• Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.

  Cancer 20100815

• Capecitabine for locally advanced and metastatic colorectal cancer: A review.

  World journal of gastrointestinal oncology 20100815

• UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy.

  British journal of cancer 20100810

• Capecitabine with radiation is an effective adjuvant therapy in gastric cancers.

  World journal of gastroenterology 20100807

• Capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy?

  Annals of oncology : official journal of the European Society for Medical Oncology 20100801

• Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100801

• Preoperative staging with chest CT in patients with colorectal carcinoma: not as a routine procedure.

  Annals of surgical oncology 20100801

• Multimodal treatment options for bilobar colorectal liver metastases.

  Langenbeck's archives of surgery 20100801

• Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature.

  International journal of clinical oncology 20100801

• Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment.

  Cancer chemotherapy and pharmacology 20100801

• The role of targeted agents in preoperative chemoradiation for rectal cancer.

  Cancer 20100801

• Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20100801

• Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20100801

• Treatment strategy for HER2-positive breast cancer.

  International journal of clinical oncology 20100801

• A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080.

  Journal of pharmacokinetics and pharmacodynamics 20100801

• Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.

  The oncologist 20100801

• Rational use of anticancer drugs and patient lawsuits in the state of São Paulo, Southeastern Brazil.

  Revista de saude publica 20100801

• [Treatment and outcome in small bowel cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100801

• Lapatinib and breast cancer: current indications and outlook for the future.

  Expert review of anticancer therapy 20100801

• [Oxaliplatin plus capecitabine for advanced gastric cancer: report of 38 cases].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20100801

• [Efficacy and safety of bevacizumab plus capecitabine for metastatic colorectal cancer].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20100801

• [Uncommon rectal adenocarcinoma metastases].

  Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti 20100801

• Cessation or dose reduction of Capecitabine due to Complications in Patients with Colon Cancer.

  Journal of the Korean Society of Coloproctology 20100801

• Clinical significance of tumor regression grade in rectal cancer with preoperative chemoradiotherapy.

  Journal of the Korean Society of Coloproctology 20100801

• Oncologic outcome after cessation or dose reduction of capecitabine in patients with colon cancer.

  Journal of the Korean Society of Coloproctology 20100801

• 5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency.

  British journal of cancer 20100727

• BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation.

  British journal of cancer 20100727

• Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom.

  British journal of cancer 20100727

• Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era.

  International journal of radiation oncology, biology, physics 20100715

• Oncological outcome of unresectable lung metastases without extrapulmonary metastases in colorectal cancer.

  World journal of gastroenterology 20100714

• Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases.

  British journal of cancer 20100713

• Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy.

  British journal of cancer 20100713

• [A pilot study of weekly versus 3-week docetaxel in combination with capecitabine in patients with anthracycline-pretreated metastatic breast cancer].

  Zhonghua yi xue za zhi 20100713

• Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100710

• Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the '2010 ASCO Annual Meeting'. Chicago, IL, USA. June 4-8, 2010.

  JOP : Journal of the pancreas 20100705

• Capecitabine/oxaliplatin as first-line treatment for metastatic colorectal cancer: a meta-analysis.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20100701

• Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer.

  Breast cancer (Tokyo, Japan) 20100701

• Clinical features of oral chemotherapy: results of a longitudinal prospective study of breast and colorectal cancer patients receiving capecitabine in the UK.

  European journal of cancer care 20100701

• Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy.

  Cancer chemotherapy and pharmacology 20100701

• Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20100701

• Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial).

  Annals of oncology : official journal of the European Society for Medical Oncology 20100701

• Combined environmental risk assessment for 5-fluorouracil and capecitabine in Europe.

  Integrated environmental assessment and management 20100701

• An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100701

• Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials.

  Breast cancer research and treatment 20100701

• Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes.

  Breast cancer research and treatment 20100701

• New drugs in neuroendocrine tumors: rising of new therapeutic philosophies?

  Current opinion in oncology 20100701

• Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.

  Oncology reports 20100701

• Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100701

• Neoadjuvant treatment of adenocarcinomas of the gastroesophageal junction and stomach - a feasibility trial combining cisplatin and docetaxel with either 5-fluorouracil or capecitabine.

  International journal of clinical pharmacology and therapeutics 20100701

• Plasma disposition of capecitabine (CCB) and its metabolites 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouracil (5'-DFUR) with two different capecitabine/oxaliplatin dosage regimens.

  International journal of clinical pharmacology and therapeutics 20100701

• Underuse of anthracyclines in women with HER-2+ advanced breast cancer.

  The oncologist 20100701

• Adjuvant chemoradiation therapy in gallbladder cancer.

  Journal of surgical oncology 20100701

• Combined-modality treatment for anal cancer: current strategies and future directions.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20100701

• Effects of Qingyi Huaji decoction on serum levels of interleukin-6, interleukin-8 and tumor necrosis factor-alpha in nude mice bearing pancreatic tumors.

  Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20100701

• Introducing national guidelines on perioperative chemotherapy for gastric cancer in Norway: a retrospective audit.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20100701

• A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer.

  Clinical colorectal cancer 20100701

• Development of bronchiolitis obliterans organizing pneumonia with platinum-based chemotherapy for metastatic rectal cancer.

  Clinical colorectal cancer 20100701

• [The role of oral fluoropyrimidines in colorectal cancer treatment--a review].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100701

• [Treatment with oral agents for breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100701

• Phase II study of capecitabine (Ro 09-1978) in patients who have failed first line treatment for locally advanced and/or metastatic cervical cancer.

  Gan to kagaku ryoho. Cancer & chemotherapy 20100701

• Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.

  Current oncology (Toronto, Ont.) 20100701

• Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer.

  Current oncology (Toronto, Ont.) 20100701

• KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies.

  Current oncology (Toronto, Ont.) 20100701

• Docetaxel second-line therapy in patients with advanced pancreatic cancer: a retrospective study.

  Anticancer research 20100701

• Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy.

  Anticancer research 20100701

• Trastuzumab plus capecitabine and docetaxel as first-line therapy for HER2-positive metastatic breast cancer: phase II results.

  Anticancer research 20100701

• Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region.

  Journal of the National Comprehensive Cancer Network : JNCCN 20100701

• Capecitabine and temozolomide: design, implementation, and preliminary outcomes from a pilot project to ensure safe prescribing of oral chemotherapy.

  Journal of oncology practice 20100701

• New trends in nucleoside biotechnology.

  Acta naturae 20100701

• Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma.

  British journal of cancer 20100629

• NICE rejects drug for metastatic breast cancer because of cost and poor efficacy.

  BMJ (Clinical research ed.) 20100611

• Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies.

  British journal of cancer 20100608

• Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment.

  British journal of cancer 20100608

• Regarding: 'Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array'.

  British journal of cancer 20100608

• Capecitabine-induced pancreatitis.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20100601

• A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer.

  American journal of clinical oncology 20100601

• A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer.

  American journal of clinical oncology 20100601

• A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100601

• Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs).

  Annals of oncology : official journal of the European Society for Medical Oncology 20100601

• Intravenous versus oral vinorelbine plus capecitabine as second-line treatment in advanced breast cancer patients. A retrospective comparison of two consecutive phase II studies.

  Breast (Edinburgh, Scotland) 20100601

• Out-of-pocket payment and cost-effectiveness of XELOX and XELOX plus bevacizumab therapy: from the perspective of metastatic colorectal cancer patients in Japan.

  International journal of clinical oncology 20100601

• Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer.

  Breast cancer research and treatment 20100601

• Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine.

  Cutaneous and ocular toxicology 20100601

• Liposomal pegylated doxorubicin and oxaliplatin as salvage chemotherapy in patients with metastatic gastric cancer treated earlier.

  Anti-cancer drugs 20100601

• Novel benzimidazole-pyrimidine conjugates as potent antitumor agents.

  European journal of medicinal chemistry 20100601

• Dosing considerations for capecitabine-irinotecan regimens in the treatment of metastatic and/or locally advanced colorectal cancer.

  American journal of clinical oncology 20100601

• Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study.

  Endocrine-related cancer 20100601

• Is there a role for mitomycin C in metastatic colorectal cancer?

  Expert opinion on investigational drugs 20100601

• Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20100601

• Novel targeted therapies in inflammatory breast cancer.

  Cancer 20100601

• Overcoming radiation resistance in inflammatory breast cancer.

  Cancer 20100601

• Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.

  Pharmacogenomics 20100601

• Genetic polymorphism of GSTP1: prediction of clinical outcome to oxaliplatin/5-FU-based chemotherapy in advanced gastric cancer.

  Journal of Korean medical science 20100601

• An APCI LC-MS/MS method for routine determination of capecitabine and its metabolites in human plasma.

  Journal of mass spectrometry : JMS 20100601

• Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20100601

• Reversible serum carcinoembryogenic antigen (CEA) elevation due to orlistat use: A case report.

  Clinics (Sao Paulo, Brazil) 20100601

• Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapy.

  Cancer research and treatment : official journal of Korean Cancer Association 20100601

• High frequency of hand foot syndrome with capecitabine.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20100601

• Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancer.

  Anticancer research 20100601

• Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.

  Cancer 20100515

• Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100515

• Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer.

  British journal of cancer 20100511

• Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510

• Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510

• [Oncological treatment of patients with pancreatic cancer].

  Ugeskrift for laeger 20100503

• Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation.

  International journal of radiation oncology, biology, physics 20100501

• N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU.

  Cancer chemotherapy and pharmacology 20100501

• A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer.

  Cancer chemotherapy and pharmacology 20100501

• Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100501

• Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies.

  Journal of cancer research and clinical oncology 20100501

• Gemcitabine-based cytotoxic doublets chemotherapy for advanced pancreatic cancer: updated subgroup meta-analyses of overall survival.

  Japanese journal of clinical oncology 20100501

• Phase II study of capecitabine in combination with thalidomide in patients with metastatic breast cancer.

  Cancer investigation 20100501

• The kinetic mechanism of human uridine phosphorylase 1: Towards the development of enzyme inhibitors for cancer chemotherapy.

  Archives of biochemistry and biophysics 20100501

• Capecitabine and oxaliplatin as second-line treatment in patients with carcinoma of unknown primary site.

  Acta oncologica (Stockholm, Sweden) 20100501

• Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.

  Breast cancer research and treatment 20100501

• Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100501

• Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study.

  Acta oncologica (Stockholm, Sweden) 20100501

• Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100501

• Clinical benefit of lapatinib-based therapy in patients with human epidermal growth factor receptor 2-positive breast tumors coexpressing the truncated p95HER2 receptor.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100501

• Current and emerging treatment strategies for anal cancer.

  Current oncology reports 20100501

• [The anti EGFR antibody indication between the Japanese and overseas guidelines].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100501

• Investigation of IVS14 + 1G > A polymorphism of DPYD gene in a group of Bosnian patients treated with 5-Fluorouracil and capecitabine.

  Bosnian journal of basic medical sciences 20100501

• Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.

  British journal of cancer 20100427

• Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer.

  British journal of cancer 20100427

• Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420

• Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420

• Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care.

  British journal of cancer 20100413

• [Efficacy observation of accelerated hyperfractionation recourse radiotherapy plus concurrent capecitabine in the treatment of locoregional recurrent rectal cancer].

  Zhonghua yi xue za zhi 20100413

• International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?

  Journal of the National Cancer Institute 20100407

• 5-Fluorouracil-induced coronary vasospasm.

  Journal of cardiovascular medicine (Hagerstown, Md.) 20100401

• A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma.

  Biomedical chromatography : BMC 20100401

• A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies.

  Cancer chemotherapy and pharmacology 20100401

• Management of metastatic breast cancer: monotherapy options for patients resistant to anthracyclines and taxanes.

  American journal of clinical oncology 20100401

• A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20100401

• Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100401

• Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer.

  Journal of cancer research and clinical oncology 20100401

• Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100401

• KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy.

  Annals of surgical oncology 20100401

• Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer.

  Annals of surgical oncology 20100401

• Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20100401

• Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study.

  Anti-cancer drugs 20100401

• Adjuvant therapy for colon cancer: learning from the past to inform the future.

  Annals of surgical oncology 20100401

• MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil.

  Cancer biology & therapy 20100401

• Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06).

  The Lancet. Oncology 20100401

• Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?

  Acta oncologica (Stockholm, Sweden) 20100401

• Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401

• Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100401

• Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer.

  Clinical breast cancer 20100401

• Evolution of capecitabine dosing in breast cancer.

  Clinical breast cancer 20100401

• Preoperative capecitabine and pelvic radiation in locally advanced rectal cancer--is it equivalent to 5-FU infusion plus leucovorin and radiotherapy?

  International journal of radiation oncology, biology, physics 20100401

• Metronomic chemotherapy for renal cancer in the landscape of targeted therapy.

  The Lancet. Oncology 20100401

• Palliative chemotherapy for pancreatic malignancies.

  The Surgical clinics of North America 20100401

• Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature.

  Canadian Urological Association journal = Journal de l'Association des urologues du Canada 20100401

• Economic evaluation of capecitabine as adjuvant or metastatic therapy in colorectal cancer.

  Expert review of pharmacoeconomics & outcomes research 20100401

• Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer.

  Expert review of anticancer therapy 20100401

• One year of complete clinical response in a metastatic breast cancer patient treated with a combination of lapatinib and gemcitabine.

  Current oncology (Toronto, Ont.) 20100401

• Recent advances in combined modality therapy.

  The oncologist 20100401

• [More effective positioning of capecitabine for advanced and metastatic breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100401

• [An effective case of liver metastasis of breast cancer treated with capecitabine + docetaxel combination therapy using vitamin B6].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100401

• Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.

  PLoS medicine 20100401

• [Short-term therapeutic effect and safety of endostar combined with XELIRI regimen in the treatment of advanced colorectal cancer].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100401

• Cost analysis of capecitabine vs 5-fluorouracil-based treatment for metastatic colorectal cancer patients.

  Journal of chemotherapy (Florence, Italy) 20100401

• Erlotinib in combination with capecitabine (5'dFUR) in resistant pancreatic cancer cell lines.

  Journal of chemotherapy (Florence, Italy) 20100401

• Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina.

  Internal medicine journal 20100401

• A phase I dose-escalation study of imatinib mesylate (Gleevec/STI571) plus capecitabine (Xeloda) in advanced solid tumors.

  Anticancer research 20100401

• Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.

  British journal of cancer 20100316

• Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experience.

  British journal of cancer 20100316

• Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.

  British journal of cancer 20100316

• Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer. In regard to MG Zampino et al. (Int J Radiat Oncol Biol Phys 2009;75:421-427).

  International journal of radiation oncology, biology, physics 20100315

• Cutaneous metastasis as first clinical manifestation of signet ring cell gastric carcinoma.

  Dermatology online journal 20100315

• Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the '2010 ASCO Gastrointestinal Cancers Symposium'. Orlando, FL, USA. January 22-24, 2010.

  JOP : Journal of the pancreas 20100305

• Capecitabine and oxaliplatin for advanced esophagogastric cancer.

  The New England journal of medicine 20100304

• Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20100301

• Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.

  Cancer chemotherapy and pharmacology 20100301

• Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100301

• An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100301

• EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100301

• Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20100301

• Capecitabine monotherapy is efficient and safe in all line settings in patients with metastatic and advanced breast cancer.

  Japanese journal of clinical oncology 20100301

• Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells.

  Endocrine-related cancer 20100301

• Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin.

  Anti-cancer drugs 20100301

• Lapatinib and metronomic capecitabine combination in an HER2-positive inflammatory breast cancer patient: a case report.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100301

• A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20100301

• A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer.

  European journal of cancer (Oxford, England : 1990) 20100301

• Treatment interruption and discontinuation in radiotherapy for rectal cancer.

  Cancer investigation 20100301

• Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20100301

• Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.

  The Lancet. Oncology 20100301

• Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials.

  International journal of oncology 20100301

• Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.

  Neuro-oncology 20100301

• Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review.

  The oncologist 20100301

• Neoadjuvant chemotherapy in MRI-staged rectal cancer.

  The Lancet. Oncology 20100301

• Chemotherapy-associated peripheral sensory neuropathy assessed using in vivo corneal confocal microscopy.

  Archives of neurology 20100301

• [Severe toxicity following capecitabine administration because of dihydropyrimidine deshydrogenase (DPD) deficiency].

  Gastroenterologie clinique et biologique 20100301

• Increased mast cell density in capecitabine-induced hand-foot syndrome: a new pathologic finding.

  Journal of drugs in dermatology : JDD 20100301

• [Preliminary study of XELOX regimen as the first-line chemotherapy in advanced or recurrent gastric cancer].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100301

• [Efficacy and safety evaluation of docetaxel plus oxaliplatin and capecitabine in the treatment of advanced gastric adenocarcinoma: a single center non-controlled phase II clinical trial].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20100301

• [Treatment possibilities in breast cancer progressing after anthracyclines and/or taxanes].

  Magyar onkologia 20100301

• Molecular therapy of pancreatic cancer.

  Minerva endocrinologica 20100301

• Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: a descriptive report.

  Clinical therapeutics 20100301

• [Chemotherapy of colonic cancer].

  Soins; la revue de reference infirmiere 20100301

• Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens.

  Histopathology 20100301

• 4-Chloro-2-{3-chloro-2-[(3,5-dimethyl-piperidin-1-yl)meth-yl]phenyl-sulfan-yl}-6-methoxy-pyrimidine.

  Acta crystallographica. Section E, Structure reports online 20100301

• Randomized phase II trial of first-line trastuzumab plus docetaxel and capecitabine compared with trastuzumab plus docetaxel in HER2-positive metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220

• Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer.

  World journal of gastroenterology 20100214

• Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100210

• Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100210

• Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial.

  British journal of cancer 20100202

• Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer.

  Cancer chemotherapy and pharmacology 20100201

• Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings?

  International journal of radiation oncology, biology, physics 20100201

• A prospective monitoring of fatal serious adverse events (SAEs) in a Dutch Colorectal Cancer Group (DCCG) phase III trial (CAIRO) in patients with advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100201

• Feasibility and efficacy of capecitabine and FOLFIRI in patients aged 65 years and older with advanced colorectal cancer: a retrospective analysis.

  Journal of cancer research and clinical oncology 20100201

• Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20100201

• North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100201

• Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma.

  European journal of endocrinology 20100201

• Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer.

  Breast cancer research and treatment 20100201

• Sickle cell crisis in a patient receiving capecitabine chemotherapy.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20100201

• Molecular predictors of response to trastuzumab and lapatinib in breast cancer.

  Nature reviews. Clinical oncology 20100201

• [Prerequisites to the administration and prevention of adverse effects of chemotherapy in colorectal cancer].

  Bulletin du cancer 20100201

• Fixed-dose every-other-week capecitabine and oxaliplatin for refractory squamous cell carcinoma of the head and neck.

  The American journal of the medical sciences 20100201

• Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM).

  Annals of oncology : official journal of the European Society for Medical Oncology 20100201

• Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20100201

• Ixabepilone.

  Clinical journal of oncology nursing 20100201

• Metastatic prostatic adenocarcinoma mimicking inflammatory breast carcinoma: a case report.

  Clinical breast cancer 20100201

• Visceral disease in patients with metastatic breast cancer: efficacy and safety of treatment with ixabepilone and other chemotherapeutic agents.

  Clinical breast cancer 20100201

• Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer.

  Future oncology (London, England) 20100201

• Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor-positive metastatic breast cancer.

  The oncologist 20100201

• Subconjunctival bevacizumab as an adjunct to trabeculectomy in eyes with refractory glaucoma: a case series.

  Korean journal of ophthalmology : KJO 20100201

• Cost effectiveness of TAC versus FAC in adjuvant treatment of node-positive breast cancer.

  Current oncology (Toronto, Ont.) 20100201

• Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada.

  Current oncology (Toronto, Ont.) 20100201

• Capecitabine-induced cardiotoxicity: case report and review of the literature.

  Current oncology (Toronto, Ont.) 20100201

• The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer.

  Cancer treatment reviews 20100201

• [Efficacy and toxicity analysis of XELOX and FOLFOX4 regimens as adjuvant chemotherapy for stage III colorectal cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100201

• Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer.

  British journal of cancer 20100119

• Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status.

  British journal of cancer 20100119

• An epigenetic mechanism for capecitabine resistance in mesothelioma.

  Biochemical and biophysical research communications 20100115

• Activity of the kinesin spindle protein inhibitor ispinesib (SB-715992) in models of breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100115

• Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.

  Journal of the National Cancer Institute 20100106

• Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer.

  British journal of cancer 20100105

• Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial.

  British journal of cancer 20100105

• Biomarkers of angiogenesis and their role in the development of VEGF inhibitors.

  British journal of cancer 20100105

• [Cardiotoxicity induced by 5-fluorouracil or capecitabine].

  Ugeskrift for laeger 20100104

• Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal caner - meta-analysis of six randomized trials.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20100101

• A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts.

  Cancer chemotherapy and pharmacology 20100101

• Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials.

  Cancer chemotherapy and pharmacology 20100101

• A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100101

• Severe palmar-plantar erytrodysesthesia after treatment with capecitabine.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20100101

• A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100101

• A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines.

  Journal of cancer research and clinical oncology 20100101

• Oral treatment of metastatic breast cancer with capecitabine: what influences the decision-making process?

  European journal of cancer care 20100101

• Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'.

  Anti-cancer drugs 20100101

• A phase II study of irinotecan and capecitabine for patients with unresectable liver-only metastases from colorectal cancer.

  Japanese journal of clinical oncology 20100101

• Prognostic Impact of [18F] FDG-PET in operable breast cancer treated with neoadjuvant chemotherapy.

  Annals of surgical oncology 20100101

• The contribution of deleterious DPYD gene sequence variants to fluoropyrimidine toxicity in British cancer patients.

  Cancer chemotherapy and pharmacology 20100101

• Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer.

  Anti-cancer drugs 20100101

• A dose escalation study of docetaxel plus capecitabine in combination with oxaliplatin in patients with advanced solid tumors.

  Acta oncologica (Stockholm, Sweden) 20100101

• Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study.

  Acta oncologica (Stockholm, Sweden) 20100101

• Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance.

  Annals of surgical oncology 20100101

• Acute aortic dissection during sorafenib-containing therapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100101

• Time to first tumor progression as outcome predictor of a second trasuzumab-based therapy beyond progression in HER-2 positive metastatic breast cancer.

  The breast journal 20100101

• Capecitabine after gastrectomy for advanced gastric cancer: have we got the patient right?

  Annals of oncology : official journal of the European Society for Medical Oncology 20100101

• Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100101

• The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.

  Journal of neuro-oncology 20100101

• Colorectal cancer in Mexico: should a middle income country invest in screening or in treatment?

  The European journal of health economics : HEPAC : health economics in prevention and care 20100101

• Interaction between capecitabine and brivudin in a patient with breast cancer.

  Nature reviews. Clinical oncology 20100101

• [Clinical features of hypersensitivity reactions to oxaliplatin among Chinese colorectal cancer patients].

  Chinese journal of cancer 20100101

• Lapatinib.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20100101

• Therapeutic usefulness of postoperative adjuvant chemotherapy with Tegafur-Uracil (UFT) in patients with breast cancer: focus on the results of clinical studies in Japan.

  The oncologist 20100101

• [Two cases of breast cancer responding to primary systemic chemotherapy containing trastuzumab without surgery].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100101

• Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types.

  Journal of experimental & clinical cancer research : CR 20100101

• A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanoma.

  PloS one 20100101

• Hypertriglyceridemia: An underdiagnosed side effect of Capecitabine chemotherapy.

  Acta oncologica (Stockholm, Sweden) 20100101

• Evolution of capecitabine dosing in colorectal cancer.

  Clinical colorectal cancer 20100101

• Colorectal cancer: response to sunitinib in a heavily pretreated colorectal cancer patient.

  Anti-cancer drugs 20100101

• Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression.

  PloS one 20100101

• A humanized anti-VEGF rabbit monoclonal antibody inhibits angiogenesis and blocks tumor growth in xenograft models.

  PloS one 20100101

• TAp73 is one of the genes responsible for the lack of response to chemotherapy depending on B-Raf mutational status.

  Journal of translational medicine 20100101

• [Dihydropyrimidine dehydrogenase deficiency and toxicity to fluoropyrimidine].

  Annales de biologie clinique 20100101

• From basic research to clinical development of MEK1/2 inhibitors for cancer therapy.

  Journal of hematology & oncology 20100101

• Long-lasting control of triple-negative metastatic breast cancer with the novel drug combination ixabepilone and capecitabine--case report.

  Onkologie 20100101

• Triple-negative breast cancer: role of specific chemotherapy agents.

  Cancer journal (Sudbury, Mass.) 20100101

• [Prinzmetal's angina in a patient treated with capecitabine: a case study].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20100101

• Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience.

  Radiation oncology (London, England) 20100101

• Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer.

  BMC medical genetics 20100101

• Targeted HER2 treatment in advanced gastric cancer.

  Oncology 20100101

• Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications.

  Radiation oncology (London, England) 20100101

• [Long-term response of liver metastases of breast cancer to capecitabine--case report].

  Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20100101

• Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.

  Diagnostic pathology 20100101

• Transient bilateral abducens neuropathy with post-tetanic facilitation and acute hypokalemia associated with oxaliplatin: a case report.

  Journal of medical case reports 20100101

• Gefitinib in combination with capecitabine as second-line therapy in patients with advanced colorectal cancer (aCRC): a phase I/II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

  Onkologie 20100101

• Recent advances in gastrointestinal oncology--updates and insights from the 2009 annual meeting of the American society of clinical oncology.

  Journal of hematology & oncology 20100101

• Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.

  Journal of hematology & oncology 20100101

• Phase II trial of XELOX as first-line treatment for patients with advanced gastric cancer.

  Chemotherapy 20100101

• The Vanishing Stenosis: ST Elevation Myocardial Infarction and Rhythm Disturbance due to Coronary Artery Spasm-Case Report and Review of the Literature.

  Case reports in medicine 20100101

• Cancer-drug associations: a complex system.

  PloS one 20100101

• Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.

  BMC cancer 20100101

• Isolated pancreatic metastasis from rectal cancer: a case report and review of literature.

  World journal of surgical oncology 20100101

• A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas.

  Oncology 20100101

• Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence.

  Radiation oncology (London, England) 20100101

• Screening mammography use and chemotherapy among female stage II colon cancer patients: a retrospective cohort study.

  BMC health services research 20100101

• [New generation chemotherapy in the treatment of operated gastric cancer--an alternative to traditional chemotherapy].

  Chirurgia (Bucharest, Romania : 1990) 20100101

• Study of low-dose capecitabine monotherapy for metastatic breast cancer.

  Chemotherapy 20100101

• Implications of anthracycline-resistant and taxane-resistant metastatic breast cancer and new therapeutic options.

  The breast journal 20100101

• Clinical evidence for overcoming capecitabine resistance in a woman with breast cancer terminating in radiologically occult micronodular pseudo-cirrhosis with portal hypertension: a case report.

  Journal of medical case reports 20100101

• A phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) as first-line chemotherapy in advanced gastric cancer: a Chinese single-center experience.

  Chemotherapy 20100101

• Cancer chemotherapy and cardiovascular risks: is capecitabine-induced hypertriglyceridemia a rare adverse effect?

  Cardiology 20100101

• [Radiochemotherapy for locally advanced anal cancer].

  Onkologie 20100101

• High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.

  Breast cancer research : BCR 20100101

• Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model.

  BMC cancer 20100101

• Capecitabine and sixth cranial nerve palsy.

  Journal of cancer research and therapeutics 20100101

• Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials.

  Journal of experimental & clinical cancer research : CR 20100101

• Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine.

  Head & neck oncology 20100101

• Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.

  Radiation oncology (London, England) 20100101

• Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response.

  The Journal of international medical research 20100101

• Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling.

  Breast disease 20100101

• Strategic options on behalf of patients with metastatic colorectal cancer: mass tumor murder versus serial tumor killing.

  Onkologie 20100101

• Oxaliplatin, irinotecan and capecitabine (OCX) for first-line treatment of advanced/metastatic colorectal cancer: a phase I trial (SAKK 41/03).

  Onkologie 20100101

• Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study.

  BMC cancer 20100101

• Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial.

  Journal of translational medicine 20100101

• L2-norm multiple kernel learning and its application to biomedical data fusion.

  BMC bioinformatics 20100101

• Feasibility study of docetaxel, oxaliplatin and capecitabine combination regimen in advanced gastric or gastroesophageal adenocarcinoma.

  Hematology/oncology and stem cell therapy 20100101

• Case report of acute aortic dissection during treatment with capecitabine for a late recurrence of breast cancer.

  Chemotherapy 20100101

• The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET.

  Breast cancer research : BCR 20100101

• Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer.

  Radiation oncology (London, England) 20100101

• A pre-post test evaluation of the impact of the PELICAN MDT-TME Development Programme on the working lives of colorectal cancer team members.

  BMC health services research 20100101

• The role of radiotherapy in multimodal treatment of pancreatic carcinoma.

  Radiation oncology (London, England) 20100101

• Update on options for treatment of metastatic castration-resistant prostate cancer.

  OncoTargets and therapy 20100101

• Anti-angiogenesis therapies: their potential in cancer management.

  OncoTargets and therapy 20100101

• The dual kinase complex FAK-Src as a promising therapeutic target in cancer.

  OncoTargets and therapy 20100101

• Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies.

  BMC cancer 20100101

• Successful treatment of recurrent small bowel adenocarcinoma by cytoreductive surgery and chemotherapy: a case report and review of the literature.

  Journal of medical case reports 20100101

• Tian Xian Liquid (TXL) induces apoptosis in HT-29 colon cancer cell in vitro and inhibits tumor growth in vivo.

  Chinese medicine 20100101

• Confirmation of a low HER2 positivity rate of breast carcinomas - limitations of immunohistochemistry and in situ hybridization.

  Diagnostic pathology 20100101

• Adverse Interaction between Capecitabine and Warfarin Resulting in Altered Coagulation Parameters: A Review of the Literature Starting from a Case Report.

  Case reports in medicine 20100101

• Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation.

  European journal of medical research 20100101

• Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data.

  Cancer informatics 20100101

• Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer.

  BMC cancer 20100101

• Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes.

  Chemotherapy 20100101

• Analysis of the thymidylate synthase gene structure in colorectal cancer patients and its possible relation with the 5-Fluorouracil drug response.

  Journal of nucleic acids 20100101

• A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906.

  Chinese medicine 20100101

• Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy.

  BMC cancer 20100101

• Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins.

  BMC cancer 20100101

• Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.

  BMC cancer 20100101

• Rapid-Onset Acute Respiratory Distress Syndrome (ARDS) in a Patient Undergoing Metastatic Liver Resection: A Case Report and Review of the Literature.

  Anesthesiology research and practice 20100101

• Pathological complete response after neoadjuvant chemotherapy with trastuzumab-containing regimen in gastric cancer: a case report.

  Journal of hematology & oncology 20100101

• Clinical study of adjuvant capecitabine monotherapy in Chinese elderly patients (aged 55-70) with stage IIa breast cancer.

  Onkologie 20100101

• Molecular biomarker analyses using circulating tumor cells.

  PloS one 20100101

• The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas.

  BMC cancer 20100101

• [Pharmacogenomics and chemotherapy].

  Recenti progressi in medicina 20100101

• Use of trastuzumab in HER2-positive metastatic breast cancer beyond disease progression: a systematic review of published studies.

  Tumori 20100101

• Toll-like receptors: role in dermatological disease.

  Mediators of inflammation 20100101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20100101

• Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tablets.

  Therapeutics and clinical risk management 20100101

• Current and emerging therapies for the treatment of pancreatic cancer.

  OncoTargets and therapy 20100101

• Active site conformational dynamics in human uridine phosphorylase 1.

  PloS one 20100101

• Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer.

  Radiation oncology (London, England) 20100101

• Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary--an experience in Taiwan.

  Radiation oncology (London, England) 20100101

• Population-based patterns of care in the first-line treatment of patients with advanced esophagogastric adenocarcinoma in Germany.

  Onkologie 20100101

• Oral systemic therapy: Not all 'win-win'.

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20100101

• NEO adjuvant chemotherapy in breast cancer: What have we learned so far?

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20100101

• A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment.

  BMC cancer 20100101

• Marine myxobacteria as a source of antibiotics--comparison of physiology, polyketide-type genes and antibiotic production of three new isolates of Enhygromyxa salina.

  Marine drugs 20100101

• Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer.

  BMC cancer 20100101

• 'Poker' association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study.

  BMC cancer 20100101

• A kernelisation approach for multiple d-Hitting Set and its application in optimal multi-drug therapeutic combinations.

  PloS one 20100101

• Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver metastases and advanced hepatic dysfunction.

  Radiation oncology (London, England) 20100101

• Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer.

  BMC cancer 20100101

• Treatment options for patients with triple-negative breast cancer.

  Journal of hematology & oncology 20100101

• Assessment of angiogenic factor, vascular endothelial growth factor, serum and urine level changes in superficial bladder tumor immunotherapy by intravesical Bacillus Calmette-Guerin.

  Urology annals 20100101

• Long-term survival of a woman with well differentiated papillary mesothelioma of the peritoneum: a case report and review of the literature.

  Journal of medical case reports 20100101

• Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells.

  Journal of hematology & oncology 20100101

• Capecitabine in breast cancer: the issue of cardiotoxicity during fluoropyrimidine treatment.

  The breast journal 20100101

• Present and future evolution of advanced breast cancer therapy.

  Breast cancer research : BCR 20100101

• Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone.

  Breast cancer research : BCR 20100101

• Triple-negative breast cancer.

  Breast cancer research : BCR 20100101

• Effects of capecitabine and celecoxib in experimental pancreatic cancer.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20100101

• Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma.

  BMC cancer 20100101

• Antiangiogenic therapy for breast cancer.

  Breast cancer research : BCR 20100101

• Complete response of brain metastases from breast cancer overexpressing Her-2/neu to radiation and concurrent Lapatinib and Capecitabine.

  The breast journal 20100101

• Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells.

  Breast cancer research : BCR 20100101

• DNA polymerase η protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy.

  Journal of translational medicine 20100101

• Sustained complete remission of human epidermal growth factor receptor 2-positive metastatic breast cancer in the liver during long-term trastuzumab (Herceptin) maintenance therapy in a woman: a case report.

  Journal of medical case reports 20100101

• Combination of oral vinorelbine and capecitabine in the treatment of metastatic breast cancer patients previously exposed to anthracyclines: a pilot study.

  Hematology/oncology and stem cell therapy 20100101

• pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs.

  PloS one 20100101

• Critical appraisal of cabazitaxel in the management of advanced prostate cancer.

  Clinical interventions in aging 20100101

• Comparison of conformal and intensity modulated radiation therapy techniques for treatment of pelvic tumors. Analysis of acute toxicity.

  Radiation oncology (London, England) 20100101

• The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer.

  Radiation oncology (London, England) 20100101

• Angiogenesis - still a worthwhile target for breast cancer therapy?

  Breast cancer research : BCR 20100101

• Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.

  BMC cancer 20100101

• Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma.

  PloS one 20100101

• Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.

  Cancer management and research 20100101

• Ixabepilone development across the breast cancer continuum: a paradigm shift.

  Cancer management and research 20100101

• New developments in treatment of ovarian carcinoma: focus on trabectedin.

  Cancer management and research 20100101

• Pancreatic resections for advanced M1-pancreatic carcinoma: the value of synchronous metastasectomy.

  HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 20100101

• Pseudomyxoma peritonei: An uncommon tumor.

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20100101

• Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20100101

• Clinical trials and progress with paclitaxel in ovarian cancer.

  International journal of women's health 20100101

• Metastatic pancreatic cancer response to treatment with cetuximab and gemcitabine plus capecitabine: a case report and review of the literature.

  Tumori 20100101

• Long-lasting response with metronomic capecitabine in advanced hepatocellular carcinoma.

  Tumori 20100101

• Pharmacological therapy of neuroendocrine tumors.

  Tumori 20100101

• Capecitabine-related intracranial hypotension syndrome mimicking dural metastasis in a breast cancer patient: case report and review of the literature.

  Journal of cancer research and therapeutics 20100101

• Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6.

  Oncology 20100101

• Durable complete response of hepatocellular carcinoma after metronomic capecitabine.

  Tumori 20100101

• Is capecitabine efficacious in triple negative metastatic breast cancer?

  Oncology 20100101

• Progression-free or overall… That is the question….

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20100101

• Gemcitabine and s-1 combination chemotherapy in patients with advanced biliary tract cancer: a retrospective study.

  Case reports in oncology 20100101

• Primary signet ring cell mucinous ovarian carcinoma: a case report and literature review.

  Case reports in oncology 20100101

• Advances in the treatment of gastroenteropancreatic neuroendocrine tumors.

  Clinical and experimental gastroenterology 20100101

• Pharmacoeconomic considerations in the treatment of breast cancer.

  ClinicoEconomics and outcomes research : CEOR 20100101

• Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment.

  Toxins 20100101

• The role of funding and policies on innovation in cancer drug development.

  Ecancermedicalscience 20100101

• Safe practice and nursing care of patients receiving oral anti-cancer medicines: a position statement from UKONS.

  Ecancermedicalscience 20100101

• Transcatheter arterial chemoembolization is a feasible palliative locoregional therapy for breast cancer liver metastases.

  International journal of surgical oncology 20100101

• Compliance and effective management of the hand-foot syndrome in colon cancer patients receiving capecitabine as adjuvant chemotherapy.

  Yonsei medical journal 20091231

• Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091220

• Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.

  British journal of cancer 20091215

• Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer.

  British journal of cancer 20091215

• Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20091201

• Blepharoptosis following oxaliplatin administration.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20091201

• Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer.

  International journal of radiation oncology, biology, physics 20091201

• Triweekly oxaliplatin plus oral capecitabine as first-line chemotherapy in elderly patients with advanced gastric cancer.

  American journal of clinical oncology 20091201

• Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20091201

• Irinotecan plus capecitabine as a second-line treatment after failure of 5-fluorouracil and platinum in patients with advanced gastric cancer.

  Japanese journal of clinical oncology 20091201

• Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.

  Bioorganic & medicinal chemistry letters 20091201

• Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials.

  British journal of cancer 20091201

• Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer--a multi-centre randomised phase II study.

  British journal of cancer 20091201

• Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial.

  The Lancet. Oncology 20091201

• Current combination chemotherapy regimens for metastatic breast cancer.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20091201

• Multicenter evaluation of a novel nanoparticle immunoassay for 5-fluorouracil on the Olympus AU400 analyzer.

  Therapeutic drug monitoring 20091201

• Survival data of patients with anthracycline- or taxane-pretreated or resistant metastatic breast cancer.

  Pharmacotherapy 20091201

• ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer.

  Expert review of anticancer therapy 20091201

• Capecitabine-induced severe hypertriglyceridaemia and diabetes: a case report and review of the literature.

  Diabetic medicine : a journal of the British Diabetic Association 20091201

• [Validation study of KRAS mutation in colorectal cancer].

  Magyar onkologia 20091201

• [Lapatinib treatment-option in trastuzumab-resistant breast cancer].

  Magyar onkologia 20091201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20091201

• Metastatic hidradenocarcinoma: Surgery and chemotherapy.

  North American journal of medical sciences 20091201

• Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120

• What does similarity mean in clinical trials?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120

• Changing the paradigm in conducting randomized clinical studies in advanced pancreatic cancer: an opportunity for better clinical development.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120

• Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120

• A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer.

  British journal of cancer 20091117

• Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies.

  British journal of cancer 20091117

• Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer.

  International journal of radiation oncology, biology, physics 20091115

• Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumab.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20091115

• Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer.

  International journal of radiation oncology, biology, physics 20091101

• Antineoplastic activity of idazoxan hydrochloride.

  Cancer chemotherapy and pharmacology 20091101

• Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study.

  Cancer chemotherapy and pharmacology 20091101

• Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma.

  Cancer chemotherapy and pharmacology 20091101

• Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20091101

• The dual role of thymidine phosphorylase in cancer development and chemotherapy.

  Medicinal research reviews 20091101

• The clinical efficacy of cytotoxic agents in locally advanced or metastatic breast cancer patients pretreated with an anthracycline and a taxane: a systematic review.

  European journal of cancer (Oxford, England : 1990) 20091101

• Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.

  International journal of cancer 20091101

• Does stent placement for advanced colon cancer increase the risk of perforation during bevacizumab-based therapy?

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20091101

• Contemporary issues and the potential uses of capecitabine in metastatic breast cancer.

  Cancer treatment reviews 20091101

• Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.

  Cancer 20091101

• Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer.

  European journal of cancer (Oxford, England : 1990) 20091101

• Altered tissue 3'-deoxy-3'-[18F]fluorothymidine pharmacokinetics in human breast cancer following capecitabine treatment detected by positron emission tomography.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20091101

• Refractory neuroendocrine tumor-response to liposomal doxorubicin and capecitabine.

  Nature reviews. Clinical oncology 20091101

• Lapatinib in metastatic breast cancer.

  Women's health (London, England) 20091101

• Capecitabine in the routine treatment of advanced breast cancer: results from a non-interventional observational study in 876 [corrected] patients.

  Onkologie 20091101

• Economic impact of alternative adjuvant chemotherapy regimens for stage III colon cancer.

  Onkologie 20091101

• Lapatinib plus letrozole for postmenopausal patients with advanced HER2(+)/HR(+) breast cancer.

  Expert review of anticancer therapy 20091101

• Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20091101

• Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer.

  Clinical breast cancer 20091101

• [The colon cancer patient with multiple hepatic metastases and peritoneal disseminations was treated by hepatic arterial infusion chemotherapy and resection of the metastatic peritoneal dissemination with successive systemic chemotherapy--a case report of the long term survivor].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [Effect of neoadjuvant chemoradiotherapy on the healing of anastomosis following low anterior resection in locally advanced rectal cancer].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20091101

• N-[2-Chloro-6-(4-chloro-6-methoxy-pyrimidin-2-ylsulfan-yl)benz-yl]-3,4-dimethyl-aniline.

  Acta crystallographica. Section E, Structure reports online 20091101

• Lapatinib: a review of its use in the treatment of HER2-overexpressing, trastuzumab-refractory, advanced or metastatic breast cancer.

  Drugs 20091022

• Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer.

  British journal of cancer 20091020

• Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study).

  British journal of cancer 20091020

• Longitudinal melanonychia induced by capecitabine.

  Dermatology online journal 20091015

• [Exploration on neoadjuvant chemoradiation in the treatment for locally advanced low rectal cancer].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20091015

• Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer.

  Journal of the National Cancer Institute 20091007

• An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.

  British journal of cancer 20091006

• Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group.

  British journal of cancer 20091006

• Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial.

  British journal of cancer 20091006

• A phase I study of an oral simulated FOLFOX with high dose capecitabine.

  Investigational new drugs 20091001

• Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment.

  Breast cancer research and treatment 20091001

• Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20091001

• Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin.

  Cancer chemotherapy and pharmacology 20091001

• Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20091001

• A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.

  Cancer chemotherapy and pharmacology 20091001

• Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents.

  Cancer chemotherapy and pharmacology 20091001

• Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.

  Breast cancer research and treatment 20091001

• A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20091001

• Subacute cutaneous lupus erythematosus induced by capecitabine.

  Clinical and experimental dermatology 20091001

• A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312.

  American journal of clinical oncology 20091001

• Capecitabine-induced stomatitis: a likely pathogenetic mechanism of oral lichenoid mucositis.

  European journal of clinical pharmacology 20091001

• Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20091001

• Artificial neural networks for prediction of response to chemoradiation in HT29 xenografts.

  International journal of radiation oncology, biology, physics 20091001

• Chemotherapy: Adjuvant chemotherapy in older patients with breast cancer.

  Nature reviews. Clinical oncology 20091001

• [Progress in chemotherapy for advanced gastric cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20091001

• Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy.

  Histopathology 20091001

• Toxicity and efficacy of 5-fluorouracil and capecitabine in a patient with TYMS gene polymorphism: A challenge or a dilemma?

  Clinical colorectal cancer 20091001

• Novel agents for the treatment of adenocarcinoma of the pancreas.

  Expert review of anticancer therapy 20091001

• Lapatinib for the treatment of HER2-overexpressing breast cancer.

  Health technology assessment (Winchester, England) 20091001

• Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinoma.

  Anticancer research 20091001

• Successful treatment of metastatic pancreatic adenocarcinoma with combination chemotherapy regimens.

  International journal of clinical oncology 20091001

• [Leakage of colorectal anastomosis after neoadjuvant therapy with bevacizumab. Case report].

  Il Giornale di chirurgia 20091001

• Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States.

  World journal of gastroenterology 20090921

• Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer.

  British journal of cancer 20090915

• Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2).

  British journal of cancer 20090915

• Structures of native human thymidine phosphorylase and in complex with 5-iodouracil.

  Biochemical and biophysical research communications 20090904

• Chemotherapy in older women with breast cancer.

  The New England journal of medicine 20090903

• Chemotherapy in older women with breast cancer.

  The New England journal of medicine 20090903

• International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.

  Journal of the National Cancer Institute 20090902

• A phase II study of first-line biweekly capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer.

  Critical reviews in oncology/hematology 20090901

• Patients' perspectives and safe handling of oral anticancer drugs at an Asian cancer center.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20090901

• Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20090901

• Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy.

  International journal of radiation oncology, biology, physics 20090901

• (188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study.

  European journal of nuclear medicine and molecular imaging 20090901

• Capecitabine and vinorelbine in metastatic breast cancer.

  European journal of cancer (Oxford, England : 1990) 20090901

• Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090901

• Preliminary validation of an optimally weighted patient-based utility index by application to randomized trials in breast cancer.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090901

• Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report.

  Journal of cardiovascular medicine (Hagerstown, Md.) 20090901

• Principles of modular tumor therapy.

  Cancer microenvironment : official journal of the International Cancer Microenvironment Society 20090901

• Subdural collections arising from calvarial metastases following discontinuation of anti-angiogenic therapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090901

• Severe drug-induced thrombocytopenia after treatment with trastuzumab but not with lapatinib.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090901

• Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090901

• Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090901

• Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer.

  The British journal of surgery 20090901

• Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival.

  Expert opinion on drug safety 20090901

• Is there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature previously presented: poster at the 2008 Gastrointestinal Cancer Symposium (Abstract No. 512).

  Expert opinion on investigational drugs 20090901

• Adjuvant chemotherapy for older adults with breast cancer: making the standard a standard.

  Women's health (London, England) 20090901

• Capecitabine as salvage treatment for lymphoepithelioma-like carcinoma of lung.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090901

• The necessity of chemotherapy in T3N0M0 colon cancer without risk factors.

  American journal of surgery 20090901

• [Efficacy of FORFIRI regimen on oxaliplatin-based chemotherapy-failed advanced colorectal cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20090901

• Cost impact of oral capecitabine compared to intravenous taxane-based chemotherapy in first-line metastatic breast cancer.

  Journal of medical economics 20090901

• Serum vitamin B12 and folate status among patients with chemotherapy treatment for advanced colorectal cancer.

  Upsala journal of medical sciences 20090901

• [A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090901

• Chemotherapy for early-stage breast cancer: a brief history.

  British journal of cancer 20090901

• Chemotherapy, which drugs and when.

  European journal of cancer (Oxford, England : 1990) 20090901

• [The development of the first line treatment of metastatic colorectal cancer (mCRC)].

  Magyar onkologia 20090901

• Gemcitabine for the treatment of metastatic breast cancer.

  Health technology assessment (Winchester, England) 20090901

• The BC Cancer Agency Compassionate Access Program: outcome analysis of patients with esophagogastric cancer.

  Current oncology (Toronto, Ont.) 20090901

• The role of neoadjuvant (HER)2-targeted therapies in (HER)2-overexpressing breast cancers.

  Current oncology (Toronto, Ont.) 20090901

• Isolated colorectal liver metastases locally progressing after stereotactic body radiotherapy rescued with surgery.

  Current oncology (Toronto, Ont.) 20090901

• Response to 5-fluorouracil in metastatic extramammary Paget disease of the scrotum presenting as pancytopenia and back pain.

  Current oncology (Toronto, Ont.) 20090901

• Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer.

  Current oncology (Toronto, Ont.) 20090901

• Lapatinib for treatment of advanced or metastasized breast cancer: systematic review.

  Sao Paulo medical journal = Revista paulista de medicina 20090901

• Cancer and chemotherapy.

  BMJ (Clinical research ed.) 20090824

• Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study.

  British journal of cancer 20090818

• Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer.

  British journal of cancer 20090818

• Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study.

  British journal of cancer 20090818

• Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090810

• Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response.

  British journal of cancer 20090804

• A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy.

  Cancer chemotherapy and pharmacology 20090801

• Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens.

  Cancer chemotherapy and pharmacology 20090801

• Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial.

  International journal of radiation oncology, biology, physics 20090801

• Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20090801

• Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature.

  Anti-cancer drugs 20090801

• Successful antiangiogenic combination therapy for pseudomyxoma peritonei with bevacizumab and capecitabine.

  Cancer biology & therapy 20090801

• Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090801

• Chemoradioimmunotherapy in locally advanced pancreatic and biliary tree adenocarcinoma: a multicenter phase II study.

  Pancreas 20090801

• Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090801

• Antitumor activity of bevacizumab in combination with capecitabine and oxaliplatin in human colorectal cancer xenograft models.

  Oncology reports 20090801

• Adjuvant chemotherapy for stages II, III and IV of colon cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20090801

• Is capecitabine a new choice of treatment for lung adenocarcinoma? A case report involving partial response in second line of treatment and hypothesis of the biological basis.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20090801

• Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results.

  The oncologist 20090801

• The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancer.

  Current oncology (Toronto, Ont.) 20090801

• Capecitabine-induced cardiotoxicity mimicking myocardial infarction.

  Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 20090801

• Acute chest pain in a patient treated with capecitabine.

  Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 20090801

• Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.

  Clinical therapeutics 20090801

• Ixabepilone: in locally advanced or metastatic breast cancer.

  Drugs 20090730

• Metastatic rectal cancer to the breast.

  Rare tumors 20090722

• Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.

  British journal of cancer 20090721

• All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial.

  British journal of cancer 20090721

• Cost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials.

  British journal of cancer 20090707

• Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.

  JOP : Journal of the pancreas 20090706

• Sirolimus can reverse resistance to gemcitabine, capecitabine and docetaxel combination therapy in pancreatic cancer.

  JOP : Journal of the pancreas 20090706

• Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes.

  Cancer chemotherapy and pharmacology 20090701

• Application of prolonged microdialysis sampling in carboplatin-treated cancer patients.

  Cancer chemotherapy and pharmacology 20090701

• Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients.

  Journal of neuro-oncology 20090701

• Synchronous colorectal liver metastases: triumph of prospective randomized trials over observational bias leads to paradigm shift.

  Annals of surgical oncology 20090701

• Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancer.

  Anti-cancer drugs 20090701

• Phase II trial of capecitabine and weekly docetaxel for metastatic castrate resistant prostate cancer.

  The Journal of urology 20090701

• Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer.

  Cancer chemotherapy and pharmacology 20090701

• Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study.

  European journal of cancer (Oxford, England : 1990) 20090701

• Travel warning with capecitabine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090701

• Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090701

• Genetic prognostic and predictive markers in colorectal cancer.

  Nature reviews. Cancer 20090701

• Acquired Fanconi syndrome after treatment with capecitabine, irinotecan, and bevacizumab.

  The Annals of pharmacotherapy 20090701

• Expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in human breast carcinoma cells and tissues.

  Anticancer research 20090701

• Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes.

  Anticancer research 20090701

• Phase I study of capecitabine, carboplatin and intensity-modulated radiation therapy for head and neck cancer.

  Anticancer research 20090701

• [Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].

  Ai zheng = Aizheng = Chinese journal of cancer 20090701

• Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study.

  British journal of cancer 20090616

• Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer: findings from the bolus, infusional, or capecitabine with camptostar-celecoxib study.

  Cancer 20090615

• New perspectives in the treatment of advanced or metastatic gastric cancer.

  World journal of gastroenterology 20090614

• Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090610

• A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer.

  British journal of cancer 20090602

• A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma.

  British journal of cancer 20090602

• Treatment in advanced colorectal cancer: what, when and how?

  British journal of cancer 20090602

• Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.

  Cancer chemotherapy and pharmacology 20090601

• Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients.

  Investigational new drugs 20090601

• Dose finding study of erlotinib combined to capecitabine and irinotecan in pretreated advanced colorectal cancer patients.

  Cancer chemotherapy and pharmacology 20090601

• DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090601

• To widen the setting of cancer patients who could benefit from metronomic capecitabine.

  Cancer chemotherapy and pharmacology 20090601

• Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090601

• The optimal therapeutic use of ixabepilone in patients with locally advanced or metastatic breast cancer.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20090601

• Gemcitabine and capecitabine chemotherapy in Japanese patients with immunotherapy-resistant renal cell carcinoma.

  International journal of urology : official journal of the Japanese Urological Association 20090601

• Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment.

  Pharmacogenomics 20090601

• [Chemotherapy of elderly patients with colorectal cancer].

  Magyar onkologia 20090601

• Evolving approaches to metastatic breast cancer previously treated with anthracyclines and taxanes.

  Clinical breast cancer 20090601

• Current role of bevacizumab in colorectal cancer.

  Clinical advances in hematology & oncology : H&O 20090601

• [Efficacy and safety of combination of irinotecan and capecitabine in patients with metastatic colorectal cancer after failure of chemotherapy with oxaliplatin].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20090601

• [Chemotherapy and biological treatment in the complex management of large intestinal and rectal carcinomas. When, why, how?].

  Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti 20090601

• Capecitabine from X-ray powder synchrotron data.

  Acta crystallographica. Section E, Structure reports online 20090601

• Dose escalation methods in phase I cancer clinical trials.

  Journal of the National Cancer Institute 20090520

• Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer.

  British journal of cancer 20090519

• Adjuvant chemotherapy in older women with early-stage breast cancer.

  The New England journal of medicine 20090514

• Chemotherapy and immunotherapy in metastatic colorectal cancer.

  The New England journal of medicine 20090514

• Chemotherapy and immunotherapy in metastatic colorectal cancer.

  The New England journal of medicine 20090514

• Chemotherapy and immunotherapy in metastatic colorectal cancer.

  The New England journal of medicine 20090514

• Capecitabine-induced acute myeloid leukaemia.

  The New Zealand medical journal 20090508

• Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer.

  Breast cancer research and treatment 20090501

• Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer.

  Breast cancer research and treatment 20090501

• Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.

  International journal of radiation oncology, biology, physics 20090501

• Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile.

  Cancer chemotherapy and pharmacology 20090501

• Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study.

  Critical reviews in oncology/hematology 20090501

• Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090501

• The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090501

• Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation.

  Journal of gastroenterology and hepatology 20090501

• Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors.

  Cancer investigation 20090501

• Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090501

• Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090501

• Current management of anal canal cancer.

  Current oncology reports 20090501

• Synthesis of potent antitumor and antiviral benzofuran derivatives.

  Bioorganic & medicinal chemistry letters 20090501

• Medical Oncology: Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer.

  Nature reviews. Clinical oncology 20090501

• Proactive management of adverse events maintains the clinical benefit of ixabepilone.

  The oncologist 20090501

• Gemcitabine-capecitabine plus intra-arterial epirubicin-cisplatin in pretreated pancreatic cancer patients: a phase I study.

  Anticancer research 20090501

• Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis.

  Anticancer research 20090501

• Single nucleotide polymorphisms and clinical outcome in patients with biliary tract carcinoma treated with epirubicin, cisplatin and capecitabine.

  Anticancer research 20090501

• [Chemotherapy for breast cancer refractory to anthracycline, taxane or trastuzumab].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090501

• [Palliative chemotherapy for metastatic breast cancer with capecitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090501

• [A case of triple negative chest wall recurrent breast cancer treated with capecitabine and docetaxel combination therapy (XT therapy)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090501

• [Toxic dermatitis due to capecitabine: presentation of 2 cases and literature review].

  Actas dermo-sifiliograficas 20090501

• HIV and anal cancer outcomes: a single institution's experience.

  Diseases of the colon and rectum 20090501

• Optimal use of taxanes in metastatic breast cancer.

  Current oncology (Toronto, Ont.) 20090501

• Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma.

  British journal of cancer 20090421

• Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090420

• Development of a sensitive and selective LC-MS/MS method for the determination of alpha-fluoro-beta-alanine, 5-fluorouracil and capecitabine in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090415

• Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090415

• Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090410

• Analysis of dermatologic events in patients with cancer treated with lapatinib.

  Breast cancer research and treatment 20090401

• Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.

  Cancer chemotherapy and pharmacology 20090401

• A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.

  Cancer chemotherapy and pharmacology 20090401

• Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20090401

• Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies.

  Investigational new drugs 20090401

• A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20090401

• HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors.

  Cancer treatment reviews 20090401

• A dynamic model of hand-and-foot syndrome in patients receiving capecitabine.

  Clinical pharmacology and therapeutics 20090401

• Preoperative concomitant radiotherapy with oral capecitabine in advanced rectal cancer within 6 cm from anal verge.

  International journal of colorectal disease 20090401

• Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090401

• The integration of chemoradiation in the care of patient with localized pancreatic cancer.

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20090401

• Costs associated with complications are lower with capecitabine than with 5-fluorouracil in patients with colorectal cancer.

  Cancer 20090401

• Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.

  Anti-cancer drugs 20090401

• Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer.

  Nature reviews. Clinical oncology 20090401

• [Colorectal cancers: prognostic and predictive factors of response to treatment].

  Bulletin du cancer 20090401

• Phase II trial of capecitabine and oxaliplatin in patients with adeno- and undifferentiated carcinoma of unknown primary.

  Onkologie 20090401

• Role of liver transplantation in the treatment of cholangiocarcinoma.

  Expert review of anticancer therapy 20090401

• Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.

  Expert review of anticancer therapy 20090401

• Clostridium perfringens liver abscess after pancreatic resection.

  Surgical infections 20090401

• Nursing considerations for capecitabine-based combination therapy.

  ONS connect 20090401

• Cardiac toxicity with anti-HER-2 therapies: what have we learned so far?

  Targeted oncology 20090401

• [Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090401

• [Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20090401

• Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients.

  British journal of cancer 20090324

• Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer.

  British journal of cancer 20090324

• Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy.

  British journal of cancer 20090324

• Unilateral taxane-induced onychopathy in a patient with a brain metastasis.

  Dermatology online journal 20090315

• Cardiotoxicity of 5-fluorouracil and capecitabine in a pancreatic cancer patient with a novel mutation in the dihydropyrimidine dehydrogenase gene.

  JOP : Journal of the pancreas 20090309

• Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region.

  Breast cancer research and treatment 20090301

• Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer.

  Breast cancer research and treatment 20090301

• Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients.

  European journal of cancer (Oxford, England : 1990) 20090301

• Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: the CORGI-L Study.

  European journal of cancer (Oxford, England : 1990) 20090301

• Caveolin-1 as a prognostic marker for local control after preoperative chemoradiation therapy in rectal cancer.

  International journal of radiation oncology, biology, physics 20090301

• Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results.

  Anti-cancer drugs 20090301

• XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis.

  Current medical research and opinion 20090301

• Emerging role of capecitabine in gastric cancer.

  Pharmacotherapy 20090301

• Unanticipated toxicity to capecitabine.

  Oncology nursing forum 20090301

• Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.

  Archives of dermatology 20090301

• Improved survival of patients with metastatic breast cancer in routine care: results of a retrospective study in a community-based oncology group practice 1995-2005.

  Onkologie 20090301

• [A patient with axillary node metastasis from breast cancer who responded to trastuzumab/capecitabine combination therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090301

• [Neoadjuvant approach for non-metastatic rectal cancer combining radiotherapy and chemotherapy. Biotargeted drugs].

  Bulletin du cancer 20090301

• An overview of HER-targeted therapy with lapatinib in breast cancer.

  Advances in therapy 20090301

• Development of cell-cycle inhibitors for cancer therapy.

  Current oncology (Toronto, Ont.) 20090301

• Phase II study of capecitabine plus cisplatin in patients with gastric cancer.

  Anti-cancer drugs 20090301

• Combined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer.

  World journal of gastroenterology 20090221

• Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090215

• Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: a retrospective study.

  World journal of gastroenterology 20090214

• Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.

  The New England journal of medicine 20090205

• Targeted therapy for advanced colorectal cancer--more is not always better.

  The New England journal of medicine 20090205

• Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

  Cancer chemotherapy and pharmacology 20090201

• Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma.

  Cancer chemotherapy and pharmacology 20090201

• Pathologic complete response after palliative 3rd line chemotherapy with capecitabine alone in metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20090201

• Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial.

  Lung cancer (Amsterdam, Netherlands) 20090201

• Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.

  Journal of cancer research and clinical oncology 20090201

• Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090201

• Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay.

  International journal of colorectal disease 20090201

• Regression of rectal cancer with radiotherapy with or without concurrent capecitabine--optimising the timing of surgical resection.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20090201

• An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016).

  Drug metabolism and disposition: the biological fate of chemicals 20090201

• Cost-effectiveness analysis of lapatinib in HER-2-positive advanced breast cancer.

  Cancer 20090201

• [Treatments of epithelial ovarian cancer by histologic subtype].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090201

• [A case of metastatic breast cancer with liver metastasis effectively treated with capecitabine and vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090201

• Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.

  Cancer investigation 20090201

• Definitive chemoradiotherapy with capecitabine and cisplatin in patients with esophageal cancer: a pilot study.

  Journal of Korean medical science 20090201

• A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer.

  Anticancer research 20090201

• Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients.

  World journal of gastroenterology 20090128

• Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience.

  British journal of cancer 20090127

• Deficient mismatch repair system in patients with sporadic advanced colorectal cancer.

  British journal of cancer 20090127

• Antiangiogenic drugs in ovarian cancer.

  British journal of cancer 20090113

• Molecular therapy for the treatment of hepatocellular carcinoma.

  British journal of cancer 20090113

• Irinotecan plus carboplatin for patients with carcinoma of unknown primary site.

  British journal of cancer 20090113

• HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer.

  British journal of cancer 20090113

• A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer.

  British journal of cancer 20090113

• Ten years of HER2-directed therapy: still questions after all these years.

  Breast cancer research and treatment 20090101

• Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report.

  Breast cancer (Tokyo, Japan) 20090101

• Oxaliplatin and capecitabine-based chemoradiotherapy for gastric cancer--an extended phase I MARGIT and AIO trial.

  International journal of radiation oncology, biology, physics 20090101

• Metastasis of breast cancer to a uterine leiomyoma.

  Breast cancer (Tokyo, Japan) 20090101

• Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine.

  Breast cancer (Tokyo, Japan) 20090101

• Capecitabine: have we got the dose right?

  Nature clinical practice. Oncology 20090101

• A comparison of XELOX with FOLFOX-4 as first-line treatment for metastatic colorectal cancer.

  Nature clinical practice. Oncology 20090101

• Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases.

  Annals of surgical oncology 20090101

• Oral fluoropyrimidines (capecitabine or S-1) and cisplatin as first line treatment in elderly patients with advanced gastric cancer: a retrospective study.

  Japanese journal of clinical oncology 20090101

• Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas.

  Japanese journal of clinical oncology 20090101

• Lessons learned from independent central review.

  European journal of cancer (Oxford, England : 1990) 20090101

• The predictive and therapeutic value of thymidine phosphorylase and dihydropyrimidine dehydrogenase in capecitabine (Xeloda)-based chemotherapy for head and neck cancer.

  The Laryngoscope 20090101

• Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells.

  Cancer cell international 20090101

• A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer.

  BMC surgery 20090101

• Capecitabine-based combination therapy for breast cancer: implications for nurses.

  Oncology nursing forum 20090101

• Ixabepilone: targeting betaIII-tubulin expression in taxane-resistant malignancies.

  Molecular cancer therapeutics 20090101

• In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models.

  Molecular cancer therapeutics 20090101

• The role of capecitabine in the management of tumors of the digestive system.

  Reviews on recent clinical trials 20090101

• Fatal drug-drug interaction of brivudine and capecitabine.

  Acta oncologica (Stockholm, Sweden) 20090101

• Phase II trial of erlotinib and capecitabine for patients with previously untreated metastatic colorectal cancer.

  Clinical colorectal cancer 20090101

• Are we HER-ting for innovation in neoadjuvant breast cancer trial design?

  Breast cancer research : BCR 20090101

• Adjuvant chemoradiotherapy for high-risk pancreatic cancer.

  Singapore medical journal 20090101

• Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology.

  Journal of hematology & oncology 20090101

• Dramatic response with capecitabine after cranial radiation to the brain parenchymal and leptomeningeal metastases from lung cancer.

  European journal of internal medicine 20090101

• Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy.

  World journal of surgical oncology 20090101

• Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I(131) KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma.

  BMC cancer 20090101

• Diagnosis and treatment of advanced breast cancer: summary of NICE guidance.

  BMJ (Clinical research ed.) 20090101

• Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.

  Oncology 20090101

• Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma.

  Journal of experimental & clinical cancer research : CR 20090101

• Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases.

  American journal of therapeutics 20090101

• Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis.

  Journal of hematology & oncology 20090101

• Implications of the structure of human uridine phosphorylase 1 on the development of novel inhibitors for improving the therapeutic window of fluoropyrimidine chemotherapy.

  BMC structural biology 20090101

• The role of UFT in metastatic colorectal cancer.

  Oncology 20090101

• Cardiac toxicity with capecitabine, vinorelbine and trastuzumab therapy: case report and review of fluoropyrimidine-related cardiotoxicity.

  Oncology 20090101

• Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenografts.

  Anticancer research 20090101

• Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin.

  Anti-cancer drugs 20090101

• Microsatellite instability: a predictive marker in metastatic colorectal cancer?

  Targeted oncology 20090101

• Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agents.

  Breast cancer research : BCR 20090101

• 'Hand-foot' syndrome-an unusual case of plantar pathology presenting to a burns unit.

  Journal of burn care & research : official publication of the American Burn Association 20090101

• Efficacy and safety of capecitabine and oxaliplatin combination as second-line treatment in advanced colorectal cancer.

  American journal of therapeutics 20090101

• A kernel-based integration of genome-wide data for clinical decision support.

  Genome medicine 20090101

• A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer.

  BMC cancer 20090101

• Update in antiepidermal growth factor receptor therapy in the management of metastatic colorectal cancer.

  Journal of oncology 20090101

• Feasibility study of biweekly capecitabine, oxaliplatin, and irinotecan in patients with untreated advanced gastric cancer.

  Tumori 20090101

• Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach.

  Journal of experimental & clinical cancer research : CR 20090101

• Assessing software impact on clinical workflow and resource utilization.

  Studies in health technology and informatics 20090101

• Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics.

  PloS one 20090101

• Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial.

  BMC cancer 20090101

• Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy.

  Journal of hematology & oncology 20090101

• Anti-EGFR Therapy: Mechanism and Advances in Clinical Efficacy in Breast Cancer.

  Journal of oncology 20090101

• Medical management of pancreatic adenocarcinoma.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20090101

• Use of probiotics in the management of chemotherapy-induced diarrhea: a case study.

  JPEN. Journal of parenteral and enteral nutrition 20090101

• Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers.

  Journal of oncology 20090101

• MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer.

  BMC cancer 20090101

• Role of oxaliplatin in the treatment of colorectal cancer.

  Therapeutics and clinical risk management 20090101

• Challenging issues in molecular-targeted therapy.

  Therapeutics and clinical risk management 20090101

• Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab.

  Therapeutics and clinical risk management 20090101

• A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer.

  BMC cancer 20090101

• Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target.

  PloS one 20090101

• Immunohistochemical characterization of subtypes of male breast carcinoma.

  Breast cancer research : BCR 20090101

• Best cases from the AFIP: urachal carcinoma.

  Radiographics : a review publication of the Radiological Society of North America, Inc 20090101

• Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy.

  World journal of surgical oncology 20090101

• Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy.

  Neoplasma 20090101

• Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy.

  PloS one 20090101

• New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer.

  Journal of hematology & oncology 20090101

• Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.

  American journal of clinical dermatology 20090101

• Onset of male gynaecomastia in a patient treated with sunitinib for metastatic renal cell carcinoma.

  Clinical drug investigation 20090101

• Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial.

  World journal of surgical oncology 20090101

• [Coronary artery disease attack caused by cytotoxic chemotherapy].

  Duodecim; laaketieteellinen aikakauskirja 20090101

• A feasibility study of weekly docetaxel with capecitabine in ovarian cancer: a promising combination of two active drugs with a potential for synergism.

  Chemotherapy 20090101

• [Bevacizumab in combination with capecitabine and irinotecan (XELIRI) in treatment of metastatic colorectal cancer].

  Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20090101

• Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2.

  PloS one 20090101

• [Laparoscopic surgery and adjuvant therapy for colon cancer].

  Onkologie 20090101

• Current oncological treatment of patients with pancreatic cancer in germany: results from a national survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society.

  Oncology 20090101

• Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapy.

  BMC cancer 20090101

• Budget impact analysis of ixabepilone used according to FDA approved labeling in treatment-resistant metastatic breast cancer.

  Journal of managed care pharmacy : JMCP 20090101

• Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer.

  BMC cancer 20090101

• Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.

  BMC cancer 20090101

• Recent advances in the management of adenocarcinoma of the small intestine.

  Gastrointestinal cancer research : GCR 20090101

• Evolving treatment of advanced colon cancer.

  Annual review of medicine 20090101

• Vorinostat in solid and hematologic malignancies.

  Journal of hematology & oncology 20090101

• Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: associations with quality of life.

  BMC gastroenterology 20090101

• Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept.

  Journal of oncology 20090101

• Clinical presentation and outcomes of patients with biliary malignancies: the Aga Khan University experience.

  Asian Pacific journal of cancer prevention : APJCP 20090101

• [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].

  Lijecnicki vjesnik 20090101

• Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study.

  BMC cancer 20090101

• [Efficiency of the capecitabine in patients with breast cancer with liver metastasis].

  Georgian medical news 20090101

• Early and late results of adjuvant treatment in colorectal cancer. The experience of the Emergency County hospital Alba Iulia-Romania.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090101

• Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluation.

  Clinical pharmacokinetics 20090101

• Cost-effectiveness analysis of capecitabine compared with bolus 5-fluorouracil/l-leucovorin for the adjuvant treatment of colon cancer in Japan.

  PharmacoEconomics 20090101

• Recent advances in systemic therapy: Advances in systemic therapy for HER2-positive metastatic breast cancer.

  Breast cancer research : BCR 20090101

• Hepatoid adenocarcinoma of the stomach - a different histology for not so different gastric adenocarcinoma: a case report.

  International seminars in surgical oncology : ISSO 20090101

• Phase I trial of metastatic renal cell carcinoma with oral capecitabine and thalidomide.

  German medical science : GMS e-journal 20090101

• Tumor biology and cancer therapy - an evolving relationship.

  Cell communication and signaling : CCS 20090101

• [Preliminary experience on the application of metallic stents for treatment of colorectal malignant stenosis].

  Annali italiani di chirurgia 20090101

• Association of cetuximab with adverse pulmonary events in cancer patients: a comprehensive review.

  Journal of experimental & clinical cancer research : CR 20090101

• Advances in the pharmacological treatment of gastro-oesophageal cancer.

  Drugs & aging 20090101

• HER2 breast cancer therapies: a review.

  Biologics : targets & therapy 20090101

• Pegylated liposomal doxorubicin in ovarian cancer.

  Therapeutics and clinical risk management 20090101

• Phase II study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer.

  Oncology 20090101

• Costs associated with capecitabine or 5-fluorouracil monotherapy after surgical resection in patients with colorectal cancer.

  Oncology 20090101

• Safety of chronic low-dose capecitabine as maintenance therapy in gastrointestinal cancers.

  Gastrointestinal cancer research : GCR 20090101

• Maintenance Capecitabine for High-Risk Gastrointestinal Tumors: Everything That's Old Is New Again.

  Gastrointestinal cancer research : GCR 20090101

• Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer.

  Breast cancer research : BCR 20090101

• Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy.

  Biologics : targets & therapy 20090101

• Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers.

  Biologics : targets & therapy 20090101

• Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study.

  BMC cancer 20090101

• Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.

  In vivo (Athens, Greece) 20090101

• Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.

  BMC cancer 20090101

• Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study.

  BMC cancer 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• [Targeted drugs for the treatment of disseminated colonic cancer].

  Vestnik Rossiiskoi akademii meditsinskikh nauk 20090101

• Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer.

  PloS one 20090101

• Different responses to two types of 5-fluorouracil prodrugs in combination with interferon-alpha in pulmonary metastases of renal cell carcinoma: a case report.

  Cases journal 20090101

• Inflammation of actinic keratosis with combination of alkylating and taxane agents: a case report.

  Cases journal 20090101

• Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.

  International journal of medical sciences 20090101

• Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer.

  BMC cancer 20090101

• Mitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular models.

  Molecular cancer 20090101

• Notch versus the proteasome: what is the target of gamma-secretase inhibitor-I?

  Breast cancer research : BCR 20090101

• Benefit of whole pelvic radiotherapy combined with neoadjuvant androgen deprivation for the high-risk prostate cancer.

  Journal of biomedicine & biotechnology 20090101

• Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network.

  BMC cancer 20090101

• Docetaxel: its role in current and future treatments for advanced gastric cancer.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20090101

• Blood loss anemia due to adenocarcinoma of the jejunum: case report and review of the literature.

  Cases journal 20090101

• Plantar erythrodysesthesia with bullous otitis externa, toxicities from sorafenib: a case report.

  Cases journal 20090101

• Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

  Breast cancer research : BCR 20090101

• Management of advanced breast cancer with the epothilone B analog, ixabepilone.

  Drug design, development and therapy 20090101

• Reirradiation to the abdomen for gastrointestinal malignancies.

  Radiation oncology (London, England) 20090101

• First-line capecitabine monotherapy for slowly progressing metastatic breast cancer: do we need aggressive treatment?

  Oncology 20090101

• Colon cancer and the elderly: from screening to treatment in management of GI disease in the elderly.

  Best practice & research. Clinical gastroenterology 20090101

• DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study.

  Journal of angiogenesis research 20090101

• Nodular regenerative hyperplasia secondary to neoadjuvant chemotherapy for colorectal liver metastases.

  Case reports in medicine 20090101

• The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay.

  Radiation oncology (London, England) 20090101

• HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy.

  BMC cancer 20090101

• APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.

  BMC cancer 20090101

• Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme.

  BMC cancer 20090101

• Vascular Endothelial Growth Factor plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?

  Journal of oncology 20090101

• The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone.

  Trials 20090101

• Are current drug development programmes realising the full potential of new agents? The scenario.

  Breast cancer research : BCR 20090101

• Chemotherapy with low-dose capecitabine as palliative treatment in a patient with metastatic breast cancer: a case report.

  Cases journal 20090101

• Review of the contemporary cytotoxic and biologic combinations available for the treatment of metastatic breast cancer.

  Clinical therapeutics 20090101

• Lapatinib: a small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor-2 tyrosine kinases used in the treatment of breast cancer.

  Clinical therapeutics 20090101

• Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090101

• Hand-foot syndrome due to capecitabine.

  Indian journal of dermatology 20090101

• Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey.

  Tumori 20090101

• Metronomic chemotherapy against cancer: from paradigm to clinical practice?

  Tumori 20090101

• [Economic evaluation of capecitabine use as first line treatment in patients with advanced gastric carcinoma in Portugal].

  Acta medica portuguesa 20090101

• Tumor lysis syndrome associated with chemotherapy in primary retroperitoneal soft tissue sarcoma by ex vivo ATP-based tumor chemo-sensitivity assay (ATP-TCA).

  International journal of general medicine 20090101

• Role of palliative radiotherapy in brain metastases.

  Indian journal of palliative care 20090101

• Targeted therapies in the management of colorectal carcinoma: role of bevacizumab.

  OncoTargets and therapy 20090101

• Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients.

  OncoTargets and therapy 20090101

• Targeting cancers in the gastrointestinal tract: role of capecitabine.

  OncoTargets and therapy 20090101

• First-line targeted therapies in the treatment of metastatic colorectal cancer - role of cetuximab.

  OncoTargets and therapy 20090101

• Role of trabectedin in the treatment of soft tissue sarcoma.

  OncoTargets and therapy 20090101

• Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab.

  OncoTargets and therapy 20090101

• Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer.

  OncoTargets and therapy 20090101

• Recurrent pneumonia due to an appendiceal mucinous cystadenocarcinoma: a rare presentation of a rare malignancy.

  Clinical medicine. Oncology 20090101

• Hospital costs of colorectal cancer care.

  Clinical medicine. Oncology 20090101

• Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer.

  Core evidence 20090101

• Oxaliplatin-induced lung fibrosis.

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20090101

• HER2 status and breast cancer therapy: recent advances.

  F1000 medicine reports 20090101

• Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancer.

  Cancer management and research 20090101

• Evolving role of cetuximab in the treatment of colorectal cancer.

  Cancer management and research 20090101

• Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations.

  Cancer management and research 20090101

• Effects of celecoxib and ly117018 combination on human breast cancer cells in vitro.

  Breast cancer : basic and clinical research 20090101

• Growth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer.

  Breast cancer : basic and clinical research 20090101

• Orbital metastasis of breast carcinoma.

  Breast cancer : basic and clinical research 20090101

• Capecitabine induced acute coronary syndrome.

  BMJ case reports 20090101

• Capecitabine (oral 5-fluorouracil pro-drug) treatment for colorectal carcinoma causing ischaemic chest pain.

  BMJ case reports 20090101

• Developments in treating metastatic colorectal cancer: Recent international reports from ASCO 2007 and 2008.

  Clinical and experimental gastroenterology 20090101

• Recent advances in the management of carcinoma of the rectum.

  Clinical and experimental gastroenterology 20090101

• Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer.

  Clinical and experimental gastroenterology 20090101

• Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081220

• Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer.

  Journal of the National Cancer Institute 20081217

• Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer.

  British journal of cancer 20081209

• A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses.

  Breast cancer research and treatment 20081201

• Preclinical discovery of ixabepilone, a highly active antineoplastic agent.

  Cancer chemotherapy and pharmacology 20081201

• Cauda equina syndrome due to leptomeningeal carcinomatosis of the ovary.

  Gynecologic oncology 20081201

• Pancreatic cancer: from molecular signature to target therapy.

  Critical reviews in oncology/hematology 20081201

• Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors.

  Breast (Edinburgh, Scotland) 20081201

• Severe skin toxicity observed with the combination of capecitabine and weekly paclitaxel in metastatic breast cancer patients.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20081201

• Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).

  Journal of surgical oncology 20081201

• A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20081201

• Activity of ixabepilone in patients with metastatic breast cancer with primary resistance to taxanes.

  Clinical breast cancer 20081201

• A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.

  Clinical breast cancer 20081201

• A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors.

  Molecular cancer therapeutics 20081201

• Residual cancer burden in locally advanced breast cancer: a superior tool.

  Current oncology (Toronto, Ont.) 20081201

• Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors.

  The oncologist 20081201

• Chemotherapy for metastatic gastric cancer in Japan.

  International journal of clinical oncology 20081201

• Integrating epothilones into the treatment of patients with metastatic breast cancer: clinical perspectives on incorporating recent data in the practice setting.

  Clinical breast cancer 20081201

• [Capecitabine combined with cisplatin as first-line therapy in Chinese patients with advanced gastric carcinoma-a phase II clinical study].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20081201

• [Docetaxel and capecitabine combination chemotherapy for patients with anthracycline-resistant metastatic breast cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20081201

• Systems biology: a therapeutic target for tumor therapy.

  Cancer microenvironment : official journal of the International Cancer Microenvironment Society 20081201

• Gemcitabine and taxanes in metastatic breast cancer: a systematic review.

  Therapeutics and clinical risk management 20081201

• Vinflunine in the treatment of bladder cancer.

  Therapeutics and clinical risk management 20081201

• Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy.

  Therapeutics and clinical risk management 20081201

• Small molecule tyrosine kinase inhibitors in pancreatic cancer.

  Biologics : targets & therapy 20081201

• Novel microtubule-targeting agents - the epothilones.

  Biologics : targets & therapy 20081201

• Bevacizumab in the treatment of HER2-negative breast cancer.

  Biologics : targets & therapy 20081201

• First-line therapeutic strategies in metastatic colorectal cancer.

  Oncology (Williston Park, N.Y.) 20081130

• Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer.

  British journal of cancer 20081104

• Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity.

  British journal of cancer 20081104

• Safety and pharmacokinetics of motesanib in combination with gemcitabine for the treatment of patients with solid tumours.

  British journal of cancer 20081104

• Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer.

  JOP : Journal of the pancreas 20081103

• Interaction between capecitabine and gemcitabine with warfarin in a patient with pancreatic cancer.

  JOP : Journal of the pancreas 20081103

• Pooled analysis of diarrhea events in patients with cancer treated with lapatinib.

  Breast cancer research and treatment 20081101

• Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as postoperative treatment for stage II and III rectal cancer.

  International journal of radiation oncology, biology, physics 20081101

• Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma.

  International journal of radiation oncology, biology, physics 20081101

• The CAP-CR study: direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabine.

  European journal of cancer (Oxford, England : 1990) 20081101

• [Molecular targets for colon cancer. VEGF, EGFR - and what else?].

  Der Pathologe 20081101

• A case of cardiogenic shock caused by capecitabine treatment.

  Nature clinical practice. Cardiovascular medicine 20081101

• Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancer.

  Anti-cancer drugs 20081101

• Application of epothilones in breast cancer therapy.

  Current opinion in oncology 20081101

• Management of bile duct tumors.

  Expert opinion on pharmacotherapy 20081101

• Vinorelbine in breast cancer.

  Expert opinion on pharmacotherapy 20081101

• Ixabepilone: a novel microtubule-stabilizing agent for the treatment of metastatic breast cancer.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081101

• Capecitabine-associated cerebellar ataxia.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081101

• Influence of capecitabine absorption on its metabolites pharmacokinetics: a bioequivalence study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20081101

• Chemotherapy and targeted agents for elderly women with advanced breast cancer.

  Recent patents on anti-cancer drug discovery 20081101

• Variation in the cost of medications for the treatment of colorectal cancer.

  The American journal of managed care 20081101

• [A phase I study of combination therapy with capecitabine and paclitaxel for patients with inoperable breast cancer or recurrent breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• Adrenal metastasis of breast cancer with involvement of the inferior vena cava.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20081101

• Role of combined-modality therapy in the management of locally advanced rectal cancer.

  Clinical colorectal cancer 20081101

• Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer.

  Clinical colorectal cancer 20081101

• [A case report of a patient with hand-foot syndrome induced by bolus 5-fluorouracil therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• Clinical utility of microarrays: current status, existing challenges and future outlook.

  Current genomics 20081101

• Capecitabine induced vasospastic angina.

  International journal of cardiology 20081030

• GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.

  British journal of cancer 20081021

• Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer.

  British journal of cancer 20081021

• Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081020

• Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer.

  Cancer 20081015

• [Influence of preoperative chemoradiotherapy, preoperative chemotherapy, and operation on immunity function in middle or lower rectal cancer patients].

  Zhonghua yi xue za zhi 20081014

• Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial.

  British journal of cancer 20081007

• A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer.

  Cancer chemotherapy and pharmacology 20081001

• Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20081001

• Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies.

  Annals of oncology : official journal of the European Society for Medical Oncology 20081001

• Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20081001

• Phase II trial of capecitabine and weekly docetaxel in metastatic renal cell carcinoma.

  Urology 20081001

• HER-2-positive metastatic breast cancer: trastuzumab and beyond.

  Expert opinion on pharmacotherapy 20081001

• Cancer of the pancreas: are we making progress? A review of studies in the US Oncology Research Network.

  Cancer control : journal of the Moffitt Cancer Center 20081001

• Lapatinib and ixabepilone for the treatment of metastatic breast cancer.

  Pharmacotherapy 20081001

• Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081001

• Bevacizumab in advanced colorectal cancer: a challenge to the current paradigm.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081001

• The combination of thalidomide and capecitabine in metastatic renal cell carcinoma -- is not the answer.

  American journal of clinical oncology 20081001

• Coronary spasm induced by capecitabine mimicks ST elevation myocardial infarction.

  Emergency medicine journal : EMJ 20081001

• FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.

  The oncologist 20081001

• An update on biochemotherapy of advanced gastric and gastroesophageal adenocarcinoma.

  Journal of the National Comprehensive Cancer Network : JNCCN 20081001

• Unraveling the biologic and clinical complexities of HER2.

  Clinical breast cancer 20081001

• Complete remission of unresectable colon cancer after preoperative chemotherapy selected by adenosine triphosphate-based chemotherapy response assay.

  Journal of Korean medical science 20081001

• Preoperative chemoradiation for locally advanced rectal cancer with capecitabine 2,000 mg/m2/day.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20081001

• Antiangiogenic effect of capecitabine combined with ginsenoside Rg3 on breast cancer in mice.

  Cancer biotherapy & radiopharmaceuticals 20081001

• New treatment options for advanced pancreatic cancer.

  Expert review of gastroenterology & hepatology 20081001

• [Combination of docetaxel and capecitabine for the treatment of anthracycline-resistant advanced breast carcinoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20081001

• Docetaxel in the treatment of squamous cell carcinoma of the head and neck.

  Therapeutics and clinical risk management 20081001

• Review of docetaxel in the treatment of gastric cancer.

  Therapeutics and clinical risk management 20081001

• Weekly docetaxel in the treatment of metastatic breast cancer.

  Therapeutics and clinical risk management 20081001

• Survival from cancer of the oesophagus in England and Wales up to 2001.

  British journal of cancer 20080923

• Survival from cancer of the stomach in England and Wales up to 2001.

  British journal of cancer 20080923

• Survival from cancer of the pancreas in England and Wales up to 2001.

  British journal of cancer 20080923

• Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration.

  British journal of cancer 20080916

• Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer.

  British journal of cancer 20080916

• Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.

  British journal of cancer 20080916

• Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer.

  British journal of cancer 20080916

• Lapatinib: a dual tyrosine kinase inhibitor for metastatic breast cancer.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080915

• Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer.

  British journal of cancer 20080902

• Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy.

  British journal of cancer 20080902

• A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer.

  British journal of cancer 20080902

• Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer.

  British journal of cancer 20080902

• Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.

  Cancer chemotherapy and pharmacology 20080901

• Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080901

• EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.

  International journal of radiation oncology, biology, physics 20080901

• Drug Insight: intracellular inhibitors of HER2--clinical development of lapatinib in breast cancer.

  Nature clinical practice. Oncology 20080901

• A modern regimen of pre-operative concurrent chemo-radiation therapy in locally advanced rectal cancer.

  Journal of surgical oncology 20080901

• A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agents.

  The Journal of urology 20080901

• Ixabepilone: a new antimitotic for the treatment of metastatic breast cancer.

  The Annals of pharmacotherapy 20080901

• Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase.

  Anti-cancer drugs 20080901

• Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer.

  Anti-cancer drugs 20080901

• Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.

  Anti-cancer drugs 20080901

• Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer.

  International journal of oncology 20080901

• A phase I study of EKB-569 in combination with capecitabine in patients with advanced colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080901

• Bilateral inflammatory metachronic ERBB2 (HER2/neu)-positive breast carcinoma: prolonged survival with combined chemotherapy and trastuzumab.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080901

• [A recurrent case of lipid-secreting carcinoma of the breast successfully treated with capecitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080901

• Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer.

  Clinical therapeutics 20080901

• Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20080901

• Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20080901

• Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

  Biologics : targets & therapy 20080901

• Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer.

  Biologics : targets & therapy 20080901

• Efficacy of the oral fluorouracil pro-drug capecitabine in cancer treatment: a review.

  Molecules (Basel, Switzerland) 20080827

• A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.

  British journal of cancer 20080819

• A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.

  British journal of cancer 20080819

• Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer.

  British journal of cancer 20080819

• Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts.

  Cancer letters 20080818

• Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a phase II single institution trial.

  British journal of cancer 20080805

• Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.

  British journal of cancer 20080805

• Polyamine catabolism in colorectal cancer cells following treatment with oxaliplatin, 5-fluorouracil and N1, N11 diethylnorspermine.

  Cancer chemotherapy and pharmacology 20080801

• Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.

  Cancer chemotherapy and pharmacology 20080801

• Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation.

  Investigational new drugs 20080801

• UFT (tegafur-uracil) in rectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080801

• Nail and periungual toxicity following capecitabine therapy.

  British journal of clinical pharmacology 20080801

• Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer.

  Nature clinical practice. Oncology 20080801

• Are capecitabine and oxaliplatin as effective as fluorouracil and cisplatin for gastroesophageal cancer?

  Nature clinical practice. Gastroenterology & hepatology 20080801

• Large bowel perforation associated with capecitabine treatment for breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080801

• Pyogenic granuloma-like lesions caused by capecitabine therapy.

  Clinical and experimental dermatology 20080801

• Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.

  Journal of the American Academy of Dermatology 20080801

• Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080801

• Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080801

• Capecitabine-induced coronary vasospasm.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080801

• Drug development in the targeted therapy era.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080801

• Selected combination therapy with sorafenib: a review of clinical data and perspectives in advanced solid tumors.

  The oncologist 20080801

• [The prevention of diarrhea while under capecitabine therapy].

  Deutsche medizinische Wochenschrift (1946) 20080801

• Epothilones in breast cancer: current status and future directions.

  Expert review of anticancer therapy 20080801

• [Clinical effect and positioning of capecitabine for metastatic breast carcinoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080801

• [Management of hand-foot syndrome in patient treated with capecitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080801

• Cetuximab treatment in a patient with metastatic colorectal cancer and psoriasis.

  Current oncology (Toronto, Ont.) 20080801

• Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.

  Clinical therapeutics 20080801

• Alternating XELFOX and XELFIRI in patients with metastatic colorectal cancer.

  American journal of clinical oncology 20080801

• Capecitabine in gastric cancer.

  Drugs of today (Barcelona, Spain : 1998) 20080801

• New treatment strategies provide more options for patients with breast cancer.

  JAMA 20080723

• Inequity in colorectal cancer treatment and outcomes: a population-based study.

  British journal of cancer 20080722

• UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study.

  British journal of cancer 20080722

• Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080720

• The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: Implications for cancer therapy.

  Biochemical pharmacology 20080715

• Ixabepilone in combination with capecitabine and as monotherapy for treatment of advanced breast cancer refractory to previous chemotherapies.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080715

• Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080710

• Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the '44th ASCO Annual Meeting'. Chicago, IL, USA. May 30 - June 3, 2008.

  JOP : Journal of the pancreas 20080710

• Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses.

  British journal of cancer 20080708

• Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20080701

• Discoid lupus erythematosus (DLE)-like lesions induced by capecitabine.

  International journal of colorectal disease 20080701

• Candidate mechanisms for capecitabine-related hand-foot syndrome.

  British journal of clinical pharmacology 20080701

• Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080701

• Pancreatic cancer--is the wall crumbling?

  Annals of oncology : official journal of the European Society for Medical Oncology 20080701

• Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.

  Annals of surgical oncology 20080701

• Combined cetuximab, capecitabine, oxaliplatin, and radiotherapy in rectal cancer: Dr. Jekyll or Mr. Hyde? In regard to Rödel et al. (Int J Radiat Oncol Biol Phys 2008;70:1081-1086.).

  International journal of radiation oncology, biology, physics 20080701

• Optimized blood sampling with cytidine deaminase inhibitor for improved analysis of capecitabine metabolites.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080701

• Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?

  The oncologist 20080701

• Adjuvant chemotherapy for colon cancer--analysis of treatment costs from the perspective of statutory sickness funds.

  Zeitschrift fur Gastroenterologie 20080701

• Dual biologic therapy in the first-line mCRC setting: implications of the CAIRO2 study.

  Clinical colorectal cancer 20080701

• Highlights from: The 44th Annual Meeting of the American Society of Clinical Oncology. Chicago, IL; May 30-June 3, 2008.

  Clinical colorectal cancer 20080701

• Preferences of patients with advanced colorectal cancer for treatment with oral or intravenous chemotherapy.

  The patient 20080701

• Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases.

  British journal of cancer 20080603

• A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers.

  British journal of cancer 20080603

• A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer.

  Breast cancer research and treatment 20080601

• Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial.

  Cancer chemotherapy and pharmacology 20080601

• A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma.

  Cancer chemotherapy and pharmacology 20080601

• PK/PD model of indisulam and capecitabine: interaction causes excessive myelosuppression.

  Clinical pharmacology and therapeutics 20080601

• Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20080601

• Role of gemcitabine in metastatic breast cancer patients: a short review.

  Breast (Edinburgh, Scotland) 20080601

• Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080601

• A well-tolerated 5-FU-based treatment subsequent to severe capecitabine-induced toxicity in a DPD-deficient patient.

  British journal of clinical pharmacology 20080601

• Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20080601

• Cerebellar toxicity with capecitabine in a patient with metastatic breast cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20080601

• New directions in the management of advanced pancreatic cancer: a review.

  Anti-cancer drugs 20080601

• Capecitabine: an overview of the side effects and their management.

  Anti-cancer drugs 20080601

• Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20080601

• Pancreatic cancer.

  Integrative cancer therapies 20080601

• Ixabepilone for the treatment of taxane-refractory breast cancer.

  Future oncology (London, England) 20080601

• Erlotinib: the first biologic in the management of pancreatic cancer.

  Expert opinion on pharmacotherapy 20080601

• Phase I dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies.

  American journal of clinical oncology 20080601

• Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial.

  American journal of clinical oncology 20080601

• [Progression in palliative chemotherapy for advanced colorectal cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20080601

• Pharmacokinetics of 5-fluorouracil in patients heterozygous for the IVS14+1G > A mutation in the dihydropyrimidine dehydrogenase gene.

  Nucleosides, nucleotides & nucleic acids 20080601

• Altered dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil containing chemotherapy.

  Nucleosides, nucleotides & nucleic acids 20080601

• Neoadjuvant chemoradiation for rectal cancer: is more better?

  Oncology (Williston Park, N.Y.) 20080601

• Capecitabine: new indication. Advanced-stage gastric cancer: oral route for some patients. Risk of palmoplantar erythrodysaesthesia.

  Prescrire international 20080601

• Mesojejunoileac liposarcoma with intrahepatic metastasis in a dog.

  The Journal of veterinary medical science 20080601

• Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer.

  Clinical breast cancer 20080601

• Gemcitabine and vinorelbine combination chemotherapy in anthracycline- and taxane-pretreated advanced breast cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20080601

• Novel cytotoxic agents: epothilones.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080515

• Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutation.

  JOP : Journal of the pancreas 20080508

• Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function.

  JOP : Journal of the pancreas 20080508

• Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study.

  British journal of cancer 20080506

• Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group.

  Cancer chemotherapy and pharmacology 20080501

• Issues and controversies in the treatment of HER2 positive metastatic breast cancer.

  Breast cancer research and treatment 20080501

• Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients.

  Journal of neurology, neurosurgery, and psychiatry 20080501

• A phase I clinical trial of low-dose interferon-alpha-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma.

  Cancer chemotherapy and pharmacology 20080501

• Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080501

• A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080501

• Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases; a new simplified technique in isolated hepatic perfusion.

  Annals of surgical oncology 20080501

• Systemic therapy for metastatic colorectal cancer: current questions.

  Cancer 20080501

• Capecitabine-associated coronary vasospasm: a case report.

  Emergency medicine journal : EMJ 20080501

• Potential regional differences for the tolerability profiles of fluoropyrimidines.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080501

• Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080501

• Pharmacoeconomic benefits of capecitabine-based chemotherapy in metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080501

• Re: Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080501

• Capecitabine and oxaliplatin for advanced esophagogastric cancer.

  The New England journal of medicine 20080501

• A phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080501

• [Acute coronary syndrome during oral capecitabine monotherapy].

  Revista espanola de cardiologia 20080501

• Use of capecitabine in refractory metastatic medullary thyroid carcinoma.

  Thyroid : official journal of the American Thyroid Association 20080501

• A carboxylesterase 2 gene polymorphism as predictor of capecitabine on response and time to progression.

  Current drug metabolism 20080501

• [Combined chemotherapy with molecular-targeted agent for breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080501

• [A case of occult breast cancer successfully treated by capecitabine in combination with weekly paclitaxel followed by FEC (75)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080501

• A novel tumor-promoting function residing in the 5' non-coding region of vascular endothelial growth factor mRNA.

  PLoS medicine 20080501

• Colon cancer: update on adjuvant therapy.

  Clinical colorectal cancer 20080501

• Is XELOX equivalent to FOLFOX or other continuous-infusion 5-fluorouracil chemotherapy in metastatic colorectal cancer?

  Clinical colorectal cancer 20080501

• Targeted therapies in breast cancer: established drugs and recent developments.

  Current clinical pharmacology 20080501

• Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling.

  British journal of cancer 20080422

• ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen.

  British journal of cancer 20080422

• Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma.

  British journal of cancer 20080422

• A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients.

  British journal of cancer 20080422

• A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours.

  British journal of cancer 20080422

• Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080420

• Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080420

• Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?

  Journal of the National Cancer Institute 20080416

• Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.

  Journal of the National Cancer Institute 20080416

• Epothilones: clinical update and future directions.

  Oncology (Williston Park, N.Y.) 20080415

• Targeting metastatic colorectal cancer in 2008: a long way from 5-FU.

  Oncology (Williston Park, N.Y.) 20080415

• Defining the optimal schedule of drug administration: art or science?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410

• Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410

• Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410

• Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410

• Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer.

  British journal of cancer 20080408

• Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study.

  British journal of cancer 20080408

• Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20080401

• A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.

  Cancer chemotherapy and pharmacology 20080401

• Topical henna for capecitabine induced hand-foot syndrome.

  Investigational new drugs 20080401

• Minimising treatment-associated risks in systemic cancer therapy.

  Pharmacy world & science : PWS 20080401

• Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial.

  Breast (Edinburgh, Scotland) 20080401

• The role of efflux and uptake transporters in [N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions.

  Drug metabolism and disposition: the biological fate of chemicals 20080401

• Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20080401

• A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080401

• Independent-model diagnostics for a priori identification and interpretation of outliers from a full pharmacokinetic database: correspondence analysis, Mahalanobis distance and Andrews curves.

  Journal of pharmacokinetics and pharmacodynamics 20080401

• Hand-foot syndrome with sclerodactyly-like changes in a patient treated with capecitabine.

  The American Journal of dermatopathology 20080401

• Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial.

  Expert review of anticancer therapy 20080401

• Capecitabine in the treatment of advanced gastric cancer.

  Future oncology (London, England) 20080401

• Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.

  Japanese journal of clinical oncology 20080401

• [A case of HER2-positive metastatic breast cancer responding to trastuzumab plus gemcitabine combination therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080401

• Preclinical investigations with epothilones in breast cancer models.

  Seminars in oncology 20080401

• Clinical studies with epothilones for the treatment of metastatic breast cancer.

  Seminars in oncology 20080401

• Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.

  Seminars in oncology 20080401

• Chemotherapy in elderly patients with colorectal cancer.

  The oncologist 20080401

• A Phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.

  Clinical breast cancer 20080401

• A Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-negative metastatic breast cancer.

  Clinical breast cancer 20080401

• Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.

  British journal of cancer 20080325

• Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells.

  British journal of cancer 20080325

• Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma.

  British journal of cancer 20080325

• Treatment of breast cancer with trastuzumab during pregnancy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080320

• Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer.

  International journal of radiation oncology, biology, physics 20080315

• A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours.

  British journal of cancer 20080311

• Sepsis from liver abscesses in metastatic colorectal carcinoma after chemoimmunotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080310

• Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008.

  JOP : Journal of the pancreas 20080308

• A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial.

  Cancer chemotherapy and pharmacology 20080301

• Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.

  International journal of radiation oncology, biology, physics 20080301

• Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20080301

• Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?

  International journal of colorectal disease 20080301

• Efficacy of combination chemotherapy with irinotecan (CPT-11) plus capecitabine in patients with metastatic or advanced colorectal carcinoma--a dual-centre phase II study: the MAC-6.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20080301

• Stevens-Johnson syndrome after treatment with capecitabine.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20080301

• Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer.

  The Journal of urology 20080301

• Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080301

• Oral treatment for gastric cancer: new choices, better choices?

  The Lancet. Oncology 20080301

• [A case of triple negative recurrent breast cancer successfully treated with capecitabine+docetaxel combination chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080301

• [Recent developments in systemic chemotherapy for hepatocellular carcinoma].

  The Korean journal of hepatology 20080301

• Ixabepilone: a novel antineoplastic agent with low susceptibility to multiple tumor resistance mechanisms.

  The oncologist 20080301

• Lapatinib: a sword with two edges.

  Pathology oncology research : POR 20080301

• The use of capecitabine in the combined-modality therapy for rectal cancer.

  Clinical colorectal cancer 20080301

• Current questions in the treatment of advanced colorectal cancer: the CAIRO studies of the Dutch Colorectal Cancer Group.

  Clinical colorectal cancer 20080301

• Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer.

  Clinical colorectal cancer 20080301

• Evaluation of quality of life in patients with metastatic colorectal cancer treated with capecitabine.

  Clinical colorectal cancer 20080301

• Options for the treatment of patients with taxane-refractory metastatic breast cancer.

  Clinical breast cancer 20080301

• Clinical experience with epothilones in patients with breast cancer.

  Clinical breast cancer 20080301

• Bevacizumab in the therapy for refractory metastatic colorectal cancer.

  Biologics : targets & therapy 20080301

• Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer.

  Biologics : targets & therapy 20080301

• Erlotinib in the treatment of advanced pancreatic cancer.

  Biologics : targets & therapy 20080301

• Prospective phase II study of brachytherapy boost as a component of neo-adjuvant chemotherapy and external beam radiation therapy in locally advanced rectal cancer.

  Journal of the Egyptian National Cancer Institute 20080301

• A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study).

  British journal of cancer 20080226

• Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080220

• Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group.

  British journal of cancer 20080212

• Clinical pharmacology of cancer therapies in older adults.

  British journal of cancer 20080212

• Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer.

  Cancer chemotherapy and pharmacology 20080201

• A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20080201

• Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer.

  Breast (Edinburgh, Scotland) 20080201

• Complete remission of a metastatic neuroendocrine tumor of the pancreas with capecitabine (Xeloda) monotherapy.

  Cancer chemotherapy and pharmacology 20080201

• Application of pressure mapping techniques to measure push and gripping forces with precision.

  Ergonomics 20080201

• Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review.

  International journal of colorectal disease 20080201

• Uracil incorporation into genomic DNA does not predict toxicity caused by chemotherapeutic inhibition of thymidylate synthase.

  DNA repair 20080201

• Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080201

• A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080201

• Effective oral chemotherapy for breast cancer: pillars of strength.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080201

• Eosinophilic fasciitis as a paraneoplastic phenomenon associated with metastatic colorectal carcinoma.

  The Australasian journal of dermatology 20080201

• Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.

  European journal of clinical pharmacology 20080201

• Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080201

• Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080201

• CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial.

  The Lancet. Oncology 20080201

• Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: a dose-escalation study.

  European journal of cancer (Oxford, England : 1990) 20080201

• Capecitabine plus oxaliplatin for the treatment of colorectal cancer.

  Expert review of anticancer therapy 20080201

• [A pilot clinical trial of gemcitabine and capecitabine chemotherapy for the treatment of advanced renal cell carcinoma failing immunotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080201

• [Two advanced/recurrent breast cancer cases effectively treated by trastuzumab/capecitabine combination therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080201

• [A 23-year delayed locoregional recurrence of breast carcinoma following mastectomy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080201

• Preoperative chemoradiation with capecitabine in locally advanced rectal cancer.

  The Netherlands journal of medicine 20080201

• Thymidine phosphorylase and dihydropyrimidine dehydrogenase are predictive factors of therapeutic efficacy of capecitabine monotherapy for breast cancer-preliminary results.

  The journal of medical investigation : JMI 20080201

• [Chemotherapy for pancreatic cancer].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080201

• Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors.

  American journal of clinical oncology 20080201

• Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtable.

  Clinical breast cancer 20080201

• [Gemcitabine combined with capecitabine in the treatment for 41 patients with relapsed or metastatic biliary tract carcinoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080201

• [Clinical observation of XELOX (Capecitabine puls Oxaliplatin): an adjuvant chemotherapy regimen used in stage III colorectal cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080201

• Trabectedin and its potential in the treatment of soft tissue sarcoma.

  Therapeutics and clinical risk management 20080201

• Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results.

  Therapeutics and clinical risk management 20080201

• Clinical study of combined use of tomudex (raltitrexed) and xeloda (capecitabine) as first-line treatment for patients with metastasizing colorectal cancer.

  Bulletin of experimental biology and medicine 20080201

• Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial.

  British journal of cancer 20080129

• A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.

  British journal of cancer 20080129

• A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours.

  British journal of cancer 20080115

• A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation.

  British journal of cancer 20080115

• Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy.

  British journal of cancer 20080115

• Capecitabine and oxaliplatin for advanced esophagogastric cancer.

  The New England journal of medicine 20080103

• The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20080101

• Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20080101

• A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20080101

• The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis.

  Cancer chemotherapy and pharmacology 20080101

• Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study.

  Journal of cancer research and clinical oncology 20080101

• Tonsillar metastasis of oesophageal adenocarcinoma.

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20080101

• Third-line therapy for metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20080101

• Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20080101

• Daily low-dose/continuous capecitabine combined with neo-adjuvant irradiation reduces VEGF and PDGF-BB levels in rectal carcinoma patients.

  Acta oncologica (Stockholm, Sweden) 20080101

• Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.

  Acta oncologica (Stockholm, Sweden) 20080101

• Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20080101

• A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancer.

  Annals of surgical oncology 20080101

• Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature.

  Acta oncologica (Stockholm, Sweden) 20080101

• A phase I safety, tolerability, and pharmacokinetic study of enzastaurin combined with capecitabine in patients with advanced solid tumors.

  Anti-cancer drugs 20080101

• Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a study of the Multidisciplinary Oncology Group on Gastrointestinal Tumors.

  Anti-cancer drugs 20080101

• Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity.

  European journal of cancer (Oxford, England : 1990) 20080101

• Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines?

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080101

• Granulomatous septal panniculitis associated with capecitabine (Xeloda).

  Journal of the European Academy of Dermatology and Venereology : JEADV 20080101

• Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer.

  Journal of translational medicine 20080101

• San Antonio Breast Cancer Symposium.

  The Lancet. Oncology 20080101

• Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours.

  European journal of nuclear medicine and molecular imaging 20080101

• Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients.

  Neoplasma 20080101

• New therapeutic options for chemotherapy-resistant metastatic breast cancer: the epothilones.

  Drugs 20080101

• Cardiac toxicity: old and new issues in anti-cancer drugs.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080101

• Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080101

• Integrating microarray and proteomics data to predict the response on cetuximab in patients with rectal cancer.

  Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 20080101

• Capecitabine-related cardiotoxicity: recognition and management.

  The journal of supportive oncology 20080101

• Guidelines for chemotherapy of biliary tract and ampullary carcinomas.

  Journal of hepato-biliary-pancreatic surgery 20080101

• Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer.

  Clinical colorectal cancer 20080101

• Opossum carboxylesterases: sequences, phylogeny and evidence for CES gene duplication events predating the marsupial-eutherian common ancestor.

  BMC evolutionary biology 20080101

• Chinese medicine and biomodulation in cancer patients--Part one.

  Current oncology (Toronto, Ont.) 20080101

• Distinguishing post-treatment changes from recurrent disease in cholangiocarcinoma: a case report.

  Journal of medical case reports 20080101

• Onycholysis associated with capecitabine in patients with breast cancer.

  Journal of cutaneous medicine and surgery 20080101

• The emerging role of lapatinib in HER2-positive breast cancer.

  Current oncology reports 20080101

• Chronic myeloid leukemia following the treatment of rectal adenocarcinoma.

  Medical oncology (Northwood, London, England) 20080101

• Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.

  BMC cancer 20080101

• Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast.

  Breast cancer research : BCR 20080101

• Drug waste minimisation and cost-containment in Medical Oncology: two-year results of a feasibility study.

  BMC health services research 20080101

• Low-dose capecitabine in breast cancer patients with symptomatic bone marrow infiltration: a case study.

  Anticancer research 20080101

• Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20080101

• Inflammation of actinic keratoses with capecitabine therapy for colon cancer.

  European journal of dermatology : EJD 20080101

• Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.

  BMC cancer 20080101

• Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases.

  BMC cancer 20080101

• Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy.

  Molecular cancer 20080101

• Capecitabine, alone and in combination, in the management of patients with colorectal cancer: a review of the evidence.

  Drugs 20080101

• Chemotherapy for metastatic gastric cancer: past, present, and future.

  Journal of gastroenterology 20080101

• Interferon-alpha plus capecitabine and thalidomide in patients with metastatic renal cell cancer.

  Journal of experimental therapeutics & oncology 20080101

• Chemotherapy with gemcitabine in advanced biliary tract carcinoma.

  Reviews on recent clinical trials 20080101

• Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule.

  Anticancer research 20080101

• Drug interaction prediction using ontology-driven hypothetical assertion framework for pathway generation followed by numerical simulation.

  BMC bioinformatics 20080101

• A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment.

  BMC cancer 20080101

• Modified CAPOX (capecitabine plus oxaliplatin) regimen every two weeks as second-line treatment in patients with advanced colorectal cancer previously treated with irinotecan-based frontline therapy: a multicenter phase II study.

  Oncology 20080101

• PPARgamma and MEK Interactions in Cancer.

  PPAR research 20080101

• Capecitabine-induced oromandibular dystonia: a case report and literature review.

  Acta oncologica (Stockholm, Sweden) 20080101

• Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison.

  BMC cancer 20080101

• The Role of PPAR-gamma and Its Interaction with COX-2 in Pancreatic Cancer.

  PPAR research 20080101

• Early distant relapse after optimal local control in locally advanced rectal cancer.

  International seminars in surgical oncology : ISSO 20080101

• Rectal cancer adjuvant chemotherapy: when is more useful?

  Anticancer research 20080101

• Palliative treatment for elderly patients with colon cancer in ten Italian medical oncology units.

  Anticancer research 20080101

• Irinotecan plus capecitabine as first-line chemotherapy in advanced colorectal cancer.

  Anticancer research 20080101

• Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer.

  Breast cancer research : BCR 20080101

• Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study.

  BMC cancer 20080101

• Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer.

  BMC cancer 20080101

• Molecular targeted therapies for breast cancer treatment.

  Breast cancer research : BCR 20080101

• Current adjuvant and targeted therapies for pancreatic adenocarcinoma.

  Current medicinal chemistry 20080101

• [Gene expression profiling in prediction of tumor response to neoadjuvant concomitant chemoradiotherapy in patients with locally advanced rectal carcinoma: pilot study].

  Casopis lekaru ceskych 20080101

• HER2 oncogenic function escapes EGFR tyrosine kinase inhibitors via activation of alternative HER receptors in breast cancer cells.

  PloS one 20080101

• Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.

  Breast cancer research : BCR 20080101

• Splenic infarct as a diagnostic pitfall in radiology.

  Journal of cancer research and therapeutics 20080101

• Novel therapies in genitourinary cancer: an update.

  Journal of hematology & oncology 20080101

• EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy.

  BMC cancer 20080101

• Targeting Her-2/neu in breast cancer: as easy as this!

  Oncology 20080101

• Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes.

  Chemotherapy 20080101

• Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.

  Journal of experimental & clinical cancer research : CR 20080101

• Late recurrence of large peri-stomal metastasis following abdomino-perineal resection of rectal cancer.

  World journal of surgical oncology 20080101

• Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS setting.

  Clinical drug investigation 20080101

• Comparison of protracted infusion 5-fluorouracil and capecitabine in adjuvant chemoradiotherapy for rectal cancer.

  Hepato-gastroenterology 20080101

• Capecitabine cardiotoxicity--case reports and literature review.

  Hepato-gastroenterology 20080101

• Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials.

  Breast cancer research : BCR 20080101

• Reirradiation of recurrent breast cancer with and without concurrent chemotherapy.

  Radiation oncology (London, England) 20080101

• A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma.

  Radiation oncology (London, England) 20080101

• Primary mucinous adenocarcinoma of appendix treated with chemotherapy and radiotherapy: a case report.

  Tumori 20080101

• [Capecitabine in colorectal carcinoma: news from ASCO 2008]].

  Tumori 20080101

• EGFR expression in gallbladder carcinoma in North America.

  International journal of medical sciences 20080101

• Novel therapies in breast cancer: what is new from ASCO 2008.

  Journal of hematology & oncology 20080101

• [Results of surgical treatment of residual and recurrent anal tumors].

  Khirurgiia 20080101

• Hypermethylation of the DPYD promoter region is not a major predictor of severe toxicity in 5-fluorouracil based chemotherapy.

  Journal of experimental & clinical cancer research : CR 20080101

• XeNA: capecitabine plus docetaxel, with or without trastuzumab, as preoperative therapy for early breast cancer.

  International journal of medical sciences 20080101

• Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4).

  World journal of surgical oncology 20080101

• Hypofractionated accelerated radiotherapy, cytoprotection and capecitabine in the treatment of rectal cancer: a feasibility study.

  Anticancer research 20080101

• Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer: a well-tolerated, active and convenient regimen.

  Anticancer research 20080101

• [Colorectal carcinoma--primary treatment in case of advanced metastization].

  Onkologie 20080101

• [Adjuvant therapy of colon carcinoma].

  Onkologie 20080101

• [Treatment of advanced pancreatic carcinoma].

  Onkologie 20080101

• [Treatment of gastric cancer].

  Onkologie 20080101

• Atypical hand-and-foot syndrome in an African American patient treated with capecitabine with normal DPD activity: is there an ethnic disparity?

  Cutaneous and ocular toxicology 20080101

• Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).

  BMC cancer 20080101

• Capecitabine and docetaxel combination for the treatment of breast cancer.

  Women's health (London, England) 20080101

• Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide.

  Breast cancer research : BCR 20080101

• Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.

  BMC cancer 20080101

• Sequential or combination chemotherapy for a patient with mCRC?

  Cancer treatment reviews 20080101

• Strong association of a common dihydropyrimidine dehydrogenase gene polymorphism with fluoropyrimidine-related toxicity in cancer patients.

  PloS one 20080101

• Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine.

  BMC cancer 20080101

• Paralytic ileus associated with capecitabine.

  Tumori 20080101

• The management of cancer in the elderly: targeted therapies in oncology.

  Immunity & ageing : I & A 20080101

• Clinical Use of PPARgamma Ligands in Cancer.

  PPAR research 20080101

• Capecitabine and mitomycin-C in the therapy of pretreated patients with metastatic colorectal cancer: single center retrospective study with 36 patients.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20080101

• Chemotherapy side-effect management using mobile phones.

  Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20080101

• The Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer.

  PPAR research 20080101

• Role of neoadjuvant treatment in cT3N0M0 rectal cancer.

  Anticancer research 20080101

• Rationale for combining biotherapy in the treatment of advanced colon cancer.

  Gastrointestinal cancer research : GCR 20080101

• Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma.

  Gastrointestinal cancer research : GCR 20080101

• Have changes in systemic treatment improved survival in patients with breast cancer metastatic to the brain?

  Journal of oncology 20080101

• The role of oral fluoropyrimidines in the treatment of advanced gastric cancer.

  Acta gastro-enterologica Belgica 20080101

• Advanced gastric cancer: an update and future directions.

  Gastrointestinal cancer research : GCR 20080101

• [Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorithm of patients with rectal carcinoma].

  Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20080101

• Palmar-plantar hyperpigmentation with capecitabine in adjuvant colon cancer.

  Journal of gastrointestinal cancer 20080101

• Medical resource use and cost of different first-line treatments for metastatic colorectal cancer in Brazil.

  Journal of medical economics 20080101

• Important bioactive molecules of erythrocytes in colorectal cancer patients after colectomy.

  The open medicinal chemistry journal 20080101

• Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors.

  Drug design, development and therapy 20080101

• Hand-foot syndrome due to capecitabine.

  Indian journal of dermatology 20080101

• The epidermal growth factor receptor family in breast cancer.

  OncoTargets and therapy 20080101

• Targeted treatment of advanced and metastaticbreast cancer with lapatinib.

  OncoTargets and therapy 20080101

• Innovations in chemotherapy and radiation therapy: Implications and opportunities for the Asia-Pacific Rim.

  Biomedical imaging and intervention journal 20080101

• Successful downstaging of high rectal and recto-sigmoid cancer by neo-adjuvant chemo-radiotherapy.

  Clinical medicine. Oncology 20080101

• Response of cutaneous metastases from breast cancer to capecitabine.

  Clinical medicine. Oncology 20080101

• Documentation of complete response in metastatic breast cancer to liver and bone achieved with trastuzumab and pegylated liposomal Doxorubicin.

  Clinical medicine. Oncology 20080101

• Adenocarcinoma Arising within a Colonic Diverticulum in a Patient with Recurrent Diverticulitis.

  Clinical medicine. Oncology 20080101

• Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: a Pilot Phase I/II Feasibility Study.

  Clinical medicine. Oncology 20080101

• Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas.

  Clinical medicine. Oncology 20080101

• Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology.

  Ecancermedicalscience 20080101

• Phase 0 Workshop at the 20th EORTC-NCI-AACR Symposium, Geneva.

  Ecancermedicalscience 20080101

• Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.

  Biochemical pharmacology 20071203

• Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53.

  British journal of cancer 20071203

• Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial.

  British journal of cancer 20071203

• A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer.

  International journal of radiation oncology, biology, physics 20071201

• Intra-arterial and systemic chemotherapy plus external hyperthermia in unresectable biliary cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20071201

• Toxicity profile and efficacy of oral capecitabine as adjuvant chemotherapy for Chinese patients with Stage III colon cancer.

  Diseases of the colon and rectum 20071201

• Severe or lethal toxicities upon capecitabine intake: is DPYD genetic polymorphism the ideal culprit?

  Trends in pharmacological sciences 20071201

• Treatment of advanced colorectal cancer in the elderly.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20071201

• FDA approves new breast cancer treatment.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071201

• Intensified irinotecan-based neoadjuvant chemoradiotherapy in rectal cancer: four consecutive designed studies to minimize acute toxicity and to optimize efficacy measured by pathologic complete response.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20071201

• How the new oral antineoplastics affect nursing practice: capecitabine serves to illustrate.

  The American journal of nursing 20071201

• Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients--results of a phase II study.

  Onkologie 20071201

• Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer.

  American journal of clinical oncology 20071201

• Combined systemic therapy and radiotherapy for bladder cancer.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20071201

• The role of adjuvant chemotherapy in colon cancer.

  Surgical oncology 20071201

• Capecitabine for treatment of advanced hepatocellular carcinoma.

  Hepato-gastroenterology 20071201

• Evolving nonendocrine therapeutic options for metastatic breast cancer: how adjuvant chemotherapy influences treatment.

  Clinical breast cancer 20071201

• Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.

  Clinical breast cancer 20071201

• Update on clinical data combining capecitabine with targeted agents in newly diagnosed colorectal cancer.

  Clinical colorectal cancer 20071201

• Update on clinical data with regimens inhibiting angiogenesis and epidermal growth factor receptor for patients with newly diagnosed metastatic colorectal cancer.

  Clinical colorectal cancer 20071201

• Targeted therapies in the management of metastatic bladder cancer.

  Biologics : targets & therapy 20071201

• [Adjuvant chemotherapy for colon cancer].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20071129

• Combining chemotherapy and targeted therapies in metastatic colorectal cancer.

  World journal of gastroenterology 20071128

• Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071120

• Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer.

  British journal of cancer 20071119

• New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20071115

• Long-term survival in a patient with acinar cell carcinoma of pancreas. A case report and review of literature.

  JOP : Journal of the pancreas 20071109

• Long-term survival on capecitabine in two gemcitabine refractory pancreatic cancer patients. Is there a pharmacogenetic explanation?

  JOP : Journal of the pancreas 20071109

• Capecitabine therapy of central nervous system metastases from breast cancer.

  Journal of neuro-oncology 20071101

• Histological evaluation of colonic anastomotic healing, during perioperative Capecitabine administration. Experimental study in rats.

  Histology and histopathology 20071101

• A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective study.

  Annals of surgical oncology 20071101

• Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20071101

• Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer.

  International journal of radiation oncology, biology, physics 20071101

• Medical treatment for advanced gastroesophageal adenocarcinoma.

  Current opinion in gastroenterology 20071101

• Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.

  Japanese journal of clinical oncology 20071101

• Capecitabine in advanced gastric cancer.

  Expert opinion on pharmacotherapy 20071101

• Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20071101

• Comments on final report of the AIO Colorectal Cancer Group Study: fluorouracil/oxaliplatin versus capecitabine/oxaliplatin.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071101

• Capecitabine plus oxaliplatin in metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071101

• Anal canal carcinoma: experience from a single Korean institution.

  Yonsei medical journal 20071031

• Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study.

  British journal of cancer 20071022

• Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases.

  British journal of cancer 20071022

• Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules.

  British journal of cancer 20071022

• Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer.

  British journal of cancer 20071022

• PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients.

  British journal of cancer 20071022

• Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071020

• Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071020

• Capecitabine induced inflammation of actinic keratoses.

  Dermatology online journal 20071013

• In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation.

  British journal of cancer 20071008

• Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial.

  British journal of cancer 20071008

• Paraneoplastic neurological syndromes and breast cancer. Regression of paraneoplastic neurological sensorimotor neuropathy in a patient with metastatic breast cancer treated with capecitabine: a case study and mini-review of the literature.

  Breast cancer research and treatment 20071001

• Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy.

  Cancer chemotherapy and pharmacology 20071001

• Docetaxel-ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclines.

  Investigational new drugs 20071001

• A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors.

  Investigational new drugs 20071001

• Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group.

  Annals of surgical oncology 20071001

• Improving adjuvant chemotherapy in breast cancer -- can we get more for less with TACT2?

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20071001

• Enhancement of capecitabine efficacy by oxaliplatin in human colorectal and gastric cancer xenografts.

  Oncology reports 20071001

• Effective second-line treatment with cetuximab and bevacizumab in a patient with hepatic metastases of colorectal cancer and hyperbilirubinemia.

  Onkologie 20071001

• Effects of capecitabine and vinorelbine on cell proliferation, metabolism and COX2 and p16 expression in breast cancer cell lines and solid tumour tissues.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20071001

• Evaluation of therapeutic efficacy of capecitabine on human breast carcinoma tissues and cell lines in vitro.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20071001

• Adjuvant therapy for pancreatic cancer.

  Expert opinion on pharmacotherapy 20071001

• [A case of recurrent breast cancer with multiple liver metastases responding to combination therapy of capecitabine and MPA].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071001

• [A case of elderly metastatic breast cancer with a complete response to treatment with capecitabine and cyclophosphamide].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071001

• Adjuvant therapy for colon cancer.

  Current gastroenterology reports 20071001

• Ixabepilone, first in a new class of antineoplastic agents: the natural epothilones and their analogues.

  Clinical breast cancer 20071001

• Comparative cytotoxicity of C-1311 in colon cancer in vitro and in vivo using the hollow fiber assay.

  Journal of chemotherapy (Florence, Italy) 20071001

• Current options for the management of rectal cancer.

  Current treatment options in oncology 20071001

• Satraplatin in the treatment of hormone-refractory metastatic prostate cancer.

  Therapeutics and clinical risk management 20071001

• Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070920

• Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070920

• Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070920

• Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer.

  Cancer 20070915

• In vitro evaluation of cancer-specific NF-kappaB-CEA enhancer-promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines.

  British journal of cancer 20070911

• Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy.

  British journal of cancer 20070911

• [Myocardial ischaemia as a result of treatment with capecitabine].

  Nederlands tijdschrift voor geneeskunde 20070908

• A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma.

  Cancer chemotherapy and pharmacology 20070901

• Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome?

  Clinical and experimental dermatology 20070901

• Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation.

  Journal of pain and symptom management 20070901

• A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer.

  Current medical research and opinion 20070901

• [Capecitabine-induced hyperpigmentation].

  Actas dermo-sifiliograficas 20070901

• Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070901

• [Laparoscopic ovarian transposition and cryopreservation of ovarian tissue before chemo-radiotherapy for rectal cancer].

  Gynecologie, obstetrique & fertilite 20070901

• Metastatic esophageal adenocarcinoma presenting in the iris.

  American journal of ophthalmology 20070901

• Histopathologic evidence of capecitabine corneal toxicity in dogs.

  Veterinary pathology 20070901

• Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study.

  Cancer investigation 20070901

• The expression of thymidine phosphorylase in cancer-infiltrating inflammatory cells in stomach cancer.

  Journal of Korean medical science 20070901

• A Phase II study of cetuximab (Erbitux) plus FOLFIRI for irinotecan and oxaliplatin-refractory metastatic colorectal cancer.

  Journal of Korean medical science 20070901

• Combined-modality therapy for rectal cancer: future prospects.

  Clinical colorectal cancer 20070901

• Two Doses of oxaliplatin with capecitabine (XELOX) in metastatic colorectal cancer.

  Clinical colorectal cancer 20070901

• Safety of capecitabine use in patients with liver dysfunction.

  Clinical advances in hematology & oncology : H&O 20070901

• Palmar-plantar erythrodysesthesia in patients receiving capecitabine and intratumor thymidine phosphorylase and dihydropyrimidine dehydrogenase: is there a pharmacologic explanation?

  Supportive cancer therapy 20070901

• Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer.

  Biologics : targets & therapy 20070901

• The molecular genetics of breast cancer and targeted therapy.

  Biologics : targets & therapy 20070901

• Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma.

  British journal of cancer 20070828

• Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.

  British journal of cancer 20070828

• Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer.

  British journal of cancer 20070820

• Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignancies.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070820

• Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site.

  Cancer 20070815

• Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070810

• Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer.

  British journal of cancer 20070806

• Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver.

  NMR in biomedicine 20070801

• Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.

  Cancer chemotherapy and pharmacology 20070801

• Clinical efficacy of capecitabine as first-line chemotherapy in metastatic breast cancer--how low can you go?

  Breast (Edinburgh, Scotland) 20070801

• Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070801

• Capecitabine as third-line treatment in patients with metastatic renal cell carcinoma after failing immunotherapy.

  Anti-cancer drugs 20070801

• Medullary thyroid cancer treated by capecitabine.

  Anti-cancer drugs 20070801

• Advanced breast cancer: chemotherapy phase III trials that change a standard.

  Anti-cancer drugs 20070801

• DPD is a molecular determinant of capecitabine efficacy in colorectal cancer.

  International journal of oncology 20070801

• [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20070801

• Epidemiology, disease progression, and economic burden of colorectal cancer.

  Journal of managed care pharmacy : JMCP 20070801

• Neoadjuvant chemotherapy enables R0 resection of locally advanced rectal cancer in a patient with a previously irradiated pelvis.

  The British journal of radiology 20070801

• A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer.

  American journal of clinical oncology 20070801

• A phase I study of docetaxel, oxaliplatin, and capecitabine in patients with metastatic gastroesophageal cancer.

  American journal of clinical oncology 20070801

• Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial results.

  American journal of clinical oncology 20070801

• A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer.

  Therapeutics and clinical risk management 20070801

• Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070715

• Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard?

  Lancet (London, England) 20070714

• Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.

  Lancet (London, England) 20070714

• Comparative analysis of xanafide cytotoxicity in breast cancer cell lines.

  British journal of cancer 20070702

• [Unilateral acral necrosis as a minor form of hand-foot syndrome. Patient with unilateral acral necrosis secondary to capecitabine therapy for metastatic breast cancer].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20070701

• Antitumor activity of edotecarin in breast carcinoma models.

  Cancer chemotherapy and pharmacology 20070701

• A nurse-/pharmacy-led capecitabine clinic for colorectal cancer: results of a prospective audit and retrospective survey of patient experiences.

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20070701

• Necrotizing fasciitis as a late complication of multimodal treatment for locally advanced head and neck cancer: a case report.

  Head & neck 20070701

• Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20070701

• A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20070701

• Successful salvage of a relapsed high risk gestational trophoblastic neoplasia patient using capecitabine.

  Gynecologic oncology 20070701

• Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy.

  Cancer 20070701

• Does addition of lapatinib to capecitabine improve outcome in women with refractory breast cancer?

  Nature clinical practice. Oncology 20070701

• A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes.

  European journal of cancer care 20070701

• Radiotherapy for localized rectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070701

• [Treatments of pancreatic cancer from the standpoint of medical oncology].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070701

• [Evaluation of therapeutic regimens for taxane-resistant recurrent/metastatic breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070701

• [A case of severe hand-foot syndrome caused by capecitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070701

• [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070701

• Low dose gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070701

• Epothilones in breast cancer: review of clinical experience.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070701

• Capecitabine and irinotecan in advanced gastric cancer.

  The Lancet. Oncology 20070701

• [Comparison of the suppressing capecitabine and 5-fluorouracil effects on the pronounce of inflammatory cells score in the induction of episcleral fibrosis after trabeculectomy].

  Vojnosanitetski pregled 20070701

• [Myocardial ischaemia as a result of treatment with capecitabine].

  Nederlands tijdschrift voor geneeskunde 20070630

• [Optimal chemotherapy for advanced and recurrent breast cancer patients].

  Nihon rinsho. Japanese journal of clinical medicine 20070628

• Mechanisms of adverse effects of anti-VEGF therapy for cancer.

  British journal of cancer 20070618

• A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.

  British journal of cancer 20070604

• [Hand-foot syndrome with capecitabine therapy].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20070601

• Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers.

  Investigational new drugs 20070601

• A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070601

• Chemotherapy of advanced gastric cancer.

  Cancer treatment reviews 20070601

• Chemoimmunotherapy in the treatment of metastatic gastric cancer.

  Anti-cancer drugs 20070601

• Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20070601

• Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies.

  Cancer science 20070601

• Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results.

  International journal of radiation oncology, biology, physics 20070601

• Acute myeloid leukaemia secondary to treatment with capecitabine for metastatic colorectal cancer.

  European journal of haematology 20070601

• Combination chemotherapy in advanced pancreatic cancer: time to raise the white flag?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601

• Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601

• Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxane.

  American journal of clinical oncology 20070601

• Capecitabine in the treatment of colorectal cancer.

  Expert review of anticancer therapy 20070601

• A phase I study of thalidomide, capecitabine and temozolomide in advanced cancer.

  Cancer biology & therapy 20070601

• Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070601

• Lapatinib in breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070601

• Outpatient-basis chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin as first-line treatment for patients with metastatic or recurrent colorectal cancer.

  Journal of Korean medical science 20070601

• The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070601

• Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report.

  The Korean journal of internal medicine 20070601

• Lapatinib plus capecitabine in patients with HER2-positive advanced breast cancer.

  Clinical advances in hematology & oncology : H&O 20070601

• A review of the role of capecitabine in the treatment of colorectal cancer.

  Therapeutics and clinical risk management 20070601

• Cetuximab in the management of colorectal cancer.

  Biologics : targets & therapy 20070601

• Biological targets for isatin and its analogues: Implications for therapy.

  Biologics : targets & therapy 20070601

• A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer.

  British journal of cancer 20070521

• Breast cancer in the elderly.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070510

• Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer?

  JOP : Journal of the pancreas 20070509

• First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study.

  British journal of cancer 20070507

• The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer.

  British journal of cancer 20070507

• Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models.

  Cancer chemotherapy and pharmacology 20070501

• Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models.

  Cancer chemotherapy and pharmacology 20070501

• Cutaneous metastasis resembling acute dermatitis in patient with advanced gastric cancer.

  Clinical and experimental dermatology 20070501

• Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.

  Cancer 20070501

• A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer.

  European journal of cancer (Oxford, England : 1990) 20070501

• Pancreatic cancer: an update.

  Current oncology reports 20070501

• The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation.

  Health technology assessment (Winchester, England) 20070501

• Diagnosis and surgical management of gallbladder cancer: a review.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20070501

• Elementary, my dear Watson.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070501

• Integration of novel agents into combined-modality treatment for rectal cancer patients.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20070501

• Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice.

  Neoplasia (New York, N.Y.) 20070501

• An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer.

  British journal of cancer 20070423

• Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.

  Journal of medicinal chemistry 20070419

• A case of capecitabine-induced coronary microspasm in a patient with rectal cancer.

  World journal of gastroenterology 20070414

• Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study.

  British journal of cancer 20070410

• Lapatinib plus capecitabine in breast cancer.

  The New England journal of medicine 20070405

• Capecitabine-induced pancolitis.

  International journal of colorectal disease 20070401

• Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

  Cancer chemotherapy and pharmacology 20070401

• Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study.

  Cancer chemotherapy and pharmacology 20070401

• Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070401

• Should DPD analysis be required prior to prescribing fluoropyrimidines?

  European journal of cancer (Oxford, England : 1990) 20070401

• Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20070401

• Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.

  Journal of cardiothoracic and vascular anesthesia 20070401

• Genome-wide screening of loci associated with drug resistance to 5-fluorouracil-based drugs.

  Cancer science 20070401

• Cetuximab plus irinotecan in refractory colorectal cancer patients.

  Expert review of anticancer therapy 20070401

• [Efficacy of docetaxel combined capecitabine on metastatic breast cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20070401

• Adjuvant treatment of colon cancer: past, present and future.

  Journal of chemotherapy (Florence, Italy) 20070401

• Treatment of advanced pancreatic cancer.

  Seminars in oncology 20070401

• Adjuvant therapy for stage II and III colorectal cancer.

  Seminars in oncology 20070401

• Parotid gland metastasis of a breast cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070401

• Capecitabine in combination with novel targeted agents in the management of metastatic breast cancer: underlying rationale and results of clinical trials.

  The oncologist 20070401

• [Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20070401

• A glucuronidation pathway of capecitabine occurs in rats but not in mice and humans.

  Drug metabolism letters 20070401

• Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials.

  British journal of cancer 20070326

• A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer.

  British journal of cancer 20070326

• Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20070315

• A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma.

  International journal of radiation oncology, biology, physics 20070315

• Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients.

  British journal of cancer 20070312

• Pancreatic cancer: are we moving forward yet? Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 20th, 2007.

  JOP : Journal of the pancreas 20070310

• Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.

  Gynecologic oncology 20070301

• A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070301

• Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compounds.

  Molecular pharmacology 20070301

• An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors.

  Anti-cancer drugs 20070301

• [A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070301

• A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients.

  Journal of cellular and molecular medicine 20070301

• Predictive value of MSH2 gene expression in colorectal cancer treated with capecitabine.

  Clinical colorectal cancer 20070301

• Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop; Orlando, Florida; January 2007.

  Clinical colorectal cancer 20070301

• Phase II study of preoperative irradiation and chemotherapy with capecitabine in patients with locally advanced rectal carcinoma.

  Journal of experimental & clinical cancer research : CR 20070301

• Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20070301

• [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070301

• Hypokalemia secondary to capecitabine: a hidden toxicity?

  Therapeutics and clinical risk management 20070301

• First line targeted therapies in breast cancer: focus on bevacizumab.

  Biologics : targets & therapy 20070301

• Trastuzumab in the management of early and advanced stage breast cancer.

  Biologics : targets & therapy 20070301

• A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.

  British journal of cancer 20070226

• A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma.

  British journal of cancer 20070226

• Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer.

  British journal of cancer 20070212

• Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study.

  British journal of cancer 20070212

• Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070201

• Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20070201

• Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer.

  Oncology reports 20070201

• Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations.

  Nature clinical practice. Oncology 20070201

• Oral capecitabine (Xeloda) in cancer treatment.

  The Nurse practitioner 20070201

• A phase II study of second-line neoadjuvant chemotherapy with capecitabine and radiation therapy for anthracycline-resistant locally advanced breast cancer.

  American journal of clinical oncology 20070201

• Capecitabine.

  The oncologist 20070201

• [Progress of study on prevention and treatment of xeloda induced hand-foot syndrome by measures of Chinese and Western medicine].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20070201

• Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy.

  Clinical breast cancer 20070201

• Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea.

  Current oncology (Toronto, Ont.) 20070201

• Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells.

  British journal of cancer 20070129

• The Hollow Fibre Assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells.

  British journal of cancer 20070115

• Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study.

  British journal of cancer 20070115

• Rapid and simultaneous determination of capecitabine and its metabolites in mouse plasma, mouse serum, and in rabbit bile by high-performance liquid chromatography.

  Journal of chromatography. A 20070105

• Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients.

  British journal of clinical pharmacology 20070101

• Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer.

  Clinical and experimental dermatology 20070101

• Concurrent radiotherapy and capecitabine, followed by high-dose methotrexate consolidation, provided effective palliation in a patient with leptomeningeal metastases from breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070101

• Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites.

  Cancer science 20070101

• Phase II analysis of paclitaxel and capecitabine in the treatment of recurrent or disseminated squamous cell carcinoma of the head and neck region.

  Head & neck 20070101

• The effect of capecitabine on the healing of colonic anastomoses in rats.

  Diseases of the colon and rectum 20070101

• Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070101

• Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070101

• Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity.

  Urologic oncology 20070101

• Use of capecitabine to prevent acute renal allograft rejection in dog erythrocyte antigen-mismatched mongrel dogs.

  Veterinary surgery : VS 20070101

• [A patient with advanced breast cancer refractory to chemotherapy accompanied by carcinomatous pleurisy and multiple bone metastasis that responded to combination therapy with high-dose toremifene and docetaxel].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070101

• Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography.

  Cardiovascular ultrasound 20070101

• Efficacy of lower dose capecitabine in patients with metastatic breast cancer and factors influencing therapeutic response and outcome.

  Southern medical journal 20070101

• Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.

  Japanese journal of clinical oncology 20070101

• Systemic anticancer therapy in gynecological cancer patients with renal dysfunction.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20070101

• Toxicities and survival among octogenarians and nonagenarians with colorectal cancer treated with chemotherapy or concurrent chemoradiation therapy.

  Clinical colorectal cancer 20070101

• Palmar-plantar erythrodysesthesia associated with scrotal and penile involvement with capecitabine.

  Clinical colorectal cancer 20070101

• Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer.

  Anticancer research 20070101

• Capecitabine: in advanced gastric or oesophagogastric cancer.

  Drugs 20070101

• Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Yoon-Koo Kang.

  Drugs 20070101

• Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Sai-Hong Ignatius Ou and Randall F. Holcombe.

  Drugs 20070101

• Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial.

  BMC cancer 20070101

• Oral vinorelbine: role in the management of metastatic breast cancer.

  Drugs 20070101

• Rapid detection of the DPYD IVS14+1G>A mutation for screening patients to prevent fluorouracil-related toxicity.

  Molecular diagnosis & therapy 20070101

• The influence of primary care prescribing rates for new drugs on spontaneous reporting of adverse drug reactions.

  Drug safety 20070101

• Facilitating oral chemotherapy treatment and compliance through patient/family-focused education.

  Cancer nursing 20070101

• Current medical treatment of pancreatic neuroendocrine tumors.

  Hepato-gastroenterology 20070101

• Phase I study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first line therapy in patients with non-resectable gastric cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• Multicenter phase II study of chemo-immunotherapy in the treatment of metastatic renal cell carcinoma.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20070101

• Dosage of capecitabine and cyclophosphamide combination therapy in patients with metastatic breast cancer.

  Anticancer research 20070101

• Does lapatinib, a small-molecule tyrosine kinase inhibitor, constitute a breakthrough in the treatment of breast cancer?

  Breast cancer (Tokyo, Japan) 20070101

• Meta analysis of advanced cancer survival data using lognormal parametric fitting: a statistical method to identify effective treatment protocols.

  Current pharmaceutical design 20070101

• A Phase I dose-finding study using an innovative sequential biweekly schedule of irinotecan followed 24 hours later by capecitabine.

  Cancer investigation 20070101

• Capecitabine-induced headache responding to diltiazem.

  Chemotherapy 20070101

• Effective treatment of locally advanced endocrine tumors of the pancreas with chemoradiotherapy.

  Neuroendocrinology 20070101

• Intermittent capecitabine monotherapy with lower dose intensity in heavily pretreated patients with metastatic breast cancer.

  Tumori 20070101

• HER-2/neu diagnostics in breast cancer.

  Breast cancer research : BCR 20070101

• [Detection of dihydropyrimidine dehydrogenase deficiency before treatment by fluoropyrimidines].

  Therapie 20070101

• Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects.

  Anticancer research 20070101

• Dose-finding study of capecitabine in combination with weekly paclitaxel for patients with anthracycline-pretreated metastatic breast cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20070101

• Capecitabine in pretreated metastatic cholangiocarcinoma. A case report and review of the literature.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20070101

• Cost considerations in the treatment of colorectal cancer.

  PharmacoEconomics 20070101

• Breast cancer metastasis to the stomach may mimic primary gastric cancer: report of two cases and review of literature.

  World journal of surgical oncology 20070101

• Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel.

  BMC clinical pharmacology 20070101

• Successful treatment with low-dose capecitabine for disseminated esophageal adenocarcinoma.

  Acta oncologica (Stockholm, Sweden) 20070101

• Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma.

  Neoplasma 20070101

• Complete remission of recurrent breast cancer with multiple liver metastases after oral capecitabine and injected trastuzumab.

  Breast cancer (Tokyo, Japan) 20070101

• Mitomycin C plus capecitabine (mixe) in anthracycline- and taxane-pretreated metastatic breast cancer. A multicenter phase II study.

  Anticancer research 20070101

• Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study.

  Anticancer research 20070101

• Antitumor activity of capecitabine and bevacizumab combination in a human estrogen receptor-negative breast adenocarcinoma xenograft model.

  Anticancer research 20070101

• [Management of capecitabine-induced hand-foot syndrome by local phytotherapy].

  Wiener medizinische Wochenschrift (1946) 20070101

• Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation.

  World journal of surgical oncology 20070101

• Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.

  Cancer journal (Sudbury, Mass.) 20070101

• [Intestinal pneumatosis and portomesenteric gas: a case review].

  Revista de medicina de la Universidad de Navarra 20070101

• Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer.

  Breast cancer research : BCR 20070101

• Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer.

  Medical oncology (Northwood, London, England) 20070101

• Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• An update on treatment advances for the first-line therapy of metastatic colorectal cancer.

  Cancer journal (Sudbury, Mass.) 20070101

• Complications after oesophagectomy with possible contribution of neoadjuvant therapy including an EGFR-antibody to a fatal outcome.

  World journal of surgical oncology 20070101

• Is an aggressive surgical approach worthwhile in biliary cancer?

  International seminars in surgical oncology : ISSO 20070101

• Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer.

  Breast cancer research : BCR 20070101

• A pilot phase II study of capecitabine plus cisplatin in the treatment of recurrent carcinoma of the uterine cervix.

  Oncology 20070101

• A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors.

  Oncology 20070101

• An open-label, multicenter study of outpatient capecitabine monotherapy in 631 patients with pretreated advanced breast cancer.

  Oncology 20070101

• Esophageal cancer in a young woman with bulimia nervosa: a case report.

  Journal of medical case reports 20070101

• The multidisciplinary management of gastrointestinal cancer. The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer.

  Best practice & research. Clinical gastroenterology 20070101

• Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET.

  Nuklearmedizin. Nuclear medicine 20070101

• Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French setting.

  Oncology 20070101

• Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer.

  Oncology 20070101

• Breast tumour angiogenesis.

  Breast cancer research : BCR 20070101

• Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes.

  Oncology 20070101

• Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.

  Oncology 20070101

• Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study.

  Oncology 20070101

• 18FDG-PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab-based therapy.

  Tumori 20070101

• [The choice of treatment in advanced gastric cancer].

  Tumori 20070101

• The principles of chemotherapy of colorectal cancer in elderly.

  Advances in gerontology = Uspekhi gerontologii 20070101

• Pulmonary carcinoid tumours: indolent but not benign.

  Oncology 20070101

• Preoperative treatment combining capecitabine with radiation therapy in rectal cancer: a GERCOR Phase II Study.

  Oncology 20070101

• Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer.

  Oncology 20070101

• Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99).

  Oncology 20070101

• Acral and palmo-plantar hyperpigmentation in a patient with disseminated hepatocellular carcinoma.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20070101

• XELOX followed by XELIRI or the reverse sequence in advanced colorectal cancer.

  Oncology 20070101

• Short time to progression under first-line chemotherapy is a negative prognostic factor for time to progression and residual survival under second-line chemotherapy in advanced pancreatic cancer.

  Oncology 20070101

• DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY (DPD) IN GI MALIGNANCIES: EXPERIENCE OF 4-YEARS.

  Pakistan journal of medical sciences 20070101

• Chemotherapy for advanced gastric cancer: review of global and Japanese status.

  Gastrointestinal cancer research : GCR 20070101

• Current status of adjuvant therapy for colon cancer.

  Gastrointestinal cancer research : GCR 20070101

• Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer.

  Gastrointestinal cancer research : GCR 20070101

• Preoperative chemoradiotherapy in the management of localized rectal cancer: the new standard.

  Gastrointestinal cancer research : GCR 20070101

• Can the sequencing of concurrent capecitabine and radiation therapy improve the therapeutic ratio in rectal cancer?

  Gastrointestinal cancer research : GCR 20070101

• Recent Developments in Cytotoxic Therapy for Advanced Gastric or Gastroesophageal Carcinoma: The Phase III Trials.

  Gastrointestinal cancer research : GCR 20070101

• Antiangiogenic agents in first-line and second-line therapy for advanced colorectal cancer.

  Gastrointestinal cancer research : GCR 20070101

• Breast cancer (metastatic).

  BMJ clinical evidence 20070101

• Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care.

  Core evidence 20070101

• Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas.

  Core evidence 20070101

• Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

  The New England journal of medicine 20061228

• Targeted therapy for metastatic breast cancer.

  The New England journal of medicine 20061228

• A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens.

  British journal of cancer 20061218

• Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.

  Cancer chemotherapy and pharmacology 20061201

• Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20061201

• A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.

  Cancer chemotherapy and pharmacology 20061201

• Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer.

  International journal of radiation oncology, biology, physics 20061201

• A phase II trial of docetaxel plus capecitabine in patients with previously treated non-small cell lung cancer.

  Japanese journal of clinical oncology 20061201

• Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis.

  International journal of radiation oncology, biology, physics 20061201

• Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation.

  Cancer 20061201

• Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061201

• Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: a GOAM phase II randomised study (FOCA trial).

  European journal of cancer (Oxford, England : 1990) 20061201

• Clinically occult cutaneous metastases.

  Journal of the American Academy of Dermatology 20061201

• Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases.

  American journal of clinical oncology 20061201

• Radiochemotherapy followed by gemcitabine and capecitabine in extrahepatic bile duct cancer: a phase I/II trial.

  American journal of clinical oncology 20061201

• Targeted agents for adjuvant therapy of colon cancer.

  Seminars in oncology 20061201

• Should preoperative or postoperative therapy be administered in the management of rectal cancer?

  Seminars in oncology 20061201

• [Successful treatment of an elderly patient with pretreated recurrent breast cancer using low-dose capecitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061201

• [Two cases of advanced pancreas cancer treated with GTX: combined use of gemcitabine, docetaxel and capecitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061201

• [Chemotherapy for metastatic breast cancer].

  Zentralblatt fur Gynakologie 20061201

• A phase I study of an all-oral combination of vinorelbine/capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes.

  Clinical breast cancer 20061201

• Capecitabine and oxaliplatin (XELOX) for the treatment of patients with metastatic gastric cancer and severe liver dysfunction.

  The Korean journal of internal medicine 20061201

• Role of erlotinib in the management of pancreatic cancer.

  Therapeutics and clinical risk management 20061201

• Gemcitabine single or combination chemotherapy in post anthracycline and taxane salvage treatment of metastatic breast cancer: retrospective analysis of 124 patients.

  Cancer research and treatment : official journal of Korean Cancer Association 20061201

• Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations.

  British journal of cancer 20061120

• Novel interpenetrating network chitosan-poly(ethylene oxide-g-acrylamide) hydrogel microspheres for the controlled release of capecitabine.

  International journal of pharmaceutics 20061106

• Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer.

  British journal of cancer 20061106

• Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy.

  British journal of cancer 20061106

• Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.

  Gynecologic oncology 20061101

• Metastatic breast cancer: an updating.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20061101

• A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061101

• Patient preference for oral or intravenous chemotherapy: a randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20061101

• Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20061101

• Irinotecan cytotoxicity does not necessarily depend on the UGT1A1 polymorphism but on fluoropyrimidine: a molecular case report.

  Oncology reports 20061101

• Pancreatic cancer: a review of recent advances.

  Expert opinion on investigational drugs 20061101

• Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients.

  Pharmacogenetics and genomics 20061101

• The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.

  Health technology assessment (Winchester, England) 20061101

• Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.

  Journal of the American Academy of Dermatology 20061101

• Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial).

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20061101

• [Two patients having recurrent breast cancer with brain metastases well controlled with a gamma knife radio-surgery].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061101

• Commentary on a phase III trial of bevacizumab plus XELOX or FOLFOX4 for first-line treatment of metastatic colorectal cancer: the NO16966 trial.

  Clinical colorectal cancer 20061101

• Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness.

  Clinical colorectal cancer 20061101

• Profiling dihydropyrimidine dehydrogenase deficiency in patients with cancer undergoing 5-fluorouracil/capecitabine therapy.

  Clinical colorectal cancer 20061101

• Capecitabine for the oral treatment of metastatic breast cancer.

  Women's health (London, England) 20061101

• St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis.

  Toxicology and applied pharmacology 20061015

• Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer.

  British journal of cancer 20061009

• Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer.

  British journal of cancer 20061009

• High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy.

  British journal of cancer 20061009

• Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.

  Cancer chemotherapy and pharmacology 20061001

• Acute coronary syndrome induced by capecitabine therapy.

  Heart, lung & circulation 20061001

• Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061001

• Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061001

• Expression of chemoresistance-related proteins in alpha-fetoprotein-producing adenocarcinoma of the digestive organs.

  Oncology reports 20061001

• Pharmacogenomics of colorectal cancer prevention and treatment.

  Cancer investigation 20061001

• Peripheral neuropathy exacerbation associated with topical 5-fluorouracil.

  Anti-cancer drugs 20061001

• Are dose-finding studies still necessary when targeted therapy is associated with chemotherapy?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061001

• Docetaxel in the treatment of gastric cancer.

  Future oncology (London, England) 20061001

• Update on capecitabine in colorectal cancer.

  The oncologist 20061001

• Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.

  The American journal of gastroenterology 20061001

• [Therapeutic efficacy of capecitabine on advanced and recurrent breast cancer with special reference to time to progression].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061001

• [Case report of advanced breast cancer responding to capecitabine and trastuzumab combination therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061001

• A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapy.

  Therapeutic drug monitoring 20061001

• Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial.

  Croatian medical journal 20061001

• Metastatic hidradenocarcinoma: efficacy of capecitabine.

  Archives of dermatology 20061001

• [Onycholysis with hyponychium exudate secondary to chemotherapy with paclitaxel and capecitabine].

  Actas dermo-sifiliograficas 20061001

• Capecitabine/Cyclophosphamide/Methotrexate for patients with metastatic breast cancer: a dose-finding, feasibility, and efficacy study.

  Clinical breast cancer 20061001

• Treating advanced breast cancer in the older woman.

  Oncology (Williston Park, N.Y.) 20061001

• The role of angiogenesis inhibition in the treatment of breast cancer.

  Clinical advances in hematology & oncology : H&O 20061001

• Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.

  Current oncology (Toronto, Ont.) 20061001

• Hemoglobin induces colon cancer cell proliferation by release of reactive oxygen species.

  World journal of gastroenterology 20060921

• Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060920

• CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II.

  British journal of cancer 20060918

• Health state utilities for metastatic breast cancer.

  British journal of cancer 20060918

• Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma.

  Cancer 20060915

• A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008.

  Cancer 20060915

• Pharmacogenetics of capecitabine in advanced breast cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060915

• A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.

  British journal of cancer 20060904

• A phase II trial of oral capecitabine in patients with platinum--and taxane--refractory ovarian, fallopian tube, or peritoneal cancer.

  Gynecologic oncology 20060901

• In response to: 'On prejudice and facts and choices', an editorial by Kohne and Folprecht.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060901

• Uridine phosphorylase in breast cancer: a new prognostic factor?

  Frontiers in bioscience : a journal and virtual library 20060901

• Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy.

  International journal of radiation oncology, biology, physics 20060901

• Thymidine phosphorylase and capecitabine: a predictive marker for therapy selection?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060901

• Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060901

• Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?

  Annals of oncology : official journal of the European Society for Medical Oncology 20060901

• Bilateral avascular necrosis of the hips after chemoradiotherapy for cervical cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20060901

• Pharmacy benefit spending on oral chemotherapy drugs.

  Journal of managed care pharmacy : JMCP 20060901

• Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicity.

  Molecular cancer therapeutics 20060901

• Capecitabine-docetaxel combination treatment.

  Expert review of anticancer therapy 20060901

• Management of hand-foot syndrome induced by capecitabine.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20060901

• Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine.

  Clinical colorectal cancer 20060901

• Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer.

  Clinical genitourinary cancer 20060901

• Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma.

  British journal of cancer 20060821

• Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).

  British journal of cancer 20060821

• Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancer.

  Cancer 20060815

• Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer.

  Cancer 20060815

• Toxic death-case after capecitabine + oxaliplatin (XELOX) administration: probable implication of dihydropyrimidine deshydrogenase deficiency.

  Cancer chemotherapy and pharmacology 20060801

• 5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma.

  Cancer chemotherapy and pharmacology 20060801

• A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma.

  International journal of radiation oncology, biology, physics 20060801

• Capecitabine in carcinoma of the pancreas.

  Expert opinion on pharmacotherapy 20060801

• Antiangiogenic therapy in metastatic prostate carcinoma complicated by cutaneous lupus erythematodes.

  The Lancet. Oncology 20060801

• Surgical adjuvant therapy for colorectal cancer: current approaches and future directions.

  Annals of surgical oncology 20060801

• New agents, combinations, and opportunities in the treatment of advanced and early-stage colon cancer.

  The Surgical clinics of North America 20060801

• Capecitabine therapy for refractory metastatic thyroid carcinoma: a case series.

  Thyroid : official journal of the American Thyroid Association 20060801

• [A phase-I clinical study of a combination therapy of vinorelbine and capecitabine in patients with advanced/recurrent breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060801

• Synergistic cytotoxic interaction in hormone-refractory prostate cancer with the triple combination docetaxel-erlotinib and 5-fluoro-5'-deoxyuridine.

  Anti-cancer drugs 20060801

• Capecitabine: a new adjuvant option for colorectal cancer.

  Clinical journal of oncology nursing 20060801

• Relationship between AUC of 5'-DFUR and toxicity of capecitabine, fluoropyrimidine carbamate analogs, and 5'-DFUR in monkeys, mice, and rats.

  The Journal of toxicological sciences 20060801

• Liquid chromatography-tandem mass spectrometric assay for the analysis of uracil, 5,6-dihydrouracil and beta-ureidopropionic acid in urine for the measurement of the activities of the pyrimidine catabolic enzymes.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060724

• An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer.

  British journal of cancer 20060717

• Management of advanced colorectal cancer: state of the art.

  British journal of cancer 20060717

• Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers.

  Cancer 20060715

• The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients.

  British journal of cancer 20060703

• The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer.

  British journal of cancer 20060703

• Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme.

  Cancer chemotherapy and pharmacology 20060701

• Neurological complications of cancer chemotherapy.

  Current opinion in oncology 20060701

• Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060701

• Biological agents versus chemotherapy in the treatment of colorectal cancer.

  Expert opinion on pharmacotherapy 20060701

• A phase II Study of the global dose and schedule of capecitabine in Japanese patients with metastatic colorectal cancer.

  Japanese journal of clinical oncology 20060701

• [Capecitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060701

• [Adjuvant treatment of colorectal cancer].

  Bulletin du cancer 20060701

• Sequential therapy with capecitabine followed by vinorelbine/cisplatin in patients with anthracycline/taxane-refractory metastatic breast cancer.

  Journal of the Chinese Medical Association : JCMA 20060701

• Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II study.

  British journal of cancer 20060619

• Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.

  British journal of cancer 20060619

• Chemoradiotherapy in gallbladder cancer.

  Journal of surgical oncology 20060615

• Dose-finding phase I clinical and pharmacokinetic study of orally administered irinotecan in patients with advanced solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060615

• The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial.

  British journal of cancer 20060605

• Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer.

  British journal of cancer 20060605

• A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma.

  British journal of cancer 20060605

• Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

  British journal of cancer 20060605

• A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer.

  British journal of cancer 20060605

• Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.

  Breast (Edinburgh, Scotland) 20060601

• Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil.

  Journal of surgical oncology 20060601

• Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs.

  Cancer science 20060601

• Neoadjuvant therapy with bevacizumab.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601

• Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060601

• Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?

  American journal of clinical oncology 20060601

• Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale).

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• Adjuvant chemotherapy of colon cancer: lymph node involvement without metastases.

  Prescrire international 20060601

• [Chemotherapy for metastatic breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• Overview of gemcitabine activity in advanced breast cancer.

  Seminars in oncology 20060601

• Use of pemetrexed in breast cancer.

  Seminars in oncology 20060601

• Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.

  Clinical breast cancer 20060601

• Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report.

  Clinical breast cancer 20060601

• [Antitumor activity and function of S-1, a new oral tegafur-based formulation].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• Rapid development of S-1 in the west for therapy of advanced gastric carcinoma.

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• [Clinical benefit of S-1 in metastatic breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• Clinical implications of angiogenesis in cancers.

  Vascular health and risk management 20060601

• Thymidine phosphorylase (platelet-derived endothelial cell growth factor) as a target for capecitabine: from biology to the bedside.

  Recent patents on anti-cancer drug discovery 20060601

• Administration of anti-HER2 antibody after nonmyeloablative allogeneic stem cell transplantation in metastatic breast cancer.

  British journal of cancer 20060522

• Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer.

  British journal of cancer 20060522

• Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes.

  Cancer 20060515

• A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.

  British journal of cancer 20060508

• Interferon-alpha plus capecitabine and thalidomide in patients with metastatic renal cell carcinoma: a pilot study.

  Investigational new drugs 20060501

• Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models.

  Cancer chemotherapy and pharmacology 20060501

• Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment.

  Oncology reports 20060501

• Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer.

  Oncology reports 20060501

• Adjuvant therapy for colon cancer.

  Current oncology reports 20060501

• Preoperative and adjuvant treatment of localized rectal cancer.

  Current oncology reports 20060501

• Evolving role of antineoplastic agents in colorectal cancer.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060501

• Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinoma.

  The Netherlands journal of medicine 20060501

• Not in the BNF.

  British journal of hospital medicine (London, England : 2005) 20060501

• Optimal treatment of metastatic colorectal cancer.

  Expert review of anticancer therapy 20060501

• [Irinotecan for the treatment of metastatic colorectal cancer].

  Bulletin du cancer 20060501

• Capecitabine-induced cerebellar toxicity.

  Clinical colorectal cancer 20060501

• First line chemotherapy of metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060501

• Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials.

  British journal of cancer 20060424

• Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial.

  British journal of cancer 20060424

• Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060420

• [Blisters unlike others].

  Revue medicale suisse 20060419

• Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.

  Cancer 20060415

• Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study.

  British journal of cancer 20060410

• A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer.

  British journal of cancer 20060410

• Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy.

  British journal of cancer 20060410

• XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer.

  British journal of cancer 20060410

• A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer.

  British journal of cancer 20060410

• Accrual delayed in adjuvant bevacizumab trial.

  Journal of the National Cancer Institute 20060405

• Fluorine nuclear magnetic resonance spectroscopy of human biofluids in the field of metabolic studies of anticancer and antifungal fluoropyrimidine drugs.

  Clinica chimica acta; international journal of clinical chemistry 20060401

• Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5'-deoxy-5-fluorouridine in breast cancer cells.

  Molecular pharmacology 20060401

• Vinorelbine in the management of breast cancer: New perspectives, revived role in the era of targeted therapy.

  Cancer treatment reviews 20060401

• Capecitabine use in geriatric oncology: an analysis of current safety, efficacy, and quality of life data.

  Critical reviews in oncology/hematology 20060401

• Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060401

• Gallbladder cancer.

  Current treatment options in gastroenterology 20060401

• Chemotherapy for advanced pancreatic cancer.

  Best practice & research. Clinical gastroenterology 20060401

• The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer.

  Best practice & research. Clinical gastroenterology 20060401

• Erlotinib or capecitabine with gemcitabine in pancreatic cancer?

  Future oncology (London, England) 20060401

• A pilot trial of gemcitabine and vinorelbine plus capecitabine in locally advanced or metastatic nonsmall cell lung cancer.

  American journal of clinical oncology 20060401

• Capecitabine monotherapy: safe and effective treatment for metastatic breast cancer.

  The oncologist 20060401

• Intraventricular metastases from rectal-sigmoid adenocarcinoma.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060401

• [Chemotherapy in nasopharyngeal carcinoma].

  Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris 20060401

• Capecitabine/Taxane combination therapy: evolving clinical utility in breast cancer.

  Clinical breast cancer 20060401

• Supportive care in the management of colon cancer.

  Supportive cancer therapy 20060401

• Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan.

  British journal of cancer 20060327

• A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer.

  International journal of radiation oncology, biology, physics 20060301

• Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20060301

• Validation of real-time reverse-transcription-polymerase chain reaction for quantification of capecitabine-metabolizing enzymes.

  Analytical biochemistry 20060301

• The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?

  Annals of oncology : official journal of the European Society for Medical Oncology 20060301

• Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060301

• Acute coronary syndrome induced by oral capecitabine.

  The Canadian journal of cardiology 20060301

• Capecitabine as an alternative in a case of fluorouracil-induced photodermatitis.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20060301

• [Adjuvant chemotherapy for colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060301

• Multicenter phase II study of fixed sequences of capecitabine combined with oxaliplatin or irinotecan in patients with previously untreated metastatic colorectal cancer.

  Clinical colorectal cancer 20060301

• Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver.

  Clinical colorectal cancer 20060301

• Tumour regression and mesorectal lymph node changes after intensified neoadjuvant chemoradiation for carcinoma of the rectum.

  APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20060301

• [Patient with haemolytic anemia and treatment with capecitabine. Review of one case and literature].

  Anales de medicina interna (Madrid, Spain : 1984) 20060301

• Small-Fiber Neuropathy Associated with Capecitabine (Xeloda)-induced Hand-foot Syndrome: A Case Report.

  Journal of clinical neuromuscular disease 20060301

• Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study.

  British journal of cancer 20060227

• [Better treatment for patients with colorectal liver metastases].

  Nederlands tijdschrift voor geneeskunde 20060218

• [Recent progress in the treatment of colorectal cancer].

  Medizinische Klinik (Munich, Germany : 1983) 20060215

• MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?

  British journal of cancer 20060213

• Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?

  British journal of cancer 20060213

• Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse.

  Breast (Edinburgh, Scotland) 20060201

• Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• Capecitabine-induced severe hypertriglyceridemia: report of two cases.

  The Annals of pharmacotherapy 20060201

• On prejudice and facts and choices.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• Phase II study of a 4-week capecitabine regimen in advanced or recurrent gastric cancer.

  Anti-cancer drugs 20060201

• Recent developments in the systemic therapy of advanced gastroesophageal malignancies.

  Expert opinion on investigational drugs 20060201

• Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201

• Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201

• The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer.

  American journal of clinical oncology 20060201

• Capecitabine plus weekly oxaliplatin in gastrointestinal tumors: a phase I study.

  American journal of clinical oncology 20060201

• An observational study examining the impact of capecitabine on warfarin antithrombotic activity and bleeding complications.

  Current medical research and opinion 20060201

• Should continuous infusion 5-fluorouracil become the standard of care in the USA as it is in Europe?

  Cancer investigation 20060201

• Use of capecitabine after renal allograft transplantation in dog erythrocyte antigen-matched dogs.

  Veterinary surgery : VS 20060201

• Clinical experience with pemetrexed in breast cancer.

  Seminars in oncology 20060201

• Capecitabine plus rofecoxib show no activity in patients with metastatic neuroendocrine tumours.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20060201

• Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer.

  Journal of Korean medical science 20060201

• [Reflexion on a good strategy of use of oxaliplatine with 5-fluorouracil and its derivatives in patients with advanced colorectal cancer].

  Bulletin du cancer 20060201

• [Oxaliplatin and preoperative chemoradiotherapy in rectal cancer].

  Bulletin du cancer 20060201

• Drug interaction between capecitabine and warfarin: a case report and review of the literature.

  International journal of clinical pharmacology and therapeutics 20060201

• Timing of significant adverse events is essential information during early development of new drugs.

  International journal of clinical oncology 20060201

• Capecitabine chemoradiation for rectal cancer after curative surgery.

  Journal of chemotherapy (Florence, Italy) 20060201

• Capecitabine/vinorelbine: an effective and well-tolerated regimen for women with pretreated advanced-stage breast cancer.

  Clinical breast cancer 20060201

• Guides for adjuvant treatment of colon cancer. TTD Group (Spanish Cooperative Group for Gastrointestinal Tumor Therapy).

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060201

• Coronary artery spasm induced by capecitabine.

  Journal of cardiovascular medicine (Hagerstown, Md.) 20060201

• Optimal timing for the administration of capecitabine with preoperative chemoradiation for locally advanced rectal cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20060201

• Antimetabolites and cancer: emerging data with a focus on antifolates.

  Expert opinion on therapeutic patents 20060201

• Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients.

  British journal of cancer 20060130

• Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: adjuvant 5-FU/cisplatin and chemoradiation with capecitabine.

  World journal of gastroenterology 20060128

• Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial.

  British journal of cancer 20060116

• 'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'.

  British journal of cancer 20060116

• Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma.

  Cancer 20060115

• Weekly paclitaxel plus capecitabine in advanced breast cancer patients: dose-finding trial of GOIRC and GOL.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060101

• A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060101

• Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060101

• Gemcitabine-related radiation recall in a patient with pancreatic cancer.

  Anti-cancer drugs 20060101

• Upregulation of thymidine phosphorylase in rectal cancer tissues by mitomycin C.

  Journal of surgical oncology 20060101

• Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma.

  BMC cancer 20060101

• [Pilot study of primary systemic chemotherapy with docetaxel (DOC), epirubicin (EPI) and capecitabine (Xeloda) in patients with advanced breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060101

• Breast cancer in limited-resource countries: treatment and allocation of resources.

  The breast journal 20060101

• [Pancreatic cancer: what is new in 2005?].

  Bulletin du cancer 20060101

• [5 -fluoropyrimidines for treatment of biliary tract cancers].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• Benefits and risks of palliative capecitabine based therapy to elderly patients with advanced colorectal cancer: Danish single centre experiences.

  Acta oncologica (Stockholm, Sweden) 20060101

• Hepatocellular carcinoma--Pathological complete response to oral capecitabine, megestrol and thalidomide.

  Acta oncologica (Stockholm, Sweden) 20060101

• Choroidal metastasis from breast carcinoma.

  Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20060101

• Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer.

  BMC cancer 20060101

• A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.

  Clinical colorectal cancer 20060101

• Is capecitabine safe in patients with gastrointestinal cancer and dihydropyrimidine dehydrogenase deficiency?

  Clinical colorectal cancer 20060101

• A pilot phase II study of capecitabine in advanced or recurrent breast cancer.

  Breast cancer (Tokyo, Japan) 20060101

• Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: an observational study.

  BMC cancer 20060101

• Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience.

  BMC cancer 20060101

• Carboxylesterases--detoxifying enzymes and targets for drug therapy.

  Current medicinal chemistry 20060101

• Salvage treatment with single-agent capecitabine in patients with heavily pretreated advanced colorectal cancer.

  Anticancer research 20060101

• [Novel methods of treatment for colorectal carcinoma: from oral chemotherapy to angiogenesis inhibitors].

  Tumori 20060101

• Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial.

  BMC cancer 20060101

• Radiosensitizers in cervical cancer. Cisplatin and beyond.

  Radiation oncology (London, England) 20060101

• Phase II study of cisplatin, etoposide and paclitaxel in locally advanced or metastatic adenocarcinoma of gastric/gastroesophageal junction.

  Indian journal of cancer 20060101

• Dramatic regression of multiple brain metastases from breast cancer with Capecitabine: another arrow at the bow?

  Cancer investigation 20060101

• Cytotoxic chemotherapy for pancreatic cancer: Advances to date and future directions.

  Drugs 20060101

• Heart failure induced by non-cardiac drugs.

  Drug safety 20060101

• Capecitabine-induced hypertriglyceridemia: a report of two cases.

  Anticancer research 20060101

• Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.

  Anticancer research 20060101

• The role of capecitabine in the treatment of colorectal cancer in the elderly.

  Anticancer research 20060101

• Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients.

  Anticancer research 20060101

• Isolated metachronous splenic metastasis from synchronous colon cancer.

  World journal of surgical oncology 20060101

• Carcinosarcoma of the colon: report of a case with morphological, ultrastructural and molecular analysis.

  BMC cancer 20060101

• Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients?

  Acta oncologica (Stockholm, Sweden) 20060101

• The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20060101

• A long-term survivor of repeated inguinal nodes recurrence of papillary serous adenocarcinoma of CUP: case report.

  International seminars in surgical oncology : ISSO 20060101

• Three case reports of hand-foot syndrome with gefitinib.

  Cancer investigation 20060101

• Capecitabine: expanding options for the treatment of patients with early or locally advanced breast cancer.

  The oncologist 20060101

• HER-2-positive metastatic breast cancer: optimizing trastuzumab-based therapy.

  The oncologist 20060101

• The role of capecitabine in first-line treatment for patients with metastatic breast cancer.

  The oncologist 20060101

• The role of chemotherapy in patients with established gastric cancer.

  Best practice & research. Clinical gastroenterology 20060101

• Whole genome expression analysis for biologic rational pathway modeling: application in cancer prognosis and therapy prediction.

  Molecular diagnosis & therapy 20060101

• Chemotherapy with mitomycin C and capecitabine in patients with advanced colorectal cancer pretreated with irinotecan and oxaliplatin.

  Tumori 20060101

• Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer.

  Oncology 20060101

• Concurrent capecitabine and upper abdominal radiation therapy is well tolerated.

  Radiation oncology (London, England) 20060101

• HER2 therapy: molecular mechanisms of trastuzumab resistance.

  Breast cancer research : BCR 20060101

• Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer.

  World journal of surgical oncology 20060101

• Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma.

  Urologic oncology 20060101

• Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer.

  Tumori 20060101

• Metastatic adenocarcinoma of the colon presenting as a monarthritis of the hip in a young patient.

  World journal of surgical oncology 20060101

• FOLFOX-4 stop and go and capecitabine maintenance chemotherapy in the treatment of metastatic colorectal cancer.

  Oncology 20060101

• A comparative study on the cost of new antibiotics and drugs of other therapeutic categories.

  PloS one 20060101

• [Metastatic colorectal cancer: adjournments from ESMO 2006].

  Tumori 20060101

• [A review of chemotherapy for metastatic colon cancer].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20060101

• [Chemotherapy registry quality in Andalusian hospital pharmacy departments].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20060101

• Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK.

  Oncology 20060101

• A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumors.

  Oncology research 20060101

• C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation.

  Biomarker insights 20060101

• Colorectal cancer: from epidemiology to current treatment.

  The Libyan journal of medicine 20060101

• Intensity modulated radiotherapy: advantages, limitations and future developments.

  Biomedical imaging and intervention journal 20060101

• Trans-arterial hepatic radioembolisation of yttrium-90 microspheres.

  Biomedical imaging and intervention journal 20060101

• Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma.

  Cancer 20051215

• Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

  Cancer 20051215

• Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20051215

• Capecitabine-induced multifocal leukoencephalopathy: a report of five cases.

  Neurology 20051213

• [Colorectal carcinoma in elderly patients].

  Praxis 20051207

• Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20051201

• Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis.

  Cancer chemotherapy and pharmacology 20051201

• Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20051201

• Pharmacokinetic modelling of 5-FU production from capecitabine--a population study in 40 adult patients with metastatic cancer.

  Journal of pharmacokinetics and pharmacodynamics 20051201

• Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer.

  Cancer treatment reviews 20051201

• Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051201

• Pegylated liposomal doxorubicin-based combination chemotherapy as salvage treatment in patients with advanced hepatocellular carcinoma.

  American journal of clinical oncology 20051201

• Perspectives in colorectal cancer - Sixth Annual Conference. Metastatic colorectal cancer.

  IDrugs : the investigational drugs journal 20051201

• The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20051201

• [Progression of adjuvant chemotherapy for colon cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20051201

• [Recent progress of chemotherapy for colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051201

• [Pharmacokinetic comparison of capecitabine and 5'-deoxy-5-fluorouridine (doxifluridine; 5'-DFUR)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051201

• [A paclitaxel-resistant case of recurrent breast cancer responded to combination therapy of capecitabine and trastuzumab].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051201

• Molecular mechanisms and targeting of colorectal cancer.

  Seminars in oncology 20051201

• Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR).

  Seminars in oncology 20051201

• Front-line therapy for advanced colorectal cancer: emphasis on chemotherapy.

  Seminars in oncology 20051201

• Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience.

  Seminars in oncology 20051201

• Adjuvant chemotherapy of stage III colon cancer.

  Seminars in oncology 20051201

• Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.

  Prescrire international 20051201

• Optimizing adjuvant chemotherapy in early-stage breast cancer.

  Oncology (Williston Park, N.Y.) 20051201

• Actinic keratosis and capecitabine therapy.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20051201

• Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.

  British journal of cancer 20051128

• Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.

  British journal of cancer 20051114

• Portal hypertension secondary to 90Yttrium microspheres: an unknown complication.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051110

• Simultaneous determination of capecitabine and its metabolites by HPLC and mass spectrometry for preclinical and clinical studies.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051105

• Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study.

  Cancer chemotherapy and pharmacology 20051101

• Is adjuvant therapy with three-dimensional conformal irradiation combined with capecitabine (Xeloda) for gastric cancer effective?

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20051101

• Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic chemotherapy in patients with HER2-positive recurrent breast cancer: findings from a case series.

  Onkologie 20051101

• Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.

  Nature clinical practice. Oncology 20051101

• Capecitabine/Oxaliplatin combinations in advanced colorectal cancer: summary of recent randomized studies.

  Clinical colorectal cancer 20051101

• Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis.

  Clinical colorectal cancer 20051101

• Cytotoxic chemotherapy for advanced colorectal cancer. Recent advances in management.

  Oncology (Williston Park, N.Y.) 20051101

• A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.

  British journal of cancer 20051031

• Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study.

  British journal of cancer 20051017

• CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials.

  British journal of cancer 20051003

• Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20051001

• Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20051001

• A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer.

  American journal of clinical oncology 20051001

• Effect of capecitabine on mean corpuscular volume of red blood cells.

  American journal of clinical oncology 20051001

• Reduced dose capecitabine is an effective and well-tolerated treatment in patients with metastatic breast cancer.

  Breast (Edinburgh, Scotland) 20051001

• Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer.

  Journal of Korean medical science 20051001

• Advanced colorectal cancer: current treatment and nursing management with economic considerations.

  Clinical journal of oncology nursing 20051001

• Rapid evolution in colorectal cancer: therapy now and over the next five years.

  The oncologist 20051001

• [A change of tumor PyNPase level at intraperitoneal and intravenous administrations of paclitaxel].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051001

• Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats.

  British journal of cancer 20050919

• Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan.

  British journal of cancer 20050905

• Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy.

  Journal of cellular physiology 20050901

• Capecitabine-warfarin interaction.

  The Annals of pharmacotherapy 20050901

• Preferential inhibition of bone metastases by 5'-deoxy-5-fluorouridine and capecitabine in the 4T1/luc mouse breast cancer model.

  Oncology reports 20050901

• What is the best chemotherapy treatment option for anthracycline and taxane pretreated metastatic breast cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901

• An adverse interaction between warfarin and fluoropyrimidines revisited.

  Clinical colorectal cancer 20050901

• [Cost-effectiveness analysis of capecitabine in combination with docetaxel in comparison to docetaxel monotherapy in advanced or metastatic breast cancer in France].

  Bulletin du cancer 20050901

• Immunohistochemical expression of thymidylate synthase as predictor of response to capecitabine in patients with advanced colorectal adenocarcinoma.

  APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20050901

• A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma.

  Yonsei medical journal 20050831

• Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study.

  British journal of cancer 20050822

• Analysis of the DPYD gene implicated in 5-fluorouracil catabolism in a cohort of Caucasian individuals.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050815

• Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050815

• Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.

  British journal of cancer 20050808

• A systematic review of taxane-containing regimens for metastatic breast cancer.

  British journal of cancer 20050808

• A phase I study of doxifluridine combined with weekly paclitaxel for metastatic gastric cancer.

  Cancer chemotherapy and pharmacology 20050801

• Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5'-deoxy-5-fluorouridine (5'-DFUR).

  Cancer chemotherapy and pharmacology 20050801

• Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050801

• A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer.

  International journal of radiation oncology, biology, physics 20050801

• Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer.

  American journal of clinical oncology 20050801

• Potential use of COX-2-aromatase inhibitor combinations in breast cancer.

  British journal of cancer 20050801

• Current stage-specific chemotherapeutic options in colon cancer.

  Expert review of anticancer therapy 20050801

• [Experience with capecitabine in patients with anthracycline and/or taxane-resistant recurrent breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050801

• [A case of recurrent breast cancer successfully treated with capecitabine monotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050801

• Patient with angina secondary to capecitabine.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20050801

• Adjuvant therapy of colon cancer: current status and future developments.

  Clinics in colon and rectal surgery 20050801

• Oral Xeloda plus bi-platinu two-way combined chemotherapy in treatment of advanced gastrointestinal malignancies.

  World journal of gastroenterology 20050728

• Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).

  British journal of cancer 20050725

• Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.

  British journal of cancer 20050725

• Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050720

• Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.

  Cancer 20050715

• Systemic therapy for metastatic colorectal cancer: current options, current evidence.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050710

• Gastrointestinal bleeding associated with concurrent capecitabine and radiotherapy in patients with pancreatic cancer.

  JOP : Journal of the pancreas 20050708

• Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study.

  Cancer chemotherapy and pharmacology 20050701

• A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050701

• Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.

  Oncology reports 20050701

• The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC).

  European journal of cancer (Oxford, England : 1990) 20050701

• Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system.

  Cancer research 20050701

• Chemotherapy for metastatic colorectal cancer.

  Journal of the National Comprehensive Cancer Network : JNCCN 20050701

• Capecitabine versus continuous-infusion 5-fluorouracil for colorectal cancer: a retrospective efficacy and safety comparison.

  Clinical colorectal cancer 20050701

• Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study.

  Clinical colorectal cancer 20050701

• Chemotherapy dosing in the setting of liver dysfunction.

  Oncology (Williston Park, N.Y.) 20050701

• Supportive care of elderly patients with cancer.

  Supportive cancer therapy 20050701

• Capecitabine as adjuvant treatment for stage III colon cancer.

  The New England journal of medicine 20050630

• Adjuvant therapy for colon cancer--the pace quickens.

  The New England journal of medicine 20050630

• [Chemotherapy of patients with colorectal carcinoma].

  Nederlands tijdschrift voor geneeskunde 20050625

• Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer.

  British journal of cancer 20050620

• Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial.

  British journal of cancer 20050620

• Capecitabine plus docetaxel combination therapy.

  Cancer 20050615

• Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF.

  British journal of cancer 20050606

• Rapid quantitation of plasma 2'-deoxyuridine by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patients.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050605

• Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide.

  The Journal of pharmacology and experimental therapeutics 20050601

• Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix.

  Gynecologic oncology 20050601

• Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.

  Gynecologic oncology 20050601

• Thymidine phosphorylase expression in tumour cells and tumour response to capecitabine plus docetaxel chemotherapy in non-small cell lung cancer.

  Journal of clinical pathology 20050601

• Gastrointestinal cancer: recent developments in medical oncology.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20050601

• Role of novel targeted therapies in the clinic.

  British journal of cancer 20050601

• Metastatic carcinoma of the gallbladder mimicking an advanced cervical carcinoma.

  Gynecologic oncology 20050601

• Localization of thymidine phosphorylase in breast cancer tissue.

  Medical molecular morphology 20050601

• A monoclonal antibody as an effective therapeutic agent in breast cancer: trastuzumab.

  Expert opinion on biological therapy 20050601

• Capecitabine: effective oral fluoropyrimidine chemotherapy.

  Expert opinion on pharmacotherapy 20050601

• Platinum-based chemotherapy in metastatic breast cancer: the Leicester (U.K.) experience.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20050601

• Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer.

  Clinical breast cancer 20050601

• Gemcitabine/capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.

  Clinical breast cancer 20050601

• Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancer.

  Expert opinion on investigational drugs 20050601

• Adverse interaction between capecitabine and warfarin resulting in altered coagulation parameters and bleeding: case report and review of the literature.

  Journal of chemotherapy (Florence, Italy) 20050601

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050601

• A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer.

  British journal of cancer 20050523

• Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer.

  British journal of cancer 20050509

• Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin.

  Journal of cancer research and clinical oncology 20050501

• Successful desensitization to oxaliplatin.

  The Annals of pharmacotherapy 20050501

• The effects of capecitabine in Raynaud's disease: a case report.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics.

  Bulletin of mathematical biology 20050501

• Adjuvant therapy for colon cancer.

  Current oncology reports 20050501

• Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050501

• The development of clinical research in CRC.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• Adjuvant therapy in colon cancer: which treatment in 2005?

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncology.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• Results of a phase II open-label study of capecitabine in combination with irinotecan as first-line treatment for metastatic colorectal cancer.

  Clinical colorectal cancer 20050501

• [Irinotecan combined with fluoropyrimidine in treatment for advanced/metastatic colorectal carcinoma].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20050501

• Albumin-bound nanoparticle paclitaxel.

  Clinical advances in hematology & oncology : H&O 20050501

• Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.

  Clinical advances in hematology & oncology : H&O 20050501

• Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Con: Pumpin' FU (or, avoiding that oral fixation).

  Clinical advances in hematology & oncology : H&O 20050501

• Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer.

  British journal of cancer 20050411

• Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401

• Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies.

  Cancer chemotherapy and pharmacology 20050401

• Development of a stereological method to measure levels of fluoropyrimidine metabolizing enzymes in tumor sections using laser scanning cytometry.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20050401

• Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer.

  Anti-cancer drugs 20050401

• Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401

• Weekly docetaxel in combination with capecitabine in patients with metastatic gastric cancer.

  American journal of clinical oncology 20050401

• Can cisplatin and infused 5-fluorouracil be replaced by oxaliplatin and capecitabine in the treatment of advanced oesophagogastric cancer? The REAL 2 trial.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20050401

• Benefits and drawbacks of the use of oral fluoropyrimidines as single-agent therapy in advanced colorectal cancer.

  Clinical colorectal cancer 20050401

• Current therapies for advanced colorectal cancer.

  Oncology (Williston Park, N.Y.) 20050401

• Management of advanced colorectal cancer in older patients.

  Oncology (Williston Park, N.Y.) 20050401

• Docetaxel in the management of advanced pancreatic cancer.

  Seminars in oncology 20050401

• Docetaxel in the treatment of esophageal cancer.

  Seminars in oncology 20050401

• Capecitabine in the treatment of colorectal cancer.

  Future oncology (London, England) 20050401

• A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours.

  British journal of cancer 20050314

• Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients.

  British journal of cancer 20050314

• Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050301

• Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.

  The Annals of pharmacotherapy 20050301

• Taxotere-5'-deoxy-5-fluorouridine combination on hormone-refractory human prostate cancer cells.

  Anti-cancer drugs 20050301

• Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: a Gynecologic Oncology Group study.

  Gynecologic oncology 20050301

• Innovations in antineoplastic therapy.

  The Nursing clinics of North America 20050301

• Phase II evaluation of docetaxel-modulated capecitabine in previously treated patients with non-small cell lung cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050301

• Advances in colon cancer chemotheapy: nursing implications.

  Home healthcare nurse 20050301

• Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial.

  British journal of cancer 20050227

• Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group.

  British journal of cancer 20050227

• Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer.

  British journal of cancer 20050214

• Systemic therapy for colorectal cancer.

  The New England journal of medicine 20050203

• A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma.

  Cancer 20050201

• A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108.

  Critical reviews in oncology/hematology 20050201

• A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050201

• Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201

• Phase I and pharmacokinetic study of oral irinotecan given once daily for 5 days every 3 weeks in combination with capecitabine in patients with solid tumors.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201

• Health economic analysis of fluoropyrimidine-based therapies of colorectal cancer from the perspective of statutory sickness funds.

  Zeitschrift fur Gastroenterologie 20050201

• UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050201

• Oral capecitabine: bridging the Atlantic divide in colon cancer treatment.

  Seminars in oncology 20050201

• Adjuvant therapy of colon cancer.

  Seminars in oncology 20050201

• Combined modality treatment for rectal cancer.

  Seminars in oncology 20050201

• A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors.

  International journal of clinical oncology 20050201

• Palmar-plantar erythrodysesthesia.

  Clinical journal of oncology nursing 20050201

• Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy.

  British journal of cancer 20050131

• [Stomach cancer].

  La Revue du praticien 20050131

• In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study.

  Anti-cancer drugs 20050101

• Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells.

  BMC cancer 20050101

• Synergistic antitumor activity of capecitabine in combination with irinotecan.

  Clinical colorectal cancer 20050101

• Importance of preclinical investigations of the integration of capecitabine into polychemotherapy regimens.

  Clinical colorectal cancer 20050101

• [Recent perspectives second-line chemotherapy for breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050101

• [Second-line chemotherapy for advanced colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050101

• Capecitabine: a review.

  Clinical therapeutics 20050101

• Optimizing the treatment of metastatic breast cancer.

  Breast cancer research and treatment 20050101

• Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages.

  Immunopharmacology and immunotoxicology 20050101

• Addition of oxaliplatin to neo-adjuvant radiochemotherapy for irresectable rectal cancer, a phase I study.

  Anticancer research 20050101

• Current status and future prospects of chemotherapy for metastatic gastric cancer: a review.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20050101

• Neoadjuvant radiotherapy and radiochemotherapy for rectal cancer.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20050101

• A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer.

  International journal of gastrointestinal cancer 20050101

• [Gemcitabine plus cisplatin therapy in breast cancer refractory to anthracyclines, docetaxel and capecitabine].

  Voprosy onkologii 20050101

• Localized hand-foot syndrome after intra-arterial hepatic chemotherapy with floxuridine: a clinical case.

  Tumori 20050101

• Phase II study of docetaxel and capecitabine in patients with metastatic or recurrent gastric cancer.

  Oncology 20050101

• A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer.

  Oncology 20050101

• Cancer cell adaptation to chemotherapy.

  BMC cancer 20050101

• Phase II study of an 'all-oral' regimen of capecitabine, idarubicin and cyclophosphamide for metastatic breast cancer--safety, efficacy and quality of life.

  Oncology 20050101

• Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial.

  Acta oncologica (Stockholm, Sweden) 20050101

• Capecitabine as third line therapy in patients with advanced colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20050101

• Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer.

  Prostate cancer and prostatic diseases 20050101

• Pharmacokinetics and metabolism of irinotecan combined with capecitabine in patients with advanced colorectal cancer.

  Anticancer research 20050101

• Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients.

  Oncology 20050101

• Combination of oral fluoropyrimidine and docetaxel: reappraisal of synergistic effect against gastric carcinoma xenografts.

  In vivo (Athens, Greece) 20050101

• The use of capecitabine in cancer: management of the hand foot syndrome.

  Acta medica Indonesiana 20050101

• Phase I trial of an all-oral combination chemotherapy regimen: topotecan and capecitabine in solid tumor patients.

  The Journal of oncology management : the official journal of the American College of Oncology Administrators 20050101

• Adjuvant treatment strategies for early colon cancer.

  Drugs 20050101

• Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer.

  BMC cancer 20050101

• Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.

  Breast cancer research : BCR 20050101

• [Healing for more patients].

  Krankenpflege Journal 20050101

• [Adjuvant therapy of colon cancer soon in tablet form].

  Krankenpflege Journal 20050101

• A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy.

  BMC cancer 20050101

• [Acute coronary syndrome in a patient previously treated with capecitabine and 5-fluorouracil].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20050101

• [Thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in soft-tissue sarcoma versus capecitabine potential].

  Voprosy onkologii 20050101

• Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer.

  Oncology 20050101

• Myelopathy after radiation therapy and chemotherapy with capecitabine and gemcitabine.

  Cancer investigation 20050101

• First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study.

  BMC cancer 20050101

• Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes.

  Oncology 20050101

• The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20050101

• Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancer.

  Acta oncologica (Stockholm, Sweden) 20050101

• Mitomycin C and capecitabine combination (MiXe) in heavily pretreated metastatic breast cancer patients. A dose-finding study.

  Anticancer research 20050101

• Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients?

  Cancer treatment reviews 20050101

• How to maximize the efficacy of taxanes in breast cancer.

  Cancer treatment reviews 20050101

• Advances in the treatment of metastatic colorectal cancer.

  The oncologist 20050101

• Evolving chemotherapy for advanced gastric cancer.

  The oncologist 20050101

• A dose escalation study of pegylated liposomal Doxorubicin (caelyx) in combination with capecitabine (xeloda) in patients with refractory solid tumors.

  Oncology 20050101

• Chemotherapy for colorectal cancer.

  Digestive surgery 20050101

• State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments.

  German medical science : GMS e-journal 20050101

• Lapatinib: the evidence for its therapeutic value in metastatic breast cancer.

  Core evidence 20050101

• A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study.

  British journal of cancer 20041213

• Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors.

  British journal of cancer 20041213

• Prodrug research: futile or fertile?

  Biochemical pharmacology 20041201

• Antimetastatic and anticancer activity of S-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer model.

  International journal of oncology 20041201

• Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99).

  Annals of oncology : official journal of the European Society for Medical Oncology 20041201

• Methods to assess tissue-specific distribution and metabolism of drugs.

  Current drug metabolism 20041201

• Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.

  Expert review of anticancer therapy 20041201

• [Significance of tissue thymidine phosphorylase and dihydropyrimidine dehydrogenase activities in ovarian cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041201

• Francisella tularensis peritonitis in stomach cancer patient.

  Emerging infectious diseases 20041201

• Gemcitabine and docetaxel in metastatic breast cancer.

  Oncology (Williston Park, N.Y.) 20041201

• Irinotecan, epirubicin, and capecitabine in metastatic adenocarcinomas: preliminary results of a phase I study.

  Oncology (Williston Park, N.Y.) 20041201

• Combined-modality therapy of rectal cancer with irinotecan-based regimens.

  Oncology (Williston Park, N.Y.) 20041201

• The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer.

  Seminars in oncology 20041201

• [Oxaliplatin plus capecitabine as a second line chemotherapy for patients with advanced gastric cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20041201

• Modelling and simulation in the development and use of anti-cancer agents: an underused tool?

  Journal of pharmacokinetics and pharmacodynamics 20041201

• Prospective phase II study of preoperative chemoradiation with capecitabine in locally advanced rectal cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20041201

• Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer.

  British journal of cancer 20041115

• Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma.

  British journal of cancer 20041115

• Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine.

  International journal of colorectal disease 20041101

• Lack of contribution of dihydrofluorouracil and alpha-fluoro-beta-alanine to the cytotoxicity of 5'-deoxy-5-fluorouridine on human keratinocytes.

  Anti-cancer drugs 20041101

• A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20041101

• Overview of bevacizumab: a new cancer therapeutic strategy targeting vascular endothelial growth factor.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041101

• Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program.

  Breast cancer research and treatment 20041101

• Synthesis of [18F]Xeloda as a novel potential PET radiotracer for imaging enzymes in cancers.

  Nuclear medicine and biology 20041101

• Chemotherapy in metastatic colorectal cancer.

  Techniques in coloproctology 20041101

• Innovative therapy for patients with brain metastases: oral treatments.

  Journal of chemotherapy (Florence, Italy) 20041101

• [Cardiotoxicity of 5-fluorouracil].

  Bulletin du cancer 20041101

• Targeting angiogenesis in cancer: clinical development of bevacizumab.

  Nature clinical practice. Oncology 20041101

• Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum.

  International journal of cancer 20041020

• Accelerated approval of oncology products: a decade of experience.

  Journal of the National Cancer Institute 20041020

• Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil.

  British journal of cancer 20041018

• Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer.

  British journal of cancer 20041018

• A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041015

• Identification of the cytosolic carboxylesterase catalyzing the 5'-deoxy-5-fluorocytidine formation from capecitabine in human liver.

  Drug metabolism and disposition: the biological fate of chemicals 20041001

• Sulfasalazine down-regulates the expression of the angiogenic factors platelet-derived endothelial cell growth factor/thymidine phosphorylase and interleukin-8 in human monocytic-macrophage THP1 and U937 cells.

  Molecular pharmacology 20041001

• Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy.

  Journal of clinical pharmacology 20041001

• [Advances in palliative and adjuvant chemotherapy of colon cancer].

  Deutsche medizinische Wochenschrift (1946) 20041001

• Studies of synergistic and antagonistic combinations of conventional cytotoxic agents with the multiple eicosanoid pathway modulator LY 293111.

  Anti-cancer drugs 20041001

• Molecular approach to breast cancer treatment.

  Seminars in oncology 20041001

• Optimizing the management of HER2-negative metastatic breast cancer with capecitabine (Xeloda).

  Seminars in oncology 20041001

• Maximizing clinical benefit with trastuzumab.

  Seminars in oncology 20041001

• Future options with capecitabine (Xeloda) in (neo)adjuvant treatment of breast cancer.

  Seminars in oncology 20041001

• Survival benefit with capecitabine/docetaxel versus docetaxel alone: analysis of therapy in a randomized phase III trial.

  Clinical breast cancer 20041001

• Final results of a phase II clinical trial of weekly docetaxel in combination with capecitabine in anthracycline-pretreated metastatic breast cancer.

  Clinical breast cancer 20041001

• [Peritoneal dissemination of ovarian cancer and tumor angiogenesis].

  Nihon rinsho. Japanese journal of clinical medicine 20041001

• Anthracycline vs nonanthracycline adjuvant therapy for breast cancer.

  Oncology (Williston Park, N.Y.) 20041001

• [The thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio in pancreatic cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20041001

• Costs of treatment of colorectal cancer in different settings in Germany.

  The European journal of health economics : HEPAC : health economics in prevention and care 20041001

• Simple determination of capecitabine and its metabolites by liquid chromatography with ultraviolet detection in a single injection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040925

• A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer.

  British journal of cancer 20040913

• Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice.

  Journal of cancer research and clinical oncology 20040901

• Cytotoxic chemotherapy for metastatic renal cell carcinoma.

  Der Urologe. Ausg. A 20040901

• Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20040901

• A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040901

• Thymidylate synthase: a critical target in cancer therapy?

  Frontiers in bioscience : a journal and virtual library 20040901

• Current status of clinical studies for colorectal cancer in Taiwan.

  Clinical colorectal cancer 20040901

• Evidence-based update of chemotherapy options for metastatic colorectal cancer.

  ANZ journal of surgery 20040901

• [New drugs for colorectal cancer].

  Praxis 20040901

• Peripheral neuropathy associated with capecitabine.

  Anti-cancer drugs 20040901

• [Capecitabine combined with TACE for advanced liver cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20040901

• Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial.

  British journal of cancer 20040831

• Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer.

  British journal of cancer 20040831

• Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation.

  British journal of cancer 20040816

• Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study.

  British journal of cancer 20040816

• Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer.

  British journal of cancer 20040802

• Severe disabling sensory-motor polyneuropathy during oxaliplatin-based chemotherapy.

  Anti-cancer drugs 20040801

• Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.

  Cancer 20040801

• Effect of capecitabine on mean corpuscular volume in patients with metastatic breast cancer.

  American journal of clinical oncology 20040801

• Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane.

  Journal of Korean medical science 20040801

• Simultaneous determination of capecitabine and its metabolite 5-fluorouracil by column switching and liquid chromatographic/tandem mass spectrometry.

  Journal of mass spectrometry : JMS 20040801

• Coming to grips with hand-foot syndrome. Insights from clinical trials evaluating capecitabine.

  Oncology (Williston Park, N.Y.) 20040801

• Cost of managing women presenting with stage IV breast cancer in the United Kingdom.

  British journal of cancer 20040705

• Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5'-deoxy-5-fluorocytidine formation.

  Drug metabolism and disposition: the biological fate of chemicals 20040701

• Efficacy of adjuvant capecitabine compared with bolus 5-fluorouracil/leucovorin regimen in dukes C colon cancer: results from the X-ACT trial.

  Clinical colorectal cancer 20040701

• Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.

  Japanese journal of clinical oncology 20040701

• Capecitabine-induced abnormalities in thyroid function tests.

  The American journal of medicine 20040615

• Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615

• Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer.

  British journal of cancer 20040614

• Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.

  International journal of radiation oncology, biology, physics 20040601

• Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study.

  British journal of cancer 20040601

• An immediate hemolytic reaction induced by repeated administration of oxaliplatin.

  Transfusion 20040601

• Phase II study of capecitabine in patients with fluorouracil-resistant metastatic colorectal carcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040601

• XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040601

• Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040601

• Noninvasive measurements of capecitabine metabolism in bladder tumors overexpressing thymidine phosphorylase by fluorine-19 magnetic resonance spectroscopy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040601

• Combined-modality therapy of rectal cancer with oxaliplatin-based regimens.

  Clinical colorectal cancer 20040601

• Oxaliplatin plus oral fluoropyrimidines in colorectal cancer.

  Clinical colorectal cancer 20040601

• [New therapy options in colorectal carcinoma].

  Therapeutische Umschau. Revue therapeutique 20040601

• [Single-agent Xeloda in the treatment of recurrent and metastatic breast cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20040601

• Nail changes during docetaxel containing combination chemotherapy.

  The Korean journal of internal medicine 20040601

• Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer.

  British journal of cancer 20040504

• Tumor lysis syndrome following a single dose of capecitabine.

  The Annals of pharmacotherapy 20040501

• New cytotoxic and molecular-targeted therapies of head and neck tumors.

  Current opinion in oncology 20040501

• Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).

  Lung cancer (Amsterdam, Netherlands) 20040501

• A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer.

  Gynecologic oncology 20040501

• Enzyme expression profiles suggest the novel tumor-activated fluoropyrimidine carbamate capecitabine (Xeloda) might be effective against papillary thyroid cancers of children and young adults.

  Cancer chemotherapy and pharmacology 20040501

• Potential for predicting toxicity and response of fluoropyrimidines in patients.

  Current drug targets 20040501

• Liver transplantation for unresectable perihilar cholangiocarcinoma.

  Seminars in liver disease 20040501

• Phase II trial of capecitabine/irinotecan and capecitabine/oxaliplatin in advanced gastrointestinal cancers.

  Clinical colorectal cancer 20040501

• Progress in the development of novel treatments for colorectal cancer.

  Oncology (Williston Park, N.Y.) 20040501

• Current strategies in previously untreated advanced colorectal cancer.

  Oncology (Williston Park, N.Y.) 20040501

• Current status of adjuvant therapy for colorectal cancer.

  Oncology (Williston Park, N.Y.) 20040501

• A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.

  British journal of cancer 20040419

• New systemic frontline treatment for metastatic colorectal carcinoma.

  Cancer 20040415

• Unusual abdominal tumors, case 1. Pseudomyxoma peritonei: response to capecitabine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040415

• Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial.

  British journal of cancer 20040405

• A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer.

  British journal of cancer 20040405

• A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer.

  Investigational new drugs 20040401

• CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique.

  International journal of radiation oncology, biology, physics 20040401

• Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neck.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20040401

• Single ascending dose tolerability, pharmacokinetic-pharmacodynamic study of dihydropyrimidine dehydrogenase inhibitor Ro 09-4889.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040401

• [Phase I clinical trial evaluation of capecitabine in concurrent combination of radiotherapy in nasopharyngeal carcinoma].

  Ai zheng = Aizheng = Chinese journal of cancer 20040401

• A pilot phase II study of capecitabine in advanced or recurrent colorectal cancer.

  Japanese journal of clinical oncology 20040401

• Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands.

  Clinical therapeutics 20040401

• Pharmacogenetics of neoplastic diseases: new trends.

  Pharmacological research 20040401

• [Phase I study of capecitabine with concurrent radiotherapy in early-stage nasopharyngeal carcinoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20040401

• [Severe toxicity after treatment with capecitabine and fluorouracil due to partial dihydropyrimidine dehydrogenase deficiency].

  Nederlands tijdschrift voor geneeskunde 20040327

• Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials.

  British journal of cancer 20040322

• Capecitabine induces severe angina-like chest pain.

  Annals of internal medicine 20040316

• Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.

  European journal of cancer (Oxford, England : 1990) 20040301

• Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040301

• Inflammation of actinic keratoses during capecitabine therapy.

  Archives of dermatology 20040301

• Thymidine phosphorylase and fluoropyrimidines efficacy: a Jekyll and Hyde story.

  Current medicinal chemistry. Anti-cancer agents 20040301

• Fulvestrant and the sequential endocrine cascade for advanced breast cancer.

  British journal of cancer 20040301

• Management of endocrine resistant breast cancer.

  The journal of the British Menopause Society 20040301

• Systemic treatment of advanced colorectal carcinoma.

  European journal of gastroenterology & hepatology 20040301

• Thymidine phosphorylase expression is preserved after radiotherapy in patients with cervical squamous cell carcinoma.

  Cancer chemotherapy and pharmacology 20040201

• Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine: a phase II trial.

  Cancer 20040201

• Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040201

• Unexpected toxicities in elderly patients treated with oral idarubicin in metastatic breast cancer: the GINECO experience.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20040201

• Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer.

  Health technology assessment (Winchester, England) 20040201

• Serious hand-and-foot syndrome in black patients treated with capecitabine: report of 3 cases and review of the literature.

  Cutis 20040201

• [First-line Xeloda (Capecitabine) treatment for advanced and recurrent colorectal cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20040201

• Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer.

  Japanese journal of clinical oncology 20040201

• The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors.

  Anti-cancer drugs 20040201

• A phase II Japanese study of a modified capecitabine regimen for advanced or metastatic colorectal cancer.

  Anti-cancer drugs 20040201

• UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer.

  British journal of cancer 20040126

• Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity.

  British journal of cancer 20040126

• Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma.

  Cancer 20040115

• [Therapy of colorectal carcinoma. To combine saves lives].

  MMW Fortschritte der Medizin 20040115

• Angiogenesis inhibitors in clinical development; where are we now and where are we going?

  British journal of cancer 20040112

• Trastuzumab-based combination therapy for breast cancer.

  Expert opinion on pharmacotherapy 20040101

• [Principles of postoperative therapy in rectal carcinoma].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20040101

• Capecitabine-induced coronary vasospasm--a case report.

  Angiology 20040101

• Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy.

  Neuro-oncology 20040101

• Management of colorectal cancer in elderly patients: focus on the cost of chemotherapy.

  Drugs & aging 20040101

• Treatment of colorectal cancer metastasis: the role of chemotherapy.

  Cancer metastasis reviews 20040101

• Complete response of severe symptomatic bone marrow metastases from heavily pretreated breast cancer with a 3-weekly trastuzumab schedule. A clinical case.

  Anticancer research 20040101

• The role of new agents in the treatment of colorectal cancer.

  Oncology 20040101

• Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?

  Breast cancer research : BCR 20040101

• Molecules magic ballet. Two Italian contributions.

  Bollettino chimico farmaceutico 20040101

• [Oral capecitabine therapy: experience and developments at the Milano Cancer Institute].

  Tumori 20040101

• Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer.

  Acta oncologica (Stockholm, Sweden) 20040101

• New chemotherapeutic advances in pancreatic, colorectal, and gastric cancers.

  The oncologist 20040101

• Bevacizumab in the treatment of breast cancer: rationale and current data.

  The oncologist 20040101

• [Capecitabine and irinotecan].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group.

  Breast cancer research : BCR 20040101

• Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors.

  Oncology 20040101

• Toxic encephalopathy induced by capecitabine.

  Oncology 20040101

• Inflammatory metastatic carcinoma of the colon: a case report and review of the literature.

  Tumori 20040101

• Liver insufficiency due to breast cancer metastases--fast biological response with capecitabine.

  Acta oncologica (Stockholm, Sweden) 20040101

• Randomized phase II study comparing mitomycin, cisplatin plus doxifluridine with cisplatin plus doxifluridine in advanced unresectable gastric cancer.

  Anticancer research 20040101

• First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer.

  Oncology 20040101

• Development of and clinical experience with capecitabine (Xeloda) in the treatment of solid tumours.

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101

• Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda).

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101

• Management of hand-foot syndrome in patients treated with capecitabine (Xeloda).

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101

• The vital role of education and information in patients receiving capecitabine (Xeloda).

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101

• Implementation of capecitabine (Xeloda) into a cancer centre: UK experience.

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101

• Implications of capecitabine (Xeloda) for cancer nursing practice.

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101

• Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.

  Medical oncology (Northwood, London, England) 20040101

• Combination therapy with capecitabine and interferon alfa-2A in patients with advanced renal cell carcinoma: a phase II study.

  Urologic oncology 20040101

• Neoadjuvant therapy of rectal cancer new treatment perspectives.

  Tumori 20040101

• [Adjuvant therapy of colonic carcinoma--soon in tablet form].

  Krankenpflege Journal 20040101

• New targets for therapy in breast cancer: farnesyltransferase inhibitors.

  Breast cancer research : BCR 20040101

• Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial.

  Oncology 20040101

• Capecitabine plus docetaxel combination chemotherapy for metastatic breast cancer.

  Breast cancer (Tokyo, Japan) 20040101

• Capecitabine: fixed daily dose and continuous (noncyclic) dosing schedule.

  Cancer investigation 20040101

• [Recent results of irinotecan therapy in colorectal cancer].

  Magyar onkologia 20040101

• [ASCO Annual Meeting 2004, New Orleans. Capecitabine in adjuvant therapy of colorectal carcinoma: first... the evidence].

  Tumori 20040101

• Oral fluoropyrimidines in colorectal cancer: a door open to the future?

  Acta gastro-enterologica Belgica 20040101

• Systemic treatment of colorectal cancer in Serbia: what have we done and what can we offer in the new century?

  Acta chirurgica Iugoslavica 20040101

• Neoadjuvant treatment for locally advanced rectal adenocarcinoma with concomitant radiotherapy and oral capecitabine.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20040101

• The RACOX phase I study: radiation (RA), capecitabine (C) and oxaliplatin (OX) as adjuvant treatment of stage II and III rectal cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20040101

• Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20031201

• [Pharmacological and clinical properties of Xeloda (Capecitabine), a new oral active derivative of fluoropyrimidine].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20031201

• A Phase II study of weekly irinotecan and capecitabine in patients with previously treated non-small cell lung cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20031201

• Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20031201

• Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function.

  Onkologie 20031201

• [Focus on cellular pharmacology of docetaxel].

  Bulletin du cancer 20031201

• Introduction. Single-agent or combination chemotherapy in metastatic breast cancer.

  Oncology (Williston Park, N.Y.) 20031201

• Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.

  Clinical advances in hematology & oncology : H&O 20031201

• A phase II trial of capecitabine (Xeloda) in recurrent ovarian cancer.

  British journal of cancer 20031117

• In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength.

  Cancer research 20031115

• The potential for oral combination chemotherapy of 5'-deoxy-5-fluorouridine, a 5-FU prodrug, and cyclophosphamide for metastatic breast cancer.

  British journal of cancer 20031103

• Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics.

  British journal of cancer 20031103

• High incidence of severe hand-foot syndrome during capecitabine-docetaxel combination chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20031101

• A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma.

  Cancer 20031101

• Capecitabine monotherapy and in combination with immunotherapy in the treatment of metastatic renal cell carcinoma.

  Anti-cancer drugs 20031101

• Complete response of brain metastases originating in breast cancer to capecitabine therapy.

  The Israel Medical Association journal : IMAJ 20031101

• Response of neoplastic meningitis from solid tumors to oral capecitabine.

  Journal of neuro-oncology 20031101

• [Combined preoperative xeloda and radiotherapy for lower rectal cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20031101

• Integrating oxaliplatin and capecitabine in adjuvant therapy of high-risk colorectal cancer.

  Clinical colorectal cancer 20031101

• Development of new agents for the treatment of advanced colorectal cancer.

  Clinical colorectal cancer 20031101

• Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly.

  British journal of cancer 20031020

• Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.

  British journal of cancer 20031020

• Supportive care of the older cancer patient.

  Critical reviews in oncology/hematology 20031015

• ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20031015

• Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20031001

• Review article: colorectal cancer chemotherapy.

  Alimentary pharmacology & therapeutics 20031001

• Systemic therapy for colorectal cancer: focus on newer chemotherapy and novel agents.

  Seminars in radiation oncology 20031001

• Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer.

  Seminars in radiation oncology 20031001

• Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889.

  International journal of cancer 20030920

• [Tumor specific therapy. Targeted breast cancer therapy].

  MMW Fortschritte der Medizin 20030918

• Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030915

• Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.

  Cancer 20030915

• Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer.

  Cancer chemotherapy and pharmacology 20030901

• Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil.

  British journal of cancer 20030901

• Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030901

• Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030901

• Onycholysis with the appearance of a 'sunset' secondary to capecitabine.

  Cutis 20030901

• [Chemotherapy for colon cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20030901

• [Doxifluridine for treatment of colorectal cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20030901

• [Intravenous continuous infusion of fluorouracil for treatment of metastatic colorectal cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20030901

• [Present status of chemotherapy for colorectal cancer in countries outside of Japan].

  Nihon rinsho. Japanese journal of clinical medicine 20030901

• [Adjuvant chemotherapy for colorectal carcinoma after curative resection].

  Nihon rinsho. Japanese journal of clinical medicine 20030901

• Onycholysis associated with capecitabine in combination with irinotecan in two patients with colorectal cancer.

  Journal of the National Cancer Institute 20030820

• Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports.

  British journal of cancer 20030818

• Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030815

• [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].

  Ugeskrift for laeger 20030811

• Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer.

  International journal of radiation oncology, biology, physics 20030801

• Multicenter phase II study of oral capecitabine (Xeloda(')) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030801

• COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: esophagus, stomach, and pancreas.

  American journal of clinical oncology 20030801

• Capecitabine: new indication. In breast cancer: inadequately assessed.

  Prescrire international 20030801

• Capecitabine-induced pancreatitis.

  Pharmacotherapy 20030801

• Oxaliplatin and capecitabine chemotherapy for advanced colorectal cancer: a single institution's experience.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20030801

• Capecitabine-induced potentiation of warfarin.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20030801

• Lethal toxicity of capecitabine due to abusive folic acid prescription?

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20030801

• Capecitabine in combination with irinotecan or oxaliplatin in advanced colorectal cancer.

  Clinical colorectal cancer 20030801

• Capecitabine-related neurotoxicity presenting as trismus.

  Clinical colorectal cancer 20030801

• Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II study.

  Anti-cancer drugs 20030801

• Current and ongoing trials with irinotecan in the United States.

  Seminars in oncology 20030801

• Capecitabine in colorectal, breast, and other solid tumors: novel therapeutic approaches. Selected abstracts from ASCO 2003.

  Oncology (Williston Park, N.Y.) 20030801

• Isolation of an unknown metabolite of capecitabine, an oral 5-fluorouracil prodrug, and its identification by nuclear magnetic resonance and liquid chromatography-tandem mass spectrometry as a glucuroconjugate of 5'-deoxy-5-fluorocytidine, namely 2'-(beta-D-glucuronic acid)-5'-deoxy-5-fluorocytidine.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030725

• Rapid deterioration in quality of life during interleukin-2- and alpha-interferon-based home therapy of renal cell carcinoma is associated with a good outcome.

  British journal of cancer 20030707

• A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines.

  International journal of oncology 20030701

• Locally advanced acinar cell carcinoma of the pancreas successfully treated by capecitabine and concurrent radiotherapy: report of two cases.

  Pancreas 20030701

• Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030701

• A case of paraneoplastic nephrotic syndrome in a patient with ovarian carcinoma.

  Yonsei medical journal 20030630

• Thalidomide therapy for renal cell carcinoma.

  Critical reviews in oncology/hematology 20030627

• Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer.

  British journal of cancer 20030616

• [Oral fluoropyrimidines in the treatment of colorectal carcinoma].

  Deutsche medizinische Wochenschrift (1946) 20030613

• Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancer.

  British journal of cancer 20030602

• A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy.

  Oral oncology 20030601

• An EORTC phase I study of capecitabine (Xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer.

  European journal of cancer (Oxford, England : 1990) 20030601

• Practical considerations in the use of oral fluoropyrimidines.

  Seminars in oncology 20030601

• A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer.

  Clinical breast cancer 20030601

• NICE recommends new treatment for breast and bowel cancer.

  BMJ (Clinical research ed.) 20030531

• Hypersensitivity and idiosyncratic reactions to oxaliplatin.

  Cancer 20030501

• Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030501

• Exudative hyponychial dermatitis associated with capecitabine and docetaxel combination chemotherapy for metastatic breast carcinoma: report of three cases.

  The British journal of dermatology 20030501

• Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experience.

  Investigational new drugs 20030501

• Phase I-II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer.

  British journal of cancer 20030422

• Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer.

  British journal of cancer 20030407

• Current Canadian experience with capecitabine: partnering with patients to optimize therapy.

  Cancer nursing 20030401

• Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030401

• Monotherapy options in the management of metastatic breast cancer.

  Seminars in oncology 20030401

• Role of capecitabine (Xeloda) in breast cancer.

  Expert review of anticancer therapy 20030401

• A pilot study of edrecolomab (Panorex, 17-1A antibody) and capecitabine in patients with advanced or metastatic adenocarcinoma.

  Cancer investigation 20030401

• Trastuzumab-based combinations in metastatic breast cancer: how to make a choice.

  Clinical breast cancer 20030401

• The evolving role of capecitabine in breast cancer.

  Clinical breast cancer 20030401

• Treatment of a patient with advanced esophageal cancer with a combination of mitomycin C and capecitabine: activation of the thymidine phosphorylase as active principle?

  Onkologie 20030401

• Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity.

  British journal of cancer 20030324

• Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.

  Bioorganic & medicinal chemistry letters 20030310

• Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer.

  British journal of cancer 20030310

• EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer.

  British journal of cancer 20030310

• Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma.

  Cancer 20030301

• Population pharmacokinetics and concentration-effect relationships of capecitabine metabolites in colorectal cancer patients.

  British journal of clinical pharmacology 20030301

• High-throughput genotyping by DHPLC of the dihydropyrimidine dehydrogenase gene implicated in (fluoro)pyrimidine catabolism.

  International journal of oncology 20030201

• Capecitabine treatment results in increased mean corpuscular volume of red blood cells in patients with advanced solid malignancies.

  Anti-cancer drugs 20030201

• Capecitabine induces rapid, sustained response in two patients with extensive oral verrucous carcinoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030201

• Hormone-refractory prostate cancer responding to capecitabine.

  Urology 20030201

• The combination of capecitabine and oxaliplatin in metastatic colorectal cancer.

  Clinical colorectal cancer 20030201

• Design and analysis of non-inferiority mortality trials in oncology.

  Statistics in medicine 20030130

• Liquid chromatography-mass spectrometry method for the analysis of the anti-cancer agent capecitabine and its nucleoside metabolites in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030105

• Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030101

• A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors.

  Cancer 20030101

• Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030101

• Capecitabine: a review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer.

  Drugs 20030101

• Capecitabine and PPE syndrome: a case report.

  The breast journal 20030101

• Docetaxel-related skin, nail, and vascular toxicity.

  The Annals of pharmacotherapy 20030101

• Unusual case of bowel infarction with invasive Aspergillus in an immunocompromised patient.

  Annals of the Academy of Medicine, Singapore 20030101

• Cardiotoxicity and capecitabine: a case report.

  Clinical journal of oncology nursing 20030101

• 25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on clinical research.

  Breast cancer research : BCR 20030101

• Recent advances in colorectal cancer therapy.

  Cancer biology & therapy 20030101

• Thymidine phosphorylase expressed in macrophages enhances antitumor effect of 5'-deoxy-5-fluorouridine on human colorectal carcinoma cells.

  Anticancer research 20030101

• A pilot phase II study of capecitabine in advanced or recurrent gastric cancer.

  Oncology 20030101

• [Metastatic breast cancer].

  Krankenpflege Journal 20030101

• Population-based pharmacoeconomic model for adopting capecitabine/docetaxel combination treatment for anthracycline-pretreated metastatic breast cancer.

  The oncologist 20030101

• [Experience with xeloda (capecitabine) as a component of chemotherapy for relapsing cisplatin-resistant ovarian tumors].

  Voprosy onkologii 20030101

• Radiological measurement of breast cancer metastases to lung and liver: comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines.

  Journal of computer assisted tomography 20030101

• Metastatic colorectal cancer: systemic treatment in the new millennium.

  Cancer control : journal of the Moffitt Cancer Center 20030101

• Irinotecan in metastatic colorectal cancer: dose intensification and combination with new agents, including biological response modifiers.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030101

• [Capecitabine: an oral chemotherapeutic agent against metastatic breast and colorectal cancer].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20030101

• Cardiac toxicity associated with capecitabine therapy.

  Acta oncologica (Stockholm, Sweden) 20030101

• Treatment of advanced disease and new drugs.

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20030101

• Xeloda and Taxotere: a review of the development of the combination for use in metastatic breast cancer.

  International journal of clinical practice 20030101

• Palliative chemotherapy after failure of high-dose chemotherapy in breast cancer--toxicity and efficacy.

  Anticancer research 20030101

• Prodrugs in genetic chemoradiotherapy.

  Current pharmaceutical design 20030101

• [The update on pancreatic cancer chemotherapy].

  Medicina (Kaunas, Lithuania) 20030101

• American Society for Clinical Oncology 39th Annual Meeting, Chicago, Illinois, USA, 31 May to 3 June 2003: breast cancer neoadjuvant and adjuvant chemotherapy--prognostic and predictive markers.

  Breast cancer research : BCR 20030101

• Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation.

  Health technology assessment (Winchester, England) 20030101

• Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives.

  Tumori 20030101

• Forced expression of cytidine deaminase confers sensitivity to capecitabine.

  Oncology 20030101

• [Use of xeloda (capecitabine) in the treatment of cancer patients (review)].

  Terapevticheskii arkhiv 20030101

• Complete and sustained remission of refractory cervical cancer following a single cycle of capecitabine. A case report.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101

• Pharmacology of oral chemotherapy agents.

  Clinical journal of oncology nursing 20030101

• Medication sheets for patients. Oral chemotherapy.

  Clinical journal of oncology nursing 20030101

• New developments in systemic chemotherapy in advanced colorectal cancer.

  Scandinavian journal of gastroenterology. Supplement 20030101

• [Systemic treatment of colorectal cancers--factual standards and perspectives].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20030101

• Short-time infusion of oxaliplatin (Eloxatin) in combination with capecitabine (Xeloda) in patients with advanced colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20030101

• The rational principles of neo-adjuvant therapy for rectal cancer.

  Acta bio-medica : Atenei Parmensis 20030101

• Colon cancer with isolated metastasis to the kidney at the time of initial diagnosis.

  International journal of gastrointestinal cancer 20030101

• Fluorouracil for allergic reactions to capecitabine.

  The Annals of pharmacotherapy 20021201

• Pyogenic granuloma-like lesions during capecitabine therapy.

  The British journal of dermatology 20021201

• Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021201

• Penetration of capecitabine and its metabolites into malignant and healthy tissue of patients with advanced breast cancer.

  International journal of clinical pharmacology and therapeutics 20021201

• [Progress in adjuvant therapy for colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20021201

• Capecitabine/irinotecan in colorectal cancer: European early-phase data and planned trials.

  Oncology (Williston Park, N.Y.) 20021201

• Current status of capecitabine in the treatment of colorectal cancer.

  Oncology (Williston Park, N.Y.) 20021201

• Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer?

  Oncology (Williston Park, N.Y.) 20021201

• Capecitabine and radiation therapy for advanced gastrointestinal malignancies.

  Oncology (Williston Park, N.Y.) 20021201

• Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity.

  Oncology (Williston Park, N.Y.) 20021201

• Pemetrexed: an active new agent for breast cancer.

  Seminars in oncology 20021201

• Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials.

  Seminars in oncology 20021201

• Chemotherapy in biliary tract carcinomas: results in India.

  Seminars in oncology 20021201

• [Chemotherapy improves prognosis in colorectal carcinoma. Soon oral therapy at home?].

  MMW Fortschritte der Medizin 20021114

• Metabolism of capecitabine, an oral fluorouracil prodrug: (19)F NMR studies in animal models and human urine.

  Drug metabolism and disposition: the biological fate of chemicals 20021101

• CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations.

  Radiology 20021101

• New drugs for patients with pancreatic cancer.

  Current opinion in oncology 20021101

• Highlights from: 27th congress of the European Society for Medical Oncology. Nice, France. October 18-22, 2002.

  Clinical colorectal cancer 20021101

• [Therapy of colorectal carcinoma in internal medicine].

  Praxis 20021023

• Oral cancer treatment: developments in chemotherapy and beyond.

  British journal of cancer 20021021

• Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20021001

• Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021001

• Radiation recall dermatitis may represent the Koebner phenomenon.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021001

• Improved survival in advanced breast cancer with docetaxel and capecitabine in combination: biological synergy or an artefact of trial design?

  European journal of cancer (Oxford, England : 1990) 20021001

• Capecitabine named-patient programme for patients with advanced breast cancer. the UK experience.

  European journal of cancer (Oxford, England : 1990) 20021001

• Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021001

• Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies.

  American journal of clinical oncology 20021001

• The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions.

  Seminars in oncology 20021001

• Single-agent vs combination therapy in advanced breast cancer: potential roles of capecitabine.

  Oncology (Williston Park, N.Y.) 20021001

• Capecitabine and docetaxel in advanced breast cancer: analyses of a phase III comparative trial.

  Oncology (Williston Park, N.Y.) 20021001

• New directions with capecitabine combinations in advanced breast cancer.

  Oncology (Williston Park, N.Y.) 20021001

• Current and planned trials with capecitabine in adjuvant/neoadjuvant therapy of breast cancer.

  Oncology (Williston Park, N.Y.) 20021001

• Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation.

  Molecular cancer therapeutics 20021001

• A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020901

• Photoeruption in a patient treated with capecitabine (Xeloda) for metastatic breast cancer.

  Journal of the American Academy of Dermatology 20020901

• Transmission of apoptosis in human colorectal tumor cells exposed to capecitabine, Xeloda, is mediated via Fas.

  Molecular cancer therapeutics 20020901

• Capecitabine induced cutaneous hyperpigmentation: report of a case.

  Journal of drugs in dermatology : JDD 20020901

• Evidence for the use of chemotherapy in breast cancer.

  International journal of clinical oncology 20020801

• [Gemcitabine-based combinations in inoperable pancreatic cancers].

  Bulletin du cancer 20020801

• A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies.

  International journal of radiation oncology, biology, physics 20020701

• Treatment side effects. Case 1. Radiation recall phenomenon after administration of capecitabine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020701

• Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients.

  British journal of cancer 20020617

• Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020615

• [Oral fluoropyrimidines registered for the treatment of metastatic colorectal carcinoma: a possible gain].

  Nederlands tijdschrift voor geneeskunde 20020615

• Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer?

  British journal of cancer 20020605

• Capecitabine: fulfilling the promise of oral chemotherapy.

  Expert opinion on pharmacotherapy 20020601

• Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020601

• Advanced colorectal cancer treatment in Europe: what have we achieved?

  Anti-cancer drugs 20020601

• Present and future treatment of pancreatic cancer.

  Seminars in oncology 20020601

• The current status of docetaxel for metastatic breast cancer.

  Oncology (Williston Park, N.Y.) 20020601

• New studies highlight benefit of Xeloda in new combination treatments for colorectal cancer.

  Expert review of anticancer therapy 20020601

• Potential of capecitabine as first-line therapy for metastatic breast cancer: dosing recommendations in patients with diminished renal function.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020601

• Thymidine kinase in epithelial ovarian cancer: relationship with the other pyrimidine pathway enzymes.

  International journal of cancer 20020520

• Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines.

  British journal of cancer 20020506

• Systemic treatment of colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20020501

• Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020501

• Future directions in adjuvant therapy for rectal cancer.

  Oncology (Williston Park, N.Y.) 20020501

• Capecitabine (Xeloda): from the laboratory to the patient's home.

  Clinical colorectal cancer 20020501

• A phase II study of mitomycin C, cisplatin and continuous infusion 5-fluorouracil (MCF) in the treatment of patients with carcinoma of unknown primary site.

  British journal of cancer 20020422

• Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.

  Cancer research 20020415

• [Current trends in pharmacotherapy of breast cancer].

  Orvosi hetilap 20020407

• Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020401

• Acute oxaliplatin-induced peripheral nerve hyperexcitability.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020401

• The treatment of advanced colorectal cancer: where are we now and where do we go?

  Best practice & research. Clinical gastroenterology 20020401

• Capecitabine in patients with breast cancer relapsing after high-dose chemotherapy plus autologous peripheral stem cell transplantation--a phase II study.

  Anti-cancer drugs 20020401

• Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.

  Prescrire international 20020401

• Capecitabine as second-line treatment for metastatic cholangiocarcinoma: a report of two cases.

  Onkologie 20020401

• Capecitabine/irinotecan combination regimens in colorectal cancer.

  Oncology (Williston Park, N.Y.) 20020401

• Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients.

  Clinical breast cancer 20020401

• Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020401

• Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020401

• First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020401

• Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy.

  British journal of cancer 20020318

• Dear doctor: we really are not sure what dose of capecitabine you should prescribe for your patient.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020315

• The effect of adjuvant 5'-deoxy-5-fluorouridine in early stage breast cancer patients: results from a multicenter randomized controlled trial.

  International journal of oncology 20020301

• Xeloda. Warning: drug interaction increase bleeding risks.

  Nursing 20020301

• Antitumor activity of combinations of anti-HER-2 antibody trastuzumab and oral fluoropyrimidines capecitabine/5'-dFUrd in human breast cancer models.

  Cancer chemotherapy and pharmacology 20020301

• Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients.

  Cancer chemotherapy and pharmacology 20020301

• Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020301

• The prodrugs of 5-fluorouracil.

  Current medicinal chemistry. Anti-cancer agents 20020301

• An evolving role for oral fluoropyrimidine drugs.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020215

• Synthesis and biological activity of the new 5-fluorocytosine derivatives, 5'-deoxy-N-alkyloxycarbonyl-5-fluorocytosine-5'-carboxylic acid.

  Bioorganic & medicinal chemistry letters 20020211

• Rational development of capecitabine.

  European journal of cancer (Oxford, England : 1990) 20020201

• Clinical experience of capecitabine in metastatic breast cancer.

  European journal of cancer (Oxford, England : 1990) 20020201

• Capecitabine as first-line treatment in colorectal cancer. Pooled data from two large, phase III trials.

  European journal of cancer (Oxford, England : 1990) 20020201

• Future treatment options with capecitabine in solid tumours.

  European journal of cancer (Oxford, England : 1990) 20020201

• Recent development of anti-cancer drugs for treatment of GI malignancies in Japan.

  Gan to kagaku ryoho. Cancer & chemotherapy 20020201

• Prediction of the response of colorectal cancer to systemic therapy.

  The Lancet. Oncology 20020201

• Population pharmacokinetic analysis of the major metabolites of capecitabine.

  Journal of pharmacokinetics and pharmacodynamics 20020201

• Thymidylate synthase: a critical target for cancer chemotherapy.

  Clinical colorectal cancer 20020201

• [The new chemotherapy of colorectal cancers].

  Presse medicale (Paris, France : 1983) 20020126

• Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020115

• Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020101

• Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20020101

• Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020101

• Treatment of patients with superficial bladder cancer by intravesical instillation of anticancer drugs plus oral chemotherapy following TUR-Bt: a randomized controlled trial.

  Oncology reports 20020101

• Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experience.

  Cancer investigation 20020101

• Drug combination approved for advanced breast cancer.

  FDA consumer 20020101

• Taxanes and capecitabine in combination: rationale and clinical results.

  Clinical breast cancer 20020101

• Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.

  Oncology reports 20020101

• [Capecitabine (xeloda) in the treatment of relapsed and metastatic breast cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20020101

• Cutaneous drug reaction case reports: from the world literature.

  American journal of clinical dermatology 20020101

• Breast cancer: single agents chemotherapy.

  Tumori 20020101

• [New therapeutic prospects with capecitabin in breast carcinoma].

  Tumori 20020101

• Thymidine phosphorylase is regulated by tamoxifen in T47D breast cancer cell line.

  Breast cancer (Tokyo, Japan) 20020101

• Comparison of ELISA level and immunohistochemical status for thymidine phosphorylase (TP) in invasive breast carcinoma.

  Anticancer research 20020101

• Capecitabine in treatment of platinum-resistant recurrent ovarian cancer.

  Anticancer research 20020101

• Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer.

  International journal of colorectal disease 20020101

• Postoperative adjuvant chemotherapy is effective in gastric cancer with serosal invasion: significance in patients chosen for multivariate analysis.

  Oncology reports 20020101

• Oral fluoropyrimidines in the treatment of advanced colorectal cancer--results of two consecutive phase II trials.

  Acta oncologica (Stockholm, Sweden) 20020101

• Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review.

  The oncologist 20020101

• Eruptive multiple lentigo-maligna-like lesions in a patient undergoing chemotherapy with an oral 5-fluorouracil prodrug for metastasizing colorectal carcinoma: a lesson for the pathogenesis of malignant melanoma?

  Dermatology (Basel, Switzerland) 20020101

• Farnesyltransferase inhibitors in breast cancer therapy.

  Cancer investigation 20020101

• The search for enhanced therapeutic index in breast cancer: targeting the tumor and modulation of enzyme expression.

  Cancer investigation 20020101

• Incorporating oral capecitabine into the treatment of breast cancer. Introduction.

  The oncologist 20020101

• Treatment for anthracycline-pretreated metastatic breast cancer.

  The oncologist 20020101

• Combination versus sequential single-agent therapy in metastatic breast cancer.

  The oncologist 20020101

• Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer?

  The oncologist 20020101

• Moving forward with capecitabine: a glimpse of the future.

  The oncologist 20020101

• The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.

  Cancer treatment and research 20020101

• [Breast Cancer Conference. Trastuzumab and capecitabine in the treatment of advanced breast cancer. Milano, 6-7 June 2002].

  Tumori 20020101

• The rational development of capecitabine from the laboratory to the clinic.

  Anticancer research 20020101

• Chemotherapy in the elderly with breast cancer.

  Forum (Genoa, Italy) 20020101

• Combination chemotherapy of the taxanes and antimetabolites: its use and limitations.

  European journal of cancer (Oxford, England : 1990) 20011201

• Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokinetics.

  Cancer chemotherapy and pharmacology 20011201

• Capecitabine and oxaliplatin in advanced colorectal cancer: a dose-finding study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011201

• Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011201

• Clinical picture: leopard-like vitiligo with capecitabine.

  Lancet (London, England) 20011110

• From the Food and Drug Administration.

  JAMA 20011107

• Mucositis as a treatment-limiting side effect in the use of capecitabine for the treatment of metastatic breast cancer.

  Journal of the American Academy of Dermatology 20011101

• Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.

  Molecular pharmacology 20011101

• Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011101

• Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011101

• An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer.

  Breast cancer research and treatment 20011101

• Capecitabine combinations in the treatment of advanced colorectal cancer.

  Clinical colorectal cancer 20011101

• Thymidylate synthase pharmacogenetics in colorectal cancer.

  Clinical colorectal cancer 20011101

• An adverse interaction between warfarin and capecitabine: a case report and review of the literature.

  Clinical colorectal cancer 20011101

• [New therapeutic options in chemotherapy of advanced colorectal cancer].

  Medizinische Klinik (Munich, Germany : 1983) 20011015

• Strategies of medical treatment for metastatic breast cancer (Review).

  International journal of oncology 20011001

• Recent advances in the use of radiosensitizing nucleosides.

  Seminars in radiation oncology 20011001

• Nonsurgical treatment of hepatocellular carcinoma.

  Seminars in oncology 20011001

• Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients.

  Cancer 20011001

• Capecitabine in the management of colorectal cancer.

  Expert review of anticancer therapy 20011001

• [Recent aspects of palliative treatment of metastasized colorectal carcinoma].

  Medizinische Klinik (Munich, Germany : 1983) 20010915

• Role of thymidine phosphorylase in biomodulation of fluoropyrimidines.

  Current pharmaceutical biotechnology 20010901

• Onychomadesis and onycholysis associated with capecitabine.

  The British journal of dermatology 20010901

• Capecitabine: a novel agent for the treatment of solid tumors.

  Anti-cancer drugs 20010901

• Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010901

• Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer.

  American journal of clinical oncology 20010801

• New options for outpatient chemotherapy--the role of oral fluoropyrimidines.

  Cancer treatment reviews 20010801

• A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans: the mechanism for tumor-selective accumulation of 5-FU.

  Pharmaceutical research 20010801

• Oral fluoropyrimidine treatment of colorectal cancer.

  Clinical colorectal cancer 20010801

• Clinical colorectal cancer: oral chemotherapy comes of age.

  Clinical colorectal cancer 20010801

• [New aspects in chemotherapy of tumors of the digestive tract].

  Vnitrni lekarstvi 20010801

• New chemotherapy approaches in colorectal cancer.

  Current opinion in oncology 20010701

• Capecitabine monotherapy in metastatic colorectal cancer.

  The Lancet. Oncology 20010701

• Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[Prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug.

  Molecular pharmacology 20010601

• Oral fluoropyrimidines among the new drugs for patients with metastatic breast cancer.

  British journal of cancer 20010601

• [Tumoral levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in elderly colorectal cancer patients].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010601

• Xeloda in colorectal cancer.

  International journal of clinical practice 20010601

• Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA.

  International journal of cancer 20010501

• Renal cell carcinoma.

  Current opinion in oncology 20010501

• Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20010501

• A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010501

• Coronary spasm induced by capecitabine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010501

• 25th European Society for Medical Oncology Congress. Hamburg, Germany. October 13-17, 2000.

  Clinical colorectal cancer 20010501

• First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.

  Clinical colorectal cancer 20010501

• Advances in the treatment of metastatic colorectal cancer.

  Clinical colorectal cancer 20010501

• Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010415

• Schedule dependency of antitumor activity in combination therapy with capecitabine/5'-deoxy-5-fluorouridine and docetaxel in breast cancer models.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010401

• Metastatic breast cancer: understanding current management options.

  Oncology nursing forum 20010401

• [Capecitabine (Ro09-1978) for therapy of advanced and recurrent gastric cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20010401

• [Oral cytostatic drug in colorectal carcinoma. Selective tumor therapy at home].

  MMW Fortschritte der Medizin 20010329

• [Chemotherapy of colonic carcinoma in the year 2001].

  Praxis 20010322

• Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.

  European journal of cancer (Oxford, England : 1990) 20010301

• Current status of oral chemotherapy for colorectal cancer.

  Oncology (Williston Park, N.Y.) 20010301

• Future directions in adjuvant therapy for stage III colon carcinoma.

  Oncology (Williston Park, N.Y.) 20010301

• Fluorouracil and the new oral fluorinated pyrimidines.

  The Annals of pharmacotherapy 20010201

• 5-fluorouracil/leucovorin versus capecitabine in patients with stage III colon cancer.

  Seminars in oncology 20010201

• The significance of thymidine phosphorylase expression in colorectal cancer.

  Oncology reports 20010101

• Development and characterization of 1C6-203, a new monoclonal antibody specific to human thymidine phosphorylase.

  The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20010101

• The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancer.

  The oncologist 20010101

• Patient selection for oral chemotherapy.

  Oncology (Williston Park, N.Y.) 20010101

• Capecitabine in colorectal cancer.

  Oncology (Williston Park, N.Y.) 20010101

• Clinical status of capecitabine in the treatment of breast cancer.

  Oncology (Williston Park, N.Y.) 20010101

• Oral fluoropyrimidine-based combination therapy in gastrointestinal cancer.

  Oncology (Williston Park, N.Y.) 20010101

• The Twenty-third Annual San Antonio Breast Cancer Symposium.

  Current medical research and opinion 20010101

• Clinical pharmacokinetics of capecitabine.

  Clinical pharmacokinetics 20010101

• The oral fluorinated pyrimidines.

  Investigational new drugs 20010101

• [Capecitabine in the treatment of colorectal cancer].

  Tumori 20010101

• Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond.

  The oncologist 20010101

• [The potential of capecitabine (Xeloda) in the treatment of disseminated solid tumors].

  Voprosy onkologii 20010101

• [Docetaxel (Taxotere) in combination with anthracycline, capecitabin (Xeloda) and new drugs].

  Tumori 20010101

• The clinical pharmacology of the oral fluoropyrimidines.

  Current problems in cancer 20010101

• Thymidine phosphorylase expression and effect of doxifluridine: a phase II study.

  Oncology reports 20010101

• A randomized study comparing oral and standard regimens for metastatic breast cancer.

  Oncology reports 20010101

• Acute cardiotoxicity during capecitabine treatment: a case report.

  Tumori 20010101

• [Xeloda (capecetabine) in the treatment of disseminated breast cancer after failure with anthracyclines and taxanes].

  Voprosy onkologii 20010101

• Thymidine phosphorylase (TP) activation: convenience through innovation.

  The oncologist 20010101

• The evolution of fluoropyrimidine therapy: from intravenous to oral.

  The oncologist 20010101

• Answering patients' needs: oral alternatives to intravenous therapy.

  The oncologist 20010101

• Optimizing the use of irinotecan in colorectal cancer.

  The oncologist 20010101

• Integrating oxaliplatin into the management of colorectal cancer.

  The oncologist 20010101

• Improving chemoradiotherapy in rectal cancer.

  The oncologist 20010101

• Vision of the future: capecitabine.

  The oncologist 20010101

• [Coronary insufficiency after an oral intake of capecitabine].

  Gastroenterologie clinique et biologique 20010101

• Disease management considerations: disease management considerations.

  Drugs 20010101

• Dose scheduling--Herceptin.

  Oncology 20010101

• Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model.

  Biopharmaceutics & drug disposition 20010101

• Oral fluoropyrimidines: are they the equivalent of parenteral infusional 5-fluorouracil?

  Cancer investigation 20010101

• Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer.

  Drugs 20010101

• Use of capecitabine as first-line therapy in patients with metastatic breast cancer relapsing after high-dose chemotherapy and autologous stem cell support.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101

• Capecitabine in breast cancer: current status.

  Clinical breast cancer 20010101

• Capecitabine (Xeloda).

  Clinical journal of oncology nursing 20010101

• Present indications for adjuvant therapy in resectable rectal cancer.

  Annali italiani di chirurgia 20010101

• Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer.

  Tumori 20010101

• [Colorectal cancer: irinotecan in combination with newer drugs].

  Tumori 20010101

• The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.

  The oncologist 19990101